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ABSTRACT

Sullivan, Kelly L. Ph.D, Purdue University, May 2015. A Comparison of Functionally
Divergent Forms of the Purine Biosynthesis Enzyme PurE. Major Professor: T.J.
Kappock.

Purines are the basic building block for essential biomolecules such as DNA, RNA,
NADH, CoA, and several essential vitamin cofactors. Most organisms have the ability to
synthesize purines through the de novo purine biosynthesis pathway.
The de novo purine biosynthesis pathway contains a rare metabolic divergence within the
eukaryotes. Animals convert CO2 and aminoimidazole ribonucleotide (AIR) to
carboxyaminoimidazole ribonucleotide (CAIR) using the enzyme aminoimidazole
ribonucleotide carboxylase (PurE2), while other eukaryotes, archaea, and bacteria use
two enzymes, N5-carboxyaminoimidazole ribonucleotide synthetase (PurK) and N5carboxyaminoimidazole ribonucleotide (NCAIR) mutase, PurE (PurE1). PurE catalyzes
formation of the sole carbon-carbon bond formed during purine biosynthesis.
Both PurE classes are proposed to generate a carbon-carbon bond using similar
chemistry. We can monitor the carbon-carbon bond forming reaction in real-time using
changes in intrinsic fluorescence that report upon electrostatic changes within the active
site. To simplify fluorescence responses, we generated mutants of PurE1 from
Acetobacter aceti (AaPurE1-W34F,W165F) and PurE2 from Treponema denticola
(TdPurE2-F79W) that have a single tryptophan fluorophore, which responds to changes
upon ligand addition as assessed by fluorescence titrations. Surprisingly, a Tyr residue,

!

xv

with ambiguous electron density in a 1.35 Å AaPurE1-W34F,W165F structure,
contributes to fluorescence.
Both PurE1 and PurE2 have similar structures and active sites. A universally conserved
serine is the sole polar contact with the substrate aminoimidazole ring and any PurE side
chain. Serine donates a hydrogen bond to the aminoimidazole N3 but may flip polarity in
PurE2 at low pH. We generated a series of serine mutants in AaPurE1 and TdPurE2,
which confirm a hydrogen-bonding role for serine, as the mutants with the highest
detectable activity are able to donate (or accept, at low pH) a hydrogen bond. Serine is
more important for PurE2 function and its role appears to be different between the two
classes.
The PurE2 active site contains a strictly conserved, class-specific lysine. Due to the
difficult task of acquiring CO2 from solution, the lysine was proposed to form a
carboxylated intermediate in PurE2 catalysis. We generated the TdPurE2-K41R mutant,
which retained both AIR carboxylase and CAIR decarboxylase activity, indicating that
formation of a lysine-carbamate is not an obligatory intermediate for PurE2 function.
PurE2 catalyzes the formation of CAIR from AIR and CO2 without any detectable side
reaction. Functional complementation assays and a crystal structure both indicated the
“inactive” TdPurE2-H40N mutant may destroy AIR, CAIR, or both. We demonstrated
that this “inactive” mutant does indeed destroy AIR in a slow O2-dependent oxygenase
activity reaction.
Due to the unusual divergence in purine biosynthesis, PurE1 is a potential antimicrobial
target; however, no enzyme activity assay is suitable for high throughput screening. We
developed a simple chemical quench that fixes the PurE1 substrate/product ratio for 24 h,
as assessed by the Bratton-Marshall assay (BMA) for diazotizable amines. The ZnSO4
stopping reagent is proposed to chelate CAIR, allowing later analysis of this acid-labile
product by BMA or a high throughput screening methods.

1

CHAPTER 1 INTRODUCTION
!
!
1.1 Background and Significance
!
!
Purines are Essential in Biological Systems. Purine biosynthesis supplies the precursors
for RNA, DNA, and coenzymes like NADH and CoA. In addition, purines serve as
starting materials for vitamins like folic acid, B12, and riboflavin1 and for the universal
methylating agent and radical initiator S-adenosylmethionine.2
Prebiotic Purine Synthesis.! Organic compounds of biochemical significance, such as
amino acids, can be synthesized from simple inorganic precursors under conditions
thought to be resemble those on primitive Earth.3 Prebiotic syntheses precede evolution.
Purine synthesis requires an activated ribose and a base, each of which could have been
formed in a prebiotic era. Adenine can be formed from the oligomerization of hydrogen
cyanide and sugars can be produced from formaldehyde by the formose reaction.4,5
Biological evolution produces customized molecular interfaces, enzymes, and ultimately
multistep biochemical pathways.6,7
Purine Biosynthesis. Contemporary purine synthesis occurs by two routes, a salvage
pathway and the de novo purine biosynthetic pathway. The purine salvage pathway
couples an activated ribose, phosphoribosyl pyrophosphate (PRPP), with bases recovered
from the degradation of nucleic acids and nucleotides.8 While energy efficient, purine
salvage requires a ready source of purine heterocycles. When purine bases are not
available, purines are biosynthesized from PRPP and various small molecules, with
considerable energy input from ATP, by the de novo purine pathway (Figure 1.1).

!

2
Purine Biosynthesis May Have Evolved from Preexisting Pathways. New metabolic
pathways are composed of enzymes that acquire new functions or biochemical roles8 in
the context of existing metabolic pathways. New enzymes evolve from gene duplication
and functional diversification of ancestral genes. The extant purine biosynthetic pathway
appears to have been assembled from two older pathways, histidine and thiamine
biosynthesis, which unlike purine biosynthesis, have no alternative biosynthetic
pathways.
Histidine

biosynthesis

generates

5-aminoimidazole-4-carboxamide

ribonucleotide

9

(AICAR) as a byproduct. Ancient microbes may have evolved PurP and PurO enzymes
as a way to recycle AICAR from IMP.10 Thiamine contains a pyrimidine derived in all
organisms from aminoimidazole ribonucleotide (AIR).11,12 Cells require very little
thiamine, meaning the AIR demand for this biosynthesis is very low.13 Excess AIR is an
intrinsically reactive molecule and is actively eliminated from cells. This may have
spurred the evolution of PurE, PurK, PurC, and PurB as a “biosynthetic bridge” to
convert any excess AIR to AICAR. PurB was already necessary to convert
adenylosuccinate to AMP; it appears to have acquired a promiscuous function and an
additional role, in AICAR biosynthesis.14
Only a few molecules of thiamine are required for cell viability, which yields a very low
flux pathway (purines are required in a 1000:1 ratio over thiamine for growth).15 The
evolution of PurF, PurD, PurT, PurL (or its multiprotein equivalent PurSQL), and PurM
would provide a high flux route for AIR production well in excess of thiamine demand.
Finally, the folate-dependent enzymes (PurN and PurH) would have only evolved after
folate appeared. The formate dependent alternatives PurT and PurP would have been
available first, and some are still used, since archaea lack folates.10,16
In summary, the purine pathway likely “evolved backwards” from AICAR to AIR to
PRPP and was very clearly driven by the high demand for adequate purines for growth.

!

3
The de novo Purine Biosynthesis Pathway Contains a Rare Metabolic Divergence. The
modern de novo purine biosynthetic pathway requires either 10 or 11 enzymatic steps.
The additional step is catalyzed by PurK and represents a rare metabolic divergence in
the carboxylation of AIR to form 4-carboxy-5-aminoimidazole ribonucleotide (CAIR).
Animals convert CO2 and AIR to CAIR using a class II PurE (PurE2; AIR carboxylase,
EC 4.1.1.21) while other eukaryotes, archaea, and bacteria use two enzymes, PurK and
class I PurE (PurE1; N5-carboxy-AIR [NCAIR] mutase, EC 5.4.99.18) (Figure 1.2).17,18
PurE1 and PurE2 catalyze the formation of the sole carbon-carbon (C−C) bond installed
during purine biosynthesis. Other pathway steps build up the purine base by forming
C−N bonds.
Carbon-Carbon Bond Chemistry. Biochemistry is the study of the molecular basis of
biology. C−C bond formation is of central importance to all life. These covalent bonds
are generally formed by a complex process that requires the intermediate formation of a
negatively charged carbon atom (carbanion), which then functions as a nucleophile in a
subsequent condensation reaction. Carbanions are typically formed by either
decarboxylation or deprotonation of a carbon acid, which is difficult for both
thermodynamic (e.g., high pKa values) and kinetic reasons.19,20 Removal of the proton is
challenging, however, the key difficulty in carbanion generation may be controlling the
reactivity for this highly unstable species.
Decarboxylases. Decarboxylases catalyze the general reaction shown in equation 1.1,
which is almost always irreversible due to the entropy gain associated with the loss of
gaseous CO2. Decarboxylases lower the barrier to carbanion cleavage of a C−C bond, an
easier task than the one confronted by carboxylases (see below). Decarboxylations are
involved in many different biological processes: isocitrate dehydrogenase (TCA cycle),
thiolase (fatty acid synthesis), glycine cleavage system (glycine catabolism), orotidine 5′monophosphate decarboxylase (pyrimidine biosynthesis), acetoacetate decarboxylase
(ketone body metabolism), and pyruvate decarboxylase (fermentation).
R-CO2⊖ + H+ → R-H+ + CO2

!

Equation 1.1

4
Several decarboxylases have carbanion stabilization strategies similar to both PurE1 and
PurE2. Acetoacetate decarboxylase proceeds through a Schiff base intermediate that
stabilizes the carbanion formed by decarboxylation. The Schiff base stabilizes a
carbanion on the α-carbon (Figure 1.2A). Thiamine-dependent decarboxylases, like
pyruvate decarboxylase, stabilize the carbanion produced by loss of CO2 from α-keto
acids (Figure 1.2B). Again the carbanion is stabilized by resonance with an “electron
sink” a positively charged nitrogen adjacent to the decarboxylated carbon. PurE1 and
PurE2 both decarboxylate CAIR to form a similar resonance-stabilized carbanion βiminium zwitterion, from which CO2 does not immediately separate. Unlike most
decarboxylases, PurE1 and PurE2 are both a decarboxylase and a carboxylase.
!
Carboxylases. Carboxylases catalyze the general reaction shown in equation 1.2. They
solve two difficult challenges: forming carbanions and trapping CO2. Like
decarboxylases, carboxylases are involved in many different biological processes: acetylCoA carboxylase (fatty acid synthesis), pyruvate carboxylase (gluconeogenesis),
phosphoenolpyruvate carboxylase (TCA cycle), and Rubisco (photosynthesis).
R-H + CO2 → R-CO2⊖ + H+

Equation 1.2

Several other carbanion-forming enzymes share similarities to the C−C bond formation
catalyzed by PurE. The citrate synthase mechanism has been extensively studied and
serves as a model for enzymatic C−C bond formation. The reaction proceeds by
formation of an acetyl-CoA carbanion (enolate), which then attacks a highly polarized
carbonyl in enzyme-bound oxaloacetate (OAA). The polarization of OAA can be directly
observed by infrared and 13C NMR spectroscopy.21,22 The subsequent steps in C−C bond
formation can be monitored by changes in pre-steady state fluorescence.23
Unlike citrate synthase, PurE1 and PurE2 have a single substrate and it is challenging to
detect carbonyl polarization by PurE. The C−C bond forming steps, however, are
amenable to study by the same fluorescence-based approach used for citrate synthase.
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Citrate synthase highlights an additional difficulty C−C forming enzymes encounter; it is
not enough to simply generate a carbanion, a suitably reactive acceptor must also be
present to avoid quenching by protonation. PurE1 and PurE2 may use hydrogen bonds to
further polarize AIR and promote the reaction between the AIR carbanion and bound
CO2 (Figure 1.3).
PurE2 and Rubisco share the rare ability to fix CO2 directly, without the need for
additional energy input or other enzymes.23–25 Rubisco cleaves ribulose 1,5-bisphosphate
in competing irreversible carboxylase and oxygenase reactions. The Rubisco oxygenase
reaction saps photosynthetic productivity.24–26 The chemistry of initial attack on CO2
shared by PurE2 and Rubisco is fundamentally different from all other known enzymes.
However, neither PurE2 nor PurE1 has any known oxygenase activity. We speculate that
the reason for this substrate specificity is PurE2 flips the sequence of steps in C−C bond
formation relative to Rubisco: AIR reacts with CO2 before carbon deprotonation (Figure
1.2). This chemical strategy may account for the vastly improved selectivity of
PurE2•AIR for CO2 over O2.
PurE1 and PurE2 Acquire CO2 Differently. PurE1 and PurE2 are thought to break and
form C−C bonds through a common ternary complex, PurE•AIR•CO2.26–28 One absolute,
class-specific difference is the source of CO2: PurE1 produces it by the decarboxylation
of bound NCAIR, while PurE2•AIR acquires CO2 directly from solution (Figure 1.2).
Subtle Structural Differences in PurE1 and PurE2 Regulate Substrate Specificity. Minor
structural differences in PurE1 and PurE2 must encode the divergent substrate specificity.
First, PurE2 cannot use NCAIR26 as a substrate and appears structurally unable to
accommodate the “flipped” ring of NCAIR.29 Second, the PurE2•AIR•CO2 ternary
complex reversibly dissociates CO2, unlike the corresponding PurE1 complex, which
quantitatively retains CO2.30 Polarization of PurE1 or PurE2-bound AIR forms the
zwitterionic form, which electrostatically attracts CO2 and helps to retain it. Confining
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CO2 in PurE1 preserves the investment made by PurK, which uses ATP to activate
bicarbonate (Figure 1.1).
PurE2•AIR contains a 6 Å long portal leading to the carboxylate/CO2-binding site that is
not present in “closed” PurE1•AIR structures. 26,28 The portal may allow CO2 to enter the
active site after AIR and bind underneath it while allowing protons to exit. The portal
also creates a polar, solvent accessible active site in PurE2. It is unclear how these class
specific differences in PurE sequence, structure, and CO2 acquisition evolved while still
maintaining similar C−C bond forming chemistry though a common PurE•AIR•CO2
ternary complex.
The 40s Loop Residues May Have Different Roles in Each PurE Class. Both PurE1 and
PurE2 have similar structures, apart from two active site loops (Figure 1.3).31,32 The 40s
loop, SAH[R/K], contains a conserved His that functions as a general acid/base that is
necessary for activity in both classes.26,28,29 The 40s loop Ser is the sole polar contact with
the substrate aminoimidazole ring and any PurE1 or PurE2 side chain (Figure 1.3). An
earlier study of PurE2 suggests that the hydrogen bond between Ser and aminoimidazole
N3 might flip polarity as a function of pH.26 No similar function is expected for PurE1. In
contrast, its first protonation equilibrium (pK1) is associated with inhibition of activity.28
Ser may have a different role in PurE1 and PurE2, producing subtle mechanistic
differences between them.
The differentially conserved 40s loop basic residue, Arg in PurE1 and Lys in PurE2,
contacts the phosphate moiety of the nucleotide (Figure 1.3). The challenging acquisition
of CO2 by PurE2 has been suggested to involve intermediate formation of an Ncarboxylated species on this Lys, which is strictly conserved in PurE2.30 Lys-carbamates
are produced in Rubisco and urease

25,33,34

active sites, and a N-terminus carbamate is

formed in hemoglobin to carry CO2.34 While this could serve to accumulate a CO2
equivalent near the active site, carbamate formation decreases electrophilic reactivity,
relative to free CO2, making it seem unlikely that this would be useful in PurE2 catalysis.

!

7
Ancestral PurEs were single proteins. Several purine biosynthesis enzymes exist as
fusion proteins containing two or more independent enzyme active sites in distinct
domains.31,35 As a general rule, bacteria have monofunctional single enzyme purine
biosynthesis proteins. Bacteria contain a single domain, monofunctional PurE1.28,36 Yeast
and plants have a bifunctional PurE1-PurK fusion protein and vertebrates have a
bifunctional PurE2

PurC fusion protein.32,37 The fusion proteins in higher eukaryotes

suggest the possibility of metabolite channeling or other regulatory phenomena added to
the essential pathway architecture not necessarily used in the ancestral monofunctional
proteins.
It is considerably more difficult to study an enzyme within a bifunctional complex
especially where the same substrate compound binds to both active sites. Until recently, it
was not possible to study PurE unless it was fused to PurK (PurK PurE fusion ADE2 in
yeast)37 or PurC (PurE2 PurC fusion in Gallus gallus and PAICS in humans)32,38. A
monofunctional PurE2 from the spirochete Treponema denticola (TdPurE2) was
discovered and verified to be a bona fide PurE2 by our laboratory.26 This allowed the
characterization of a monofunctional PurE2, without interference from a separate active
site that also binds CAIR, for the close comparison to PurE1 needed for mechanistic
studies.
Which PurE Class was First? In many cases, enzyme divergence can be traced back to a
common ancestor (or ancestral form) by phylogenetic analyses. When it comes to PurE,
an unambiguous hypothesis about its evolutionary history has proven elusive. Phylogenic
analyses do not provide a clear hypothesis that can account for the contemporary
distribution of PurE classes or reveal how they many have diverged.26 One might
presume that, enzymes in higher eukaryotes (e.g. PurE2) are the more modern form,
diverged from ancestral forms in microbes (PurE1). However, PurE2 is found throughout
all kingdoms of life and eukaryotes have PurE1 and PurE2 in about equal numbers.26
PurE2 is used by animals (many of which have readily available CO2 via the
bloodstream); but PurE2 is also found in a small number of bacteria, pathogenic protozoa
(primitive eukaryotes), and archaea (Figure 1.4).39–46 Lateral gene transfer may have
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happened from an animal host in all but the last case. In addition, de novo purine
biosynthesis is not present in many parasites, the simpler eukaryotes that might help
reconstruct the evolutionary history of eukaryotic PurE.
Does an Ambidextrous PurE1/PurE2 Exist? Evolutionary analysis is extremely
problematic to perform with current forms of PurE1 and PurE2. Like PurE, mammalian
paraoxonases were a family of enzymes with poorly understood evolutionary origins. The
discovery of structurally similar bacterial enzymes with similar activity was used in the
reconstruction of a phylogenetic tree, which established evolutionary origin and revealed
the sequence divergences that led to the modern family of paraoxonases. Going one step
further, the authors designed and characterized an ancestral paraoxonase with
ambidextrous activity.47,48
Phylogenic analysis similar to those discussed above might require the discovery (or
design) of an ambidextrous PurE1/PurE2. Characterization of an ambidextrous
PurE1/PurE2 could help to pinpoint the key residue differences associated with PurE
sequence and structure that occurred during the divergence of one PurE class from the
other.
Does CO2 Availability Dictate the Selection of a Particular PurE Class? CO2 availability
is the leading candidate to explain the “choice” of PurE class: bicarbonate is abundant in
air-exposed water, charged, easy to bind, and unreactive; CO2 is the opposite.49
PurE2 can directly use CO2, while, PurE1 requires NCAIR as a ready source of CO2.
NCAIR is formed either from bicarbonate and ATP by PurK (Figure 1.1) or by the
spontaneous carboxylation of AIR N6 under high CO2 and high pH. NCAIR is highly
labile with a half–life of only 0.9 min-1 at 37 °C and pH 7.8.18
Environmental pH also influences CO2 availably. At low pH, NCAIR is less stable and
CO2 is favored over bicarbonate. The PurE equilibria are also influenced by pH: CAIR
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formation is favored over decarboxylation at high pH in PurE1 and PurE2. PurE2 favors
CAIR decarboxylation in acid or at low pCO2.26,27,36
We will consider the four environmental conditions presented in Figure 1.5.
1) High CO2 and high pH, such as the bloodstream or the gastrointestinal tract in
animals and deep-sea hydrothermal fields,50,51 may support any PurE
configuration.
2) High CO2 and low pH, such as sediments and the deep sea surrounding deepsea hydrothermal vents,51,52 may support organisms possessing PurE2 since
NCAIR formation is disfavored.
3) Low CO2 and high pH, such as atmospheric conditions or shallow fresh water
like tide pools and the littoral zone of lakes and rivers,53,54 would require
PurE1+PurK. PurK would be necessary to incorporate bicarbonate into
NCAIR, as a ready source of CO2.
4) Low CO2 and low pH, such as deep-sea hydrothermal vents,55 could support
organisms possessing either PurE2 or PurE1+PurK (potential reasons for
PurE2 are discussed further in Chapter 5).
We hypothesize that CO2 availability could influence the presence of a certain PurE class
within an organism. However, the possibility of random inheritance cannot be ruled out.
Newly Identified Microbial pure2 Genes are Found in Organisms from Predicted
Environments. Prior to the work done with T. denticola PurE2, only a single other
microbial purE2 gene had been identified.26 With the abundance of new genome
sequences available, a BLAST search revealed six new microbial PurE2s from
thermophilic and green sulfur bacteria (D. thermophilum, O. profundus, D. orientale, M.
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salmonicolor, B. graminisolvens) and pathogenic protozoa (B. hominis) that inhabit the
niches we would predict, deep sea environments and the gastrointestinal tract in animals,
which have high CO2 availability and high pH (Figure 1.4-1.5).39–46
PurE1 is an Unexploited Antibiotic Target. The “magic bullet” concept put forth by Paul
Ehrlich is the basis for all chemotherapies.56–58 Current antibiotics halt essential microbial
functions such as cell wall, DNA and protein synthesis and lead to cell stasis or death.59–
61

An emerging focus in anti-infective agents is to target virulence factors rather than

essential targets, which are under greater selective pressure that leads to the inevitable
acquisition of drug resistance.62–64 PurE1 has been validated as an anti-infective target
with inhibitor studies currently underway.65–67 The PurE-associated chemical divergence
in purine biosynthesis nicely fits the “magic bullet” model: if PurE1 can be selectively
inhibited, PurE2 should be unaffected. Achieving this challenging level of targeted
specificity may require a detailed knowledge of the chemical mechanism used by PurE1
and PurE2.
Characteristics of PurE1 and PurE2 Examined in this Work. PurE1 from Acetobacter
aceti PurE1 and Treponema denticola PurE2 are used here to explore the chemistry of
C−C bond cleavage and CO2 acquisition.!!
!
Chapter 2 details published work on metal stopping reagents for the PurE1 reaction.
!
Chapter 3 reports on the characterization of single-tryptophan AaPurE1 forms and the
fluorescence changes associated with ligand binding. The results allowed the
identification of the primary fluorophore (the molecule responsible for observed emission
intensity upon excitation) and characterization of its fluorescence responses to ligand
binding, which further studies can use to elucidate the chemistry of C−C bond formation.
Chapter 4 details the structural and kinetic characterization of 40s loop Ser mutants in
AaPurE1 and TdPurE2. We found that this universally conserved Ser is important but not
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necessary for activity in both classes, interestingly it may have different roles in PurE1
and in PurE2.
Chapter 5 is a short description of the role associated with the 40s loop Lys in TdPurE2
mutants. The results rule out the possibility that a Lys carbamate is an obligatory
intermediate in catalysis.
Chapter 6 is a short description of oxygenase activity in the “inactive” TdPurE2-H40N
mutant. The detection of oxygenase activity in the highly CO2 specific PurE2 may further
the understanding of specificity in CO2 fixing enzymes.
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Figure 1.1 The de novo purine biosynthesis pathway. Steps 1–10 define the pathway in
animals. Steps 3a, 4a, 6a, 6b, 9a and 10a represent variations of the pathway found in
microbes, plants, or fungi. Thiamine biosynthesis requires AIR and histidine biosynthesis
supplies AICAR.
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Figure 1.2 Decarboxylase reactions. (A) Acetoacetate decarboxylase forms a stabilized
carbanion. (R = Lys) (B) Thiamine-dependent pyruvate decarboxylase forms a stabilized
carbanion (R = aminopyrimidine ring and R’ = hydroxyethyl side chain of the thiamine
cofactor). (C) CAIR decarboxylation (R= ribose 5’-phosphate) begins with protonation,
avoiding a non-stabilized vinyl carbanion, then decarboxylation. Both PurE1 and PurE2
form a ternary PurE•AIR•CO2 complex. The conversion of NCAIR→CAIR by PurE1
requires an aminoimidazole ring flip and the qualitative retention of CO2 and AIR.
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Figure 1.3 Sequence alignments and active site contacts in PurE1 and PurE2. (A) The
40s and 70s loops contain universal (black background) and class-specific (colored
background) residues. The critical His is indicated with a star. Triangles denote other
polar contacts with bound nucleotides (hydrogen bond donor, ▲; acceptor, ▼). The
universally conserved Ser is denoted by a grey triangle, it may flip polarity in PurE2 at
low pH. Treponema denticola PurE2 (TdPurE2) residue numbers are given. (B) PurE1
and PurE2 active site contacts with CAIR (A. aceti PurE1 residues shown in blue and T.
denticola PurE2 residues shown in red).
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Figure 1.4 Phylogenetic tree illustrating PurE2 exists in diverse organisms throughout all
three kingdoms. The newly identified PurE2s from green sulfur and thermophilic bacteria
and pathogenic protozoa from (Figure 1.5) are included.
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Figure 1.5 Possible PurE combinations in different environmental conditions. There are
three known PurE combinations to consider: PurE2, PurE1+PurK, or PurE1-only without
a recognizable PurK.31 No known organisms have both a PurE1 and PurE2, this may be
due to controlling metabolic flux of CO2 and bicarbonate.
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Figure 1.6 Diagnostic regions in newly identified purE2 genes. (A) The 40s and 70s
loops contain universal (bold letters) and class-specific (colored background) residues.
The critical His is indicated with a star. Triangles denote other polar contacts with bound
nucleotides (hydrogen bond donor, ▲; acceptor, ▼). The universally conserved Ser is
denoted by a grey triangle, it may flip polarity in PurE2 at low pH. Treponema denticola
PurE2 (TdPurE2) residue numbers are given. All PurEs shown are microbial, with the
exception of B. hominis.
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CHAPTER 2 METAL STOPPING REAGENTS FACILITATE
DISCONTINUOUS ACTIVITY ASSAYS OF PURE1
!
!
!
2.1

Introduction

De novo purine biosynthesis harbors an unusual divergence in a ubiquitous biosynthetic
pathway.1 In most microbes and nonmetazoan eukaryotes, a class I PurE [PurE1, Ncarboxyaminoimidazole ribonucleotide (NCAIR) mutase, EC 5.4.99.18] reversibly
converts NCAIR to 4-carboxy-5-aminoimidazole ribonucleotide (CAIR) (Figure 2.1).2
Animals produce CAIR by a different route, using a class II PurE (PurE2, 5aminoimidazole ribonucleotide (AIR) carboxylase, EC 4.1.1.21)3–5. Microbial
pathogenesis relies upon purine biosynthesis6 particularly purE1, which is therefore a
promising but unexploited antibiotic target.7,8 Inhibitors selective for PurE1 could have
antibacterial, antifungal, or herbicidal activity.9 In this work, we describe a functional
assay for PurE that is compatible with inhibitor identification by high-throughput
screening (HTS) methods.
Currently available PurE1 functional assays are not amenable to HTS methods. A
continuous ultraviolet (UV) assay that monitors the absorbance decrease due to CAIR
decarboxylation2,10,11 is subject to spectral interference by many candidate inhibitors.
*The text within this chapter is taken from the manuscript written in October 2013 by
T.J. Kappock, K.L. Sullivan, and E.A. Mullins, with the exception of Figure 2.8 and
Figures 2.10-2.12 and the text shown in italics throughout. T. J. Kappock performed the
experiments with NiNTA and NiIDA columns and the nickel stopping experiments with
EcPurE1. E. A. Mullins performed all HPLC analyses
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CAIR synthesis assays are complicated by the acid lability of the NCAIR substrate2,12,13,
the need for multiple coupling enzymes,9,14 and, for discontinuous assays detecting
inorganic phosphate production, handling of malachite green reagent15 and a background
due to formation of phosphate by the coupling enzymes. The Bratton-Marshall assay
(BMA)16 was used in early studies of PurE2,3 but seldom thereafter. The BMA yields
intensely colored AIR and CAIR derivatives, AIR-BM and CAIR-BM (Figure 2.1),
which possess characteristic visible absorbance spectra,17 are relatively stable, and
might be suitable for HTS methods. The BMA, however, requires multiple, timed
reagent additions that would be difficult to implement during parallel screens. An
alternative would be to stop the PurE1 reaction prior to BMA workup using a reagent
that does not alter product yields.

2.2 Materials and Methods
!
AICAR (>98% purity) was purchased from Sigma (St. Louis, MO) or Toronto Research
Chemicals (Toronto, Canada). Other chemicals were purchased from Sigma; all were
used without further purification. AIR was synthesized by enzyme-mediated
decarboxylation.1

4-Carboxy-5-aminoimidazole

ribonucleoside

(CAIRs)

was

synthesized by saponification of 5-aminoimidazole-4-carboxamide ribonucleoside
(AICARs).18
NiNTA agarose (Qiagen; Valencia, CA) was placed in a Micro Bio-Spin column
(BioRad; Hercules, CA). NiIDA was prepared by saturating Chelex 100 (BioRad) with
NiSO4, followed by extensive water washing to rinse off unbound metal, and a portion
was transferred to a Micro Bio-Spin column. A 3 mL disposable syringe plugged with
cotton (cosmetic 100% cotton, 0.5 mL) was washed three times with H2O to remove
soluble fibers. Another 3 mL disposable syringe containing a layer of sand (0.5 mL)
sandwiched between cotton layers (0.5 mL each) was washed with H2O and then
absolute ethanol (200 proof).
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PurE1 from Acetobacter aceti and PurE2 from Treponema denticola were isolated as
described previously.5,19 Protein concentrations were determined by the method of
Bradford using bovine serum albumin as the standard.20
Absorbance spectra were recorded on a Cary 100 UV-vis spectrophotometer or an
Agilent 8453 diode-array spectrophotometer. Absorbance spectra were vertically shifted
(by less than 0.001 A) to set the absorbance value at 800 nm at zero. 1H NMR spectra
were recorded on a Bruker 500 MHz NMR spectrometer, using 5 mm o.d. tubes and
sample concentrations of ∼25% (w/v) in D2O.
Synthesis of CAIR. AICAR (50 mg, 0.15 mmol) was placed in a 25 mL round bottom
flask containing LiOH (8 mL of a 1 M aqueous solution, 8 mmol). The flask was sealed
with a septum and the mixture was stirred at 125 °C under a N2 atmosphere. A positive
pressure of N2 was maintained using a balloon, with a small vent needle inserted to
allow slow solvent evaporation. After ∼2 h, the reaction mixture volume was ∼2 mL.
The reaction vessel was then sealed under a N2 atmosphere and held for another 2.5 h at
125 °C. The reaction mixture was cooled to room temperature and deionized H2O (2
mL) was added with stirring. The mixture was cooled to 0 °C and HCl (2 N) was added
to adjust the pH to ∼7, as judged by spotting on pH test strips. The solution was forced
by air pressure through a column packed with cotton to remove particulates. The filtered
solution was then lyophilized to dryness. The resulting solid was resuspended in cold
absolute ethanol (3 x 15 mL) and transferred as a suspension to a column packed with
cotton and sand. Air pressure was used to blow out residual ethanol. Cold deionized H2O
(20 mL) was applied to the cotton/sand column to dissolve CAIR, which was recovered
and lyophilized to furnish a white powder (42.5 mg, 85% yield). 1H NMR (500 MHz,
D2O 4.84): δ 8.03 (s, 1H), 5.73 (d, J = 6.4 Hz, 1H), 4.63 (m, 1H), 4.42 (m, 1H), 4.32 (m,
1H), 4.03 (m, 2H).
Fluorescence Emission Spectra. Spectra were recorded on a Horiba Fluoromax-3
fluorometer thermostated with a Peltier Accessory and a Wavelength Electronics
temperature controller using a 1 cm pathlength fluorometer cell that contained 2.0 mL of
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AIR (0-23.8 µM), CAIR (0-23.8 µM), or AICAR (0-33 µM) in 50 mM Tris-HCl, pH 8.
The excitation wavelength was 295 nm (2 nm slit width) and emission spectra were
collected from 305 to 450 nm (5 nm slit width). A buffer only-spectrum was subtracted
from as the background from all spectra.
LiOH Titrations. LiOH titrations (0-6.7 mM, neutralized to pH 8 with HCl, from 100
mM stock) were performed in 50 mM Tris-HCl, pH 8, with CAIR (10.5 µM) at 30 °C.
CAIR fluorescence emission spectra were recorded as described above.
CAIR Synthesis Without Plastic Vessels. CAIR synthesis was carried out according to
the above protocol with a single exception: no plastic vessels were used during
synthesis. Instead only glassware soaked overnight in concentrated nitric acid was used.
Fluorescence emission spectra of CAIR from this synthesis were recorded as described
above.
CAIR Synthesis with Extensive EtOH Washes. CAIR synthesis was carried out according
to the above protocol with a single exception: the lyophilized CAIR was resuspended in
cold absolute ethanol (10 x 25 mL) and transferred as a suspension to a column packed
with cotton and sand. Fluorescence emission spectra of CAIR from this synthesis were
recorded as described above.
Metal Content of CAIR. CAIR titrations (0-50 µM CAIR, from 600 µM stock) were
performed in 50 mM Tris-HCl, pH 8, with 8-Hydroxyquinoline-5-sulfonic acid (HQS; 1
mM) at 30 °C. CAIR fluorescence emission spectra were recorded as described above.
Removal of Metals from CAIR. EDTA titrations (0-20 mM, from a 200 mM stock) were
performed in 50 mM Tris-HCl, pH 8, with CAIR (33 µM) at 30 °C. CAIR fluorescence
emission spectra were recorded as described above.
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CAIR (0.5 mL, 1 mM) in 50 mM Tris-HCl, pH 8 was incubated with Chelex-100 resin
(0.5 mg of the sodium form prepared as in Bio-Rad manual) rocking, for 1 h at 4 °C.
The CAIR solution was centrifuged (max speed, 30 s), the supernatant transferred, and
diluted to 33 µM in the same buffer and CAIR fluorescence emission spectra were
recorded as described above.
CAIR Separation from the Fluorescent Species. CAIR (235 nmoles) was applied to a
silica column (0.6 cm x 2.2 cm) equilibrated in the one of the following solvents: water,
25% EtOH, 50% EtOH, 75% EtOH, or 100 % EtOH. A single CV of the same solvent
was applied, the flow-thru collected, analyzed by BMA for the presence of CAIR, and
fluorescence emission spectra were recorded as described above
CAIR (490 nmoles) in 50 mM Tris-HCl pH, 8 was mixed with 27 mg of C18 media
(activated with MeOH and washed with 50 mM Tris-HCl pH, 8) and incubated rocking,
for 4 h at 4 °C. The C18 mixture was transferred to a mini spin column (Qiagen) and
eluted by centrifugation at (1000 g for 30 s). The elution was analyzed for the presence
of CAIR by UV-endpoint assay and fluorescence emission spectra were recorded as
described above.
CAIR (490 nmoles) in 50 mM Tris-HCl, pH 8 was applied to a ZnIDA (1.5 x 1 cm)
column equilibrated in the same buffer. Buffer was applied (6 CV) and the flow-thru
collected. The fractions were analyzed for the presence of CAIR by BMA and ZnSO4 by
the addition HQS (0.5 mM final concentration). HQS fluorescence was detected using a
handheld UV lamp.
CAIR Quantitation Assays. CAIR samples (0.5 mL) were mixed 1:1 with orcinol
reagent, heated to 100 °C for 30 min, cooled to ambient temperature, and quantitated at
670 nm. A blank spectrum was recorded from a solution containing a 1:1 orcinol reagent
to water that was processed at described above. CAIR samples were referenced to an
AMP calibration curve, AMP standards (5-250 µM, 10 mM stock solution standardized
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at 260 nm, ε260 = 15.4 mM-1 cm-1) were mixed with orcinol reagent and processed as
described above. Orcinol reagent [0.1% (w/v) orcinol acid and 0.1% (w/v) iron (III)
chloride hexahydrate in concentrated HCl] was freshly prepared before use.
Phosphate ashing assays of CAIR were performed using a published method.21 The
CAIR sample (0.05 mL, 1 mM) in a 13 x 100 mm Pyrex test tube was mixed with and
equal volume of 10%. Mg(NO3)2•6H2O in ethanol; the mixture was evaporated to
dryness over a flame with rapid shaking and further heated in the flame until brown
fumes were no longer observed. The mixture cooled to ambient temperature, 0.3 mL of
1 M HCl was added, the tube was capped, and heated at 100 °C for 15 min. An ascorbic
acid mixture (0.7 mL) (1 part 10% ascorbic acid to 6 parts of 0.42% ammonium
molybdate•4H2O in 1 M H2SO4) was then added and heated at 45 °C for 20 min. The
solution was then read at 820 nm against a blank containing water in place of the CAIR
solution.
Enzyme Activity Assays. A unit is defined as the amount of enzyme that produces 1 µmol
product per min.
Continuous assays of PurE1-mediated CAIR decarboxylation were performed using a
published method.11 A final volume of 0.6 mL in a masked, 1 cm path length cuvette
containing 50 mM Tris·HCl, pH 8.0, and CAIR (4–80 µM) was incubated at 30 °C for at
least 3 min. Reactions were initiated by the addition of Acetobacter aceti PurE1 (27 ng;
2.4 nM subunits). The initial velocity of CAIR decomposition (∆ε260 = 8930 M−1 cm−1)
was recorded at 260 nm, with a correction for a small background slope. CAIR was
quantitated by endpoint assay using the same method, except that 50 µg mL−1
Treponema denticola PurE2 was the enzyme.
Discontinuous reaction mixtures (Vrxn, 0.15–2.0 mL final volume) contained 50 mM
Tris·HCl, pH 8, 6-80 µM CAIR (12 nmol total), and 26–320 ng (MPurE1) Acetobacter
aceti PurE1 (10 nM subunits). After incubation at 30 °C for a period ∆t ranging from 1–
6 min, ZnSO4 (VZn, 6 µL, of a 5 mM stock; equivalent to a three-fold molar excess over
the amount of CAIR initially present) was added to stop the reaction and the mixture
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was vortexed briefly. An aliquot (Vrxn/1.2 mL) of each quenched mixture was
withdrawn, adjusted to either 0.5 or 2.0 mL with buffer, and subjected to BMA analysis
as described in the caption to Figure 6.7, except that the sample volume was larger.
The final analyte volume (Va) was either 0.9 or 3.6 mL, depending on the cuvette used
for analysis. A dilution correction factor Cdil was computed using equation 1.
!

!!"# = ! ! !×!

!!"# !!!!"
!!"#

Equation 1

The amount of AIR formed was determined from absorbance readings of the BMA
reaction mixture, containing AIR-BM and CAIR-BM in varying ratios, for both the
quenched reaction mixtures (!!!"" ) and a no-enzyme control, processed in otherwise
identical fashion (!!"#$%"&
). The differential extinction coefficient for AIR formation was
!""
∆ε500 = 13,600 M−1 cm−1. The cuvette pathlength (!) was 1 or 4 cm for Va of 0.9 and 3.6
mL, respectively. Three replicate assays were performed at each [CAIR]. Reaction
velocities (v) for AIR formation were computed using equation 2.
! =!
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Equation 2

One set of reaction mixtures (containing 40 µM CAIR) was quenched with ZnSO4 as
above, then incubated at room temperature for 24 h prior to BMA workup. Kinetic
constants were obtained by non-linear least-squares fitting to the Michaelis-Menten
equation with gnuplot (version 4.4).
Matrix-assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry. BMA
reaction mixtures containing 25 nmol of nucleotide or nucleoside were prepared as
described in the caption to Fig. 2. Mass spectra were recorded on an ABI 4800 MALDI
time-of-flight (TOF)/time-delayed fragmentation (TDF) instrument (AB SCIEX;
Framingham, MA). The matrix was α-cyano-4-hydroxycinnamic acid in 50%
acetonitrile and 0.1% trifluoroacetic acid.
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High-Pressure Liquid Chromatography (HPLC) Analysis of BM Derivatives. HPLC
analysis was performed using a Waters (Milford, MA) Breeze system equipped with a
Waters 717plus autosampler. A ZORBAX Eclipse XDB-C18 column (4.6 × 150 mm, 5
µM; Agilent, Santa Clara, CA) with a C18 guard column (4.6 × 12.5 mm, 5 µM) was
developed at 0.5 mL/min with dual- wavelength monitoring (260 nm / 500 nm). Buffer
A was 150 mM sodium acetate, 200 mM sodium phosphate, pH 4.6. Buffer B was buffer
A containing 30% methanol. The gradient program was: 0–5 min, 0% B; 5–25 min, 0 to
100% B; 25–30 min, 100% B, 35–55 min, 100 to 0% B; 55–60 min, 0% B.
Immobilized-Metal Affinity Chromatography (IMAC). NiIDA and NiNTA columns (0.4
mL bed volume) were equilibrated in 25 mM (N-morpholino)propanesulfonic acid
(MOPS), pH 7.4. All operations were carried out under gravity flow at room
temperature. A 1:1 mixture of AIR:CAIR (15 nmol combined, in 0.6 mL MOPS buffer)
was applied to each column, which were then developed by the adding more MOPS
buffer one bed volume at a time. Column fractions were analyzed by the BMA. CAIR
adhering to the washed NiNTA column was completely displaced by the addition of
excess NiSO4 solution (data not shown).
Molecular model construction. A CAIR model (residue type C2R) was obtained from
the HIC- Up server22 and positioned using the Pymol23 Pair Fitting “wizard” onto the
organic ligands in a template crystal structure. The templates were 5-coordinate,
distorted square pyramidal complexes [Zn(picH)(pic)Cl] (pic = picolinate, picH =
picolinic acid)24 and [CuL2(H2O)] (L = 5-amino-1-tolylimidazole-4-carboxylate).25 The
second complex contains the same heterocycle that is present in CAIR.

2.3

Results

!
A New Synthesis Produces Highly Pure CAIR. The first task was to determine an
extinction coefficient for CAIR-BM at 500 nm, a goal that requires pure CAIR. A new
CAIR synthesis, which uses LiOH to saponify aminoimidazole-4-carboxamide
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ribonucleotide (AICAR) and thereby facilitates salt removal (see materials and
methods), furnished CAIR in high yield (85%) and purity (99%). No peak corresponding
to AIR H2 peak was observed in 1H NMR spectra (Figure 2.2). Mass spectrometry (MS)
analysis of BMA reaction mixtures revealed only the expected molecular ions for single
BM adducts and ions present in control mixtures (Table 2.1). HPLC analysis of CAIR
subjected to BMA workup showed 97% CAIR-BM / 3% AIR-BM (Figure 2.3); a small
amount of AIR evidently forms during the BMA acid quench step. CAIR-BM appears to
consist of a mixture of species that cannot be resolved by HPLC but that possess the
same molecular formula. An isobaric mixture might also account for the complex shape
of the CAIR-BM visible spectrum (Figure 2.4). Aliquots of a solution containing pure
CAIR were (1) used to determine an accurate CAIR concentration, by complete
conversion to AIR followed by BMA analysis, and (2) used to obtain a spectrum of
!"#$!!"
CAIR-BM, which gave !!""
= 11,200 M-1 cm-1 (for comparison ε!"#!!"
= 24,800
!""

M-1 cm-1. 17
ZnSO4 or NiSO4 are Sufficient to Quench the PurE1 Reaction. The second task was to
identify an enzyme quenching method that is compatible with BMA workup and product
analysis. CAIR and analogues form stable complexes in which aminoimidazole N3 and
O7 atoms (Figure 2.1) coordinate a transition metal ion.

25

(CAIR)-metal (n = 2 or 3)

complexes (Figure 2.5) do not bind to or inhibit chicken PurE2 in the presence of excess
free CAIR

26–28

Mg2+ inhibits PurE2-mediated CAIR decarboxylation but not AIR

carboxylation, consistent with the formation of a low-affinity metal-CAIR complex.1,10
To determine if transition metals can rapidly and reversibly form CAIR-metal
complexes, a ten-fold molar excess (relative to the initial CAIR concentration) of NiSO4
or ZnSO4 was added to UV-monitored CAIR decarboxylation reaction mixtures. CAIR
decarboxylation stopped immediately, but could be restarted by the addition of EDTA
(Fig. 2.6). EDTA had no effect on BMA workup; the initial acidification step apparently
dissociates CAIR complexes formed with either Ni2+ or Zn2+.
ZnSO4 is a Better Stopping Reagent than NiSO4. Zn2+ appeared to form a CAIR
complex with higher kinetic stability than Ni2+, and to pose fewer concerns with regard
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to toxicity, spectral overlap with (C)AIR-BM, and redox chemistry. A CAIR
decarboxylation reaction mixture incubated at 30 °C was stopped at ∼30% completion
by the addition of ∼3 molar equivalents of ZnSO4 (Figure 2.7). Equivalent yields of
CAIR-BM were obtained if the BMA workup was delayed by up to 4 h. In contrast,
Ni2+-stopped reactions lost CAIR at the rate of about 10% per h at 30 °C (data not
shown). A saturation curve employing ZnSO4 quenching gave kinetic constants similar
to the standard continuous UV assay (Figure 2.8). Indistinguishable velocities were
obtained at 40 µM CAIR for a quenched reaction worked up promptly or after a 24 h
delay. Therefore ZnSO4 is a suitable stopping reagent for PurE1 reaction mixtures.
Formation of the Ni2+-CAIR Complex is Reversible. Metal stopping reagents are
proposed to work by rapid substrate depletion, an uncommon mode of enzyme inhibition
(e.g., vancomycin).29,30 Immobilized metal affinity chromatography (IMAC) was used to
test if CAIR binds to Ni2+, immobilized on a nitrilotriacetic acid (NTA) column. An
equimolar mixture of CAIR and AIR was applied to the NiNTA column. The first
column fraction contained pure AIR, consistent with selective retention of CAIR on the
column as a CAIR-Ni2+ complex (Figures 2.9 and 2.10). Subsequent fractions contained
CAIR, indicating that the Ni2+-CAIR interaction was reversible (data not shown). While
these results do not exclude the possibility that PurE1 is inhibited by direct protein-metal
interactions, they indicate that the rapid formation of a stable CAIR-transition metal
complex is sufficient to account for ZnSO4-mediated arrest of CAIR decarboxylation.
CAIR Synthesized by the New Method Contains a Fluorescent Species. We observed that
CAIR, synthesized by the new method reported in this chapter, contains a fluorescent
species with a λmax = 405 nm (Figure 2.11). No such signal has been reported for
AIR/CAIR synthesized by previous methods that use different reaction conditions.
Therefore, we attempted to identify the source of the fluorescent species.
1.1 We first turned our attention to the synthesis of CAIR. Could the staring materials
themselves be fluorescent?
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1.1a Fluorescence emission spectra were obtained for the starting materials
LiOH and AICAR (data not shown). Neither of these compounds is fluorescent,
therefore we decided to check the synthesis conditions.
1.2 We considered the fluorescent species could be leached from plastic vessels used
during CAIR synthesis.
1.2a To ensure fluorescent contaminants could not come from the reaction
vessels, CAIR was synthesized using only nitric acid washed glassware.
However, the fluorescent species was still observed (data not shown). The
fluorescent species does not appear to be a consequence of the plastic vessels
or the starting materials.
2.1 We then wanted to know if the fluorescent species could be separated from CAIR.
2.1a . The last step of synthesis involves washing CAIR in ice cold EtOH (45
mL total) we attempted to remove the fluorescent species by extensive washing
of CAIR in ice cold EtOH (250 mL total). The fluorescence emission spectra had
slightly diminished intensity, but the additional washes sacrificed the yield of
CAIR (data not shown), indicating removal of the fluorescent species also
removes CAIR. Therefore, we attempted several other separation techniques.
2.1b Zn2+ tightly chelates CAIR and we exploited this property to purify CAIR.
CAIR was applied to a ZnIDA column. However, CAIR strips the metal off the
column and co-elutes with fluorescent species (data not shown).
2.1c CAIR may absorb to silica. Therefore, silica columns were used to separate
CAIR from the fluorescent species. Again, CAIR co-elutes with fluorescent
species (data not shown).
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2.1d CAIR should not absorb to hydrophobic C18 media. Therefore, C18 media
was used to purify CAIR. Again, CAIR co-elutes with fluorescent species
(Figure 2.12). The fluorescent species has a linear correlation to CAIR
concentration (before and after C18 separation), indicating that the fluorescent
species is associated with CAIR and was not separated by any of the methods
attempted.
3.1 We then considered that the fluorescent species could be due to a metal contaminant.
3.1a Metal chelates of HQS fluoresce intensely and the addition of HQS to a
solution allows one to determine if metals are present. Titration of CAIR into
HQS confirmed the presence of metals in the solution (data not shown). If these
metals are responsible for the observed fluorescent species, we may be able to
remove them and see a decrease in fluorescence intensity.
3.1b Metals were removed from CAIR solution by the addition of EDTA or by
treatment with chelex. Removal of metals did not alleviate the intensity of the
fluorescent species, indicating it is not sensitive to the presence of metals.
4.1 All attempts to purify the fluorescent species failed and in each case the fluorescent
species co-elutes with CAIR. The fluorescent species could be CAIR itself or a
derivative of CAIR
4.1a CAIR was the only species detected by 1H-NMR (Figure 2.2) and MS
analysis (data not shown). Therefore, we wanted to confirm that the only
species in solution is intact CAIR. We performed multiple assays (orcinolribose, phosphate, BMA-N6 of CAIR, UV endpoint-CAIR β-anomer) to
ensure only intact CAIR was present in solution. The values from these assays
agree (CAIR 1.0 ± 0.3 mM) and demonstrate that we have only intact CAIR in
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solution. The use of multiple analytical techniques has not been successful in
detecting any species other than CAIR.
The results presented above indicate that only CAIR is present in solution and always
co-partitions with the fluorescent species. We were therefore forced to conclude that the
fluorescent species could be CAIR.

2.4

Discussion

We Have Developed a PurE1 Assay that is Specific and Suitable for HTS. The method
can be used to screen candidate inhibitors that absorb UV light, a common practical
concern for detecting initial hits, which often have low potency and therefore require
high compound concentrations that cause significant spectral interference. PurE1mediated CAIR decarboxylation can be stopped by a single liquid addition, of a ZnSO4
solution, and subjected to the BMA workup hours later. BMA-detected PurE1 screens
require no other enzymes and can be used to screen candidate inhibitors that do not
contain diazotizable amines or strong metal chelators. A related method might be
employed for functional assays of the other enzyme known to use CAIR as a substrate,
5-aminoimidazole-4-N-succinylcarboxamide

ribonucleotide

(SAICAR)

synthetase

(PurC, EC 6.3.2.6) the other enzyme known to use CAIR as a substrate. SAICAR has
recently been shown to activate cancer metabolism via pyruvate kinase isoform M2.31
CAIR Synthesized by the New Method Contains a Fluorescent Species. AIR and CAIR
synthesized by an earlier method involving KOH have no intrinsic fluorescence. KOH
saponified CAIR is less pure, with more AIR present (in as-isolated CAIR), forms more
dark polymeric decay products (and a greater tendency to form them), and potentially
quenchers that might mask the intrinsic fluorescence of CAIR. The new CAIR synthesis
produces a very pure, apparently fluorescent product. This could be an unrecognized
property of aminoimidazoles that was previously not observed due to older synthesis
methods.
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The Fluorescent Species Cannot be Removed from CAIR. All attempts to remove the
fluorescent species failed; therefore, to minimize the contribution of the fluorescent
species (λmax at 405 nm) to fluorescence titration data, emission for all AIR and CAIR
spectra were monitored at 320 nm. There is less contribution of the fluorescent species
at 320 nm then at the AaPurE1 λmax at 338 nm (Figure 6.12).

!
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2.6

Figures

!
Figure 2.1 PurE1 reaction and CAIR/AIR detection by Bratton–Marshall assay (BMA).
NCAIR decarboxylates to AIR (half-life of 0.9 min at pH 7.8 and 30 °C) during the
enzyme assay,2 an acid-dependent process that goes to completion during the BMA. R5P
= ribosyl 5’-phosphate, R = H (AIR-BM) or COO- (CAIR-BM). CAIR aminoimidazole
atoms are numbered as in PDB residue type C2R.
!
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!
Figure 2.2 1H NMR spectrum of CAIR (500 MHz) in D2O. AIR H2 would give a singlet
with δ ∼ 8.3 ppm; only the CAIR H2 signal is observed in this region (orange box). AIR
H1′ would give a doublet with δ ∼ 5.80 ppm; only the CAIR H1′ signal is observed in
this region (blue box). Due to facile solvent exchange, AIR H4 (δ ∼ 6.3 ppm) is typically
not detected under these conditions.17
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Table 2.1 MALDI-TOF MS analysis of selected BM derivatives. a
[M+K+] (m/z)

[M+H+] (m/z)
BM derivative

obs

exp

obs

exp

AIR-BM

493.09

493.16

none

531.12

CAIR-BM

537.11

537.15

575.06

575.11

CAIRs-BM

457.14

457.18

495.10

495.14

AICAR-BM

536.09

536.17

574.05

574.12

AICARs-BM

456.13

456.20

494.09

494.15

a

Observed peaks (obs) were the most abundant molecular ions that were not
observed in control spectra. BMA controls were prepared without a diazotizable
amine. Exact masses (exp) were computed using ChemBioDraw 12.0
(CambridgeSoft).
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Figure 2.3 HPLC analysis of BMA reaction mixtures containing CAIR-BM (red trace,
26.4 min) or AIR-BM (blue trace, 28.1 min). Contaminating AIR-BM can be seen in the
CAIR-BM trace as a peak at 27.8 min, as confirmed by co-injection with authentic AIRBM (data not shown). The AIR chromatogram has been scaled by 45%.
!
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Figure 2.4 Visible absorbance spectra for CAIR-BM (red trace), AIR-BM (blue trace),
and a 30:70 mixture of AIR-BM:CAIR-BM (black trace). Spectra of AIR-BM and
CAIR-BM consistently cross at a single wavelength, 541 nm (vertical arrow). Spectra
were recorded on a Cary 100 spectrophotometer.
!
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Figure 2.5 Wall-eyed stereodiagram depicting a speculative model of a [Zn(CAIR)2Cl]
complex. The model was built as described above, using a [Zn(picH)(pic)Cl] complex24
as the template. All atoms are presented in ball-and-stick depictions, in which each
sphere radius is one-quarter of the van der Waals radius. The dotted sphere depicts the
full van der Waals radius for Zn2+. In this view, the Zn atom and the front
aminoimidazole ring are approximately coplanar in the plane of the page. The Zn−Cl
bond, which is tilted towards the viewer and to the right, defines the tetragonal axis,
which has approximate twofold symmetry in these complexes.
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Figure 2.6 Nickel stops CAIR decarboxylation by E. coli PurE1. The reaction mixture
(0.7 mL) initially contained 100 µM CAIR in 50 mM Tris·HCl, pH 8.0 (37 °C). CAIR
decarboxylation was initiated by the addition of PurE1 at t = 0. A unit is defined as the
amount of PurE1 that catalyzes 1 µmol CAIR decarboxylation per min. Absorbance
changes at 260 nm (black trace, 0.0021 units) were converted to [CAIR] using the
!"#$⟶!"#
differential extinction coefficient Δ!!"#
= 8930 M-1 cm-1. The addition of 1 mM
NiSO4 stops CAIR decarboxylation (red trace, ∼0 units). Full activity (blue trace, 0.0024
units) was restored upon the addition of 5 mM EDTA. ZnSO4 also immediately stops
CAIR decarboxylation but enzyme activity was not restored as quickly after the addition
of EDTA (data not shown). These data have been digitized from a strip-chart recording.
!
!
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!
Figure 2.7 Zn ions stop CAIR decarboxylation. Reaction mixtures (1.26 mL final
volume) at 30 °C contained 50 mM Tris-HCl, pH 8.0, 42 µM CAIR, and 0.13 µg
Acetobacter aceti PurE1 (0.005 units).19 At 5 min, ZnSO4 (0.1 mM) was added to one
reaction. Aliquots (0.2 mL) were removed prior to the addition of enzyme (zero time
point) and at indicated intervals, and immediately added to a 1.7 mL centrifuge tube
containing a freshly prepared mixture of 20% (w/v) trichloroacetic acid / 1.33 M
potassium phosphate, pH 1.4, (0.1 mL) and 0.1% (w/v) sodium nitrite (0.1 mL). After 3
min, 0.5% (w/v) ammonium sulfamate (0.1 mL) was added to destroy excess nitrite.
After an additional min, Bratton–Marshall reagent [0.1 mL of 0.1% (w/v) N-(1naphthyl)ethylenediamine dihydrochloride] was added. After 10 min, the solution (0.6
mL) was centrifuged (16,000g, 30 s) to eliminate bubbles and the absorbance at 500 nm
(A500) was recorded. CAIR consumption was quantitated using a differential extinction
!"#$!!"
!"#!!"
coefficient for CAIR to AIR conversion, ∆!!"" = !!""
− ! !!!!
=13,600 ± 1600
-1
-1
!"#!!"
M cm . [CAIR] values at time t were determined using (!!""
− !!!"" )/Δε500,
where !!"#!!"
was from a control reaction in which CAIR was completely converted to
!""
AIR. The symbols and error bars represent the mean and standard deviation,
respectively, for at least three independent replicates of ZnSO4-quenched (filled circles)
and unquenched control (open circles) reactions. Concentrations determined at t > 5 min
were significantly different in quenched and control reaction mixtures [one-tailed t-test,
P-value <0.01 (**) or <0.001 (***)]. The slope of the line connecting the first two points
corresponds to 0.003 units of enzyme activity, comparable to the 0.004 units expected
under the reaction conditions. 19
2+
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Figure 2.8 PurE1 saturation curves for continuous assays (open circles and blue trace)
and discontinuous ZnSO4-quenched, BMA-detected assays (filled circles, black trace).
The symbols and error bars shown for the discontinuous assays represent the mean and
standard deviation of three replicate measurements at each [CAIR]. One triplicate assay
was subjected to BMA analysis 24 h after the quenching step (red symbol). Each solid
line is a non-linear least-squares fit to the Michaelis-Menten equation: continuous assay,
Vmax = 40 ± 2 units mg−1 and Km = 11 ± 1 µM; discontinuous, Vmax =40 ± 2 units mg−1
and Km =17 ± 3 µM.
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Figure 2.9 CAIR reversibly binds Ni2+. A 1:1 mixture of AIR:CAIR was applied to
IMAC columns developed in MOPS buffer (pH 7.4). BMA derivatives were prepared
from the fractions emerging from Ni2+-loaded nitrilotriacetic acid (NTA) and
iminodiacetic (IDA) columns. Spectra correspond to BMA derivatives of the first
fractions recovered from NiIDA (black trace) or NiNTA (blue trace) columns of equal
volume. A NiIDA–NiNTA difference spectrum (red trace) is consistent with the
spectrum of pure CAIR-BM (Figure 6.4). A reference spectrum (purple trace) obtained
using the undiluted 1:1 AIR:CAIR mixture applied to both columns shows the same
proportion of BMA derivatives present in the NiIDA fraction. Spectra were recorded on
an Agilent 8453 spectrophotometer.
Wavelength, nm

!
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Figure 2.10 Fractions from IMAC columns loaded with a 1:1 mixture of CAIR:AIR
then derivatized by the BMA. A NiNTA fraction (center tube) contains mainly the
orange-colored AIR-BM. A NiIDA fraction (left tube) resembles a standard (15 nmol
total AIR+CAIR) containing BM derivatives of the mixture applied to each column
(right tube). The images are derived from a single photograph, trimmed at the gap.
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Figure 2.11 CAIR and AIR fluoresence emission spectra. CAIR and AIR (0 µM-23.8
µM, 0.6 mM stocks) were added to 50 mM Tris-HCl, pH 8.0. (A) CAIR emission
spectra. (B) AIR emission spectra. Black line- no nucleotide present, light gray line12.8 µM CAIR/AIR added, and dark gray line- 23.8 µM CAIR/AIR added.
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Figure 2.12 Fluorescence emission spectra of C18 separation of fluorescent species. (A)
Emission spectra of the CAIR solution prior to the C18 cleanup. (B) Emission spectra of
the CAIR solution after cleanup by C18 media. (C) F at λmax (405 nm) is plotted vs.
[CAIR]. The fluorescent species has F with a linear correlation to [CAIR] concentration.
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CHAPTER 3 FLUORESCENCE CHANGES ASSOCIATED WITH LIGAND
BINDING TO SINGLE-TRYPTOPHAN FORMS OF PURE1 AND PURE2
!
!
!
3.1 Introduction
!
Monitoring intrinsic protein fluorescence changes can be a powerful tool to study ligand
binding, catalysis, conformational changes, and protein folding.1–3 The use of intrinsic
fluorescence requires the aromatic amino acids tryptophan (Trp), or tyrosine (Tyr), and
occasionally phenylalanine (Phe). Protein fluorescence is dominated by the Trp
fluorophore. The number and position of Trp residues is of particular importance. If we
have a detailed understanding of the photophysical basis of Trp fluorescence changes,
then one can go beyond using them as empirical reporter groups to understanding
something about the enzyme chemistry.
Monitoring C

C bond Formation by Intrinsic Fluorescence. Changes in intrinsic

fluorescence can be used to monitor an enzymatic reaction in real time. In particular,
fluorescence is sensitive to the charge distribution within the active site that occur as an
intact enzyme reacts with its natural substrate. This method has been successfully used to
detect C C bond formation by citrate synthase (Chapter 1).4

Our long-term goal is to learn how the mechanism of C C bond formation differs in
PurE1 and PurE2 using fluorescence changes as a real time reporter. As a prerequisite,
we must first determine how fluorescence due to each Trp residue responds to ligand
binding in both PurE1 and A. aceti. (AaPurE1) and PurE2 from T. denticola (TdPurE2).
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Single-Trp Proteins Simplify Fluorescence Changes. The fluorescence properties of Trp
and its parent indole have been extensively studied and are sensitive to changes within
the environment within a given protein.3–5 Environmental changes can be monitored by
changes in emission wavelength (maximum at λmax), fluorescence quantum yield (Φ, the
ratio of photons emitted by the fluorophore to the number absorbed), fluorescence decay
rates, accessibility to quenchers (Stern-Volmer interactions), resonance-energy transfer
(FRET), and other phenomena. Some of these properties are not variable and are useless;
however, the λmax and Φ are highly variable among proteins and rely on the environment
of the Trp(s).
For proteins, like AaPurE1, containing multiple Trps (Figure 3.1), changes in
fluorescence or shift of the λmax could result from a single-Trp fluorophore or could be
due to contributions from several fluorophores. Single-Trp proteins, whether naturally
occurring or engineered, are used to simplify the photophysics of an enzyme and allow
one to link changes in intrinsic fluorescence to changes in the protein.4,6–12
Fluorescence Responses are Difficult to Predict. Upon ligand addition, the intrinsic
fluorescence of a protein may be enhanced, quenched, or remain unchanged. It is easy to
measure fluorescence changes, but it is challenging to understand the photophysical
origin of a particular fluorescence change. For instance Trp fluorescence quenching by an
acceptor quencher can occur by electron transfer or nonradiative energy transfer.3,13
Differentiation between the two types of quenching is important because we need to
know what intermediates are in catalysis and how these could relate to Trp fluorescence
quenching.
Photo-excited indoles and indole derivatives such as Trp can be transiently oxidized
leading to rapid quenching of fluorescence.14,15 The addition of an electron-withdrawing
fluorine to the indole ring raises the ionization potential which makes oxidation difficult
and should suppress quenching due to electron transfer.16
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Trp Analogs. Trp analogs can be incorporated into a protein of interest by recombinant
expression in a bacterial strain that is auxotrophic for Trp (Table 3.1 and Figure 3.2).17
Fluorinated Trp analogs are often used as

19

F NMR probes,18,19 but are also useful as

fluorescence probes.20–24 If fluorescence changes occur due to electron transfer from the
Trp indole, these should be diminished upon replacement by 5-fluorotryptophan (5FW).
E. coli PurE1 and A. aceti PurE1 Have Opposite Fluorescence Responses to CAIR
Binding. Mutation of the conserved active site His to a neutral amino acid eliminates
PurE1 decarboxylase activity, allowing for the determination of CAIR dissociation
constants (Kds) by fluorescence titrations. The fluorescence of EcPurE1-H45N or H45Q
is strongly quenched by the addition of CAIR, but the fluorescence of AaPurE1-H59N or
H59Q is moderately enhanced.25,26
A. aceti (AaPurE1) and E. coli PurE1 (EcPurE1) have a 58% sequence identity and
similar 3D structures.27 Each PurE1 contains multiple Trps, but AaPurE1 contains a Trp
(Trp97) that has no equivalent in EcPurE1.
This divergent effect of CAIR binding on fluorescence may be due to the additional Trp
in AaPurE1 or a different nucleotide complex bound within the active site. EcPurE1H45N forms a complex containing CAIR (PDB codes 2nsl; H45Q is 2nsj), but AaPurE1H59N (PDB code 2fwp) contains the AIR•CO2 ternary complex (Figure 3.2). The
different fates of CAIR suggest a difference between the two similar proteins. A variation
in a polar side chain could explain the difference in bound nucleotide; however, no
changes were observed within 10 Å of CAIR or AIR•CO2.
Our working hypothesis is that the difference in fluorescence responses between the two
forms of PurE1 is due to the presence of Trp97 in AaPurE1.
!
This chapter examines how each Trp fluorophore responds to ligand binding in both
PurE1 and A. aceti. (AaPurE1) and PurE2 from T. denticola (TdPurE2). Once we
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understand the photophysical basis of Trp fluorescence changes of PurE1 and PurE2, we
are positioned to use these fluorescence changes as a real time reporter of C C bond
formation.

3.2

Materials and Methods

Materials. Chemicals were obtained from Sigma or Fisher in the highest purity available
unless otherwise noted. CAIR was prepared as described in Chapter 1.28 AIR was
synthesized from CAIR using Treponema denticola PurE2 (TdPurE2) and quantitated by
Bratton-Marshall assay as described previously.29 Oligodeoxynucleotides (ODNs) were
obtained from Integrated DNA Technologies and used without further purification.
Restriction endonucleases, Q5 DNA polymerase, CIP, and T4 DNA ligase were obtained
from New England Biolabs. Mutagenesis was accomplished using Quikchange
Mutagenesis using kits (Agilent). Phenyl Sepharose CL-6B was obtained from Sigma
Hydroxyapatite (Bio-Gel® HT) and Bradford reagent were obtained from Bio-Rad. PD10 desalting columns were obtained from GE Health Care.
Methods. Protein concentrations were determined by the method of Bradford with bovine
serum albumin as the standard.30 Protein concentrations of 5-fluorotryptophan containing
proteins were determined by the method of Scopes by measuring protein concentrations
at 205 nm in 0.1 M potassium sulfate, 5 mM potassium phosphate, adjusted to pH 7 with
potassium hydroxide.31 Small-scale centrifugation steps were performed using an
Eppendorf 5424 centrifuge. All other centrifugation steps were performed using a
Beckman Avanti J-E centrifuge with a JLA-10.5 or JA-20 rotor. Cell disruption was
performed by sonication using a Fisher Scientific Dismembrator 550 at 25% output, (1
min each separated by 1 min cooling intervals) at 4 °C. Spectroscopic measurements
were recorded on a Varian CARY-100 UV/Vis spectrophotometer thermostated by a
Cary Dual Peltier Accessory temperature controller. Steady state fluorescence
measurements were recorded on a Horiba Fluoromax-3 fluorometer thermostated with a
Peltier Accessory and a Wavelength Electronics temperature controller. Data were
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analyzed using Origin (OriginLab, Northampton, MA) or using gnuplot 4.4 by T. J.
Kappock. Plasmid DNA was sequenced by the staff of the Purdue University Genomics
Core Facility. Full-length protein masses were determined by matrix-assisted laser
desorption/ionization mass spectrometry (MALDI-MS) on a Voyager-DE PRO mass
spectrometer (Applied Biosystems, Framingham, MA) by Connie Bonham. Liquid
chromatography-mass spectrometry (LC-MS) was performed using an Accela HPLC
system (Thermo) connected to a Finnigan LTQ mass spectrometer (Thermo) operated in
positive ion mode by Tzu-Yi Yang.
Standard Conditions for Q5 PCR. Standard PCRs (50 µL final volume) contained Q5
DNA polymerase (1 unit), two ODNs (50 nmol each, Table 3.3), template DNA (14 ng),
dNTPs (25 nmol each), MgCl2 (2 mM), and Q5 buffer (1x, proprietary components). PCR
products were amplified with standard conditions: annealing temperature of 52 °C with a
30 s hot start followed by melting, annealing, and extension times of 10 s, 30 s, and 30s
for 25 cycles with a final extension time of 5 min.
Standard Conditions for Quikchange PCR. Standard PCRs (50 µL final volume)
contained PfuUltra polymerase (1 unit), two ODNs (50 nmol each, Table 3.3), template
DNA (70 ng), dNTP mix (1 µL of proprietary stock concentration), and reaction buffer
(1x, proprietary components). PCR products were amplified with standard conditions:
annealing temperature of 52 °C with a 30 s hot start followed by melting, annealing, and
extension times of 60 s, 60 s, and 8 min for 16 cycles with a final extension time of 7
min.
Construction of AaPurE1 Plasmids for Protein Expression. Plasmid pJK175 which
encodes the wild-type AaPurE1 with an extra methionine and plasmid pJK283 which
encodes the catalytically inactive AaPurE1-H59N were used as templates for the
generation of mutants.26 Catalytically active mutants were generated using Quikchange II
mutagenesis kits with plasmid pJK175 (70 ng) as template and an appropriate ODN pair
(Table 3.3) to create plasmids pJK505 (AaPurE1-W34F), pJK506 (AaPurE1-W165F),
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pJK507

(AaPurE1-W34F,

(AaPurE1-W97Y,W165F),

W165F),

pJK525

(AaPurE1-W34F,W97Y),

pJK559

(AaPurE1-W34F,Y154F,W165F),

pJK526
pJK562

(AaPurE1- W34F,Y154L,W165F), pJK563 (AaPurE1-W34F,Y154I,W165F), pJK601
(AaPurE1-Y154F),

pJK603

(AaPurE1-W34F,Y154F),

and

pJK663

(AaPurE1-

Y154F,W165F). Catalytically inactive mutants were generated using Quikchange II
mutagenesis kits with plasmid pJK283 (70 ng) as template and an appropriate ODN pair
(Table 3.3) to create plasmids pJK508 (AaPurE1-W34F,H59N,W165F), pJK509
(AaPurE1-W34F,H59N),

pJK510

(AaPurE1-H59N,W165F),

pJK600

(AaPurE1-

W34F,H59N,Y154F, W165F), pJK602 (AaPurE1-H59N,Y154F), pJK604 (AaPurE1W34F,H59N,Y154F), pJK664 (AaPurE1-H59N,Y154F,W165F), pJK665 (AaPurE1W34F,H59N,W97Y), and pJK666 (AaPurE1-H59N,W97Y,W165F).
Construction of AaPurE1fwf Plasmid for Expression with T5 Promoter. A 0.2 kb product
containing the T5 promoter32 was amplified using standard Q5 PCR conditions from
template plasmid acs1 (25 ng), using ODNs 2410 and 2411. The PCR product was
purified using a Qiagen PCR purification kit, digested with BglII and NdeI, and ligated
into the same sites of the destination vector pJK507 to yield AaPurE1-W34F,W165F
expression plasmid pJK698.
Construction of TdPurE2–F79W Plasmid pJK648. A 0.32 kb primary PCR product
containing purE2 was amplified using standard Q5 PCR conditions from template
pJK376 (14 ng), using ODNs 2124 and 2329. The crude product was digested with DpnI
and purified using a Qiagen PCR purification kit. A 0.421 kb primary PCR product
containing purE2 was amplified using standard Q5 PCR conditions from template
pJK376 (14 ng), using ODNs 2125 and 2330. The crude product was digested with DpnI
and purified using a Qiagen PCR purification kit. Cross-over PCR product was obtained
using standard Q5 PCR conditions, with a single exception: the annealing time was
increased to 1 min, from a mixture containing primary PCR products (25 ng each) and
ODNs 2124 and 2125. The 0.79 kb cross-over product was digested with NdeI and XhoI,
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and ligated into the same sites of the destination vector pET23a to yield TdPurE2-F79W
expression plasmid pJK648.
AaPurE1 Overexpression and Isolation. AaPurE1 was overexpressed and isolated
according to a previously published protocol.26 BL21(DE3) cells transformed with the
appropriate plasmid (Table 3.4 and Table 3.5) were grown to saturation at 37 °C in LB
containing 100 µg mL-1 ampicillin (Amp). After a 1:50 dilution into fresh medium, cells
were grown at 37 °C to OD600 = 0.6. IPTG (0.4 mM) was added and growth was
continued for an additional 4 h. All subsequent steps were performed at 4 °C. Cells (4 g
L-1 of culture) were harvested by centrifugation (5000 g, 15 min), resuspended in 50 mM
Tris-HCl, 100 mM KCl, pH 8 (6 mL g-1 of cells), and disrupted by sonication. The lysate
was cleared by centrifugation (30000 g, 30 min) and the supernatant adjusted to 1%
streptomycin from a 10% (w/v) stock. Solids were removed by centrifugation (30000 g,
30 min) and the supernatant adjusted to 35% saturation (208 g L-1) by the addition of
solid ammonium sulfate over 30 min, with continuous stirring. After stirring overnight,
solids were collected by centrifugation (30000g, 10 min). The pellet was redissolved in a
minimal volume of 10 mM potassium phosphate, pH 8 (Buffer A) and applied in 2.5 mL
portions to a PD10 column (1.5 × 5 cm) equilibrated in Buffer A. Desalted protein
fractions were applied to a hydroxyapatite column (2.5 × 1.5 cm) equilibrated in Buffer A
and AaPurE1 was eluted with 10 column volumes (CV) of Buffer A. Fractions containing
AaPurE1, which does not adsorb to hydroxyapatite, were pooled and concentrated to > 3
mg mL-1 with an Amicon ultrafiltration device containing a YM30 membrane. The
protein solution was frozen by drop-wise addition to liquid N2 and stored at -80 °C.
Mutant AaPurE1 Overexpression and Isolation. All AaPurE1 forms were overexpressed
and isolated as detailed above for wild-type AaPurE1.26 Fresh column media were used
for each mutant to avoid any possibility of cross-contamination. AaPurE1 mutants were
concentrated to >3 mg mL-1 with an Amicon ultrafiltration device containing a YM30
membrane. Protein solutions were frozen by drop-wise addition to liquid N2 and stored at
-80 °C.
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Biosynthetic Incorporation of the 5FW Analog in AaPurE1fwf. AaPurE1fwf was
overexpressed by adapting previously published protocols.18,33 DL41 cells transformed
with plasmid pJK698 and pCDFDuet (to incorporate the lacI gene)34 were grown on LB
+ 1% glucose medium containing 100 µg mL-1 ampicillin and 100 µg mL-1 streptomycin
(LB-Amp/Stm). A single colony was used to inoculate a LB-Amp/Stm + 1% glucose
culture (5 mL) that was grown to OD600 = 0.8 at 37 °C. Cells were harvested by
centrifugation (2500 g, 10 min), resuspended in sterile glycerol (1 mL; 50% v/v) and
stored at -80 °C. A LB-Amp/Stm + 1% glucose culture (50 mL) was inoculated from the
frozen stock, grown to an OD600 = 0.8, and harvested by centrifugation (2500 g, 10 min).
Cells were resuspended in sterile glycerol (5 mL 50% v/v) and stored at -80 °C. The
larger frozen starter culture was used to inoculate a M9 minimal media-Amp/Stm + 0.5%
glucose culture (1L) supplemented with amino acids (40 mg L-1 of each amino acid in
water; prepared by weighing out each amino acid separately and adjusting to pH to 7 with
sodium hydroxide) and thiamine (0.01 mM) and grown at 37 °C until OD600 = 0.5. Cells
were washed twice with 0.9% NaCl (250 mL) and resuspended into fresh M9 minimal
media-Amp/Stm (1L) supplemented with amino acids (40 mg L-1 of each amino acid
except tryptophan; prepared as above), DL-5-fluorotryptophan (100 mg L-1), and
thiamine (0.01 mM). The resuspended culture was incubated for 10 min before IPTG
addition (1 mM) and grown at 37 °C for an additional three hours before harvesting the
cells by centrifugation (5000 g, 15 min). AaPurE1fwf-5FW was isolated as wild-type
AaPurE1.26
Mutant TdPurE2 Overexpression and Isolation. TdPurE2-F79W was overexpressed and
isolated like wild-type TdPurE2.29 CC1215 cells transformed with plasmid pJK648 and
were grown to saturation at 37 °C in MGD media35 containing 100 µg mL-1 ampicillin
(Amp). After a 1:100 dilution into fresh ZYM 5052-Amp35 medium, cells were grown at
37 °C for 4.5 h and shifted to 15 °C for an additional 16 h. All subsequent steps were
performed at 4 °C. Cells (4 g L-1 of culture) were harvested by centrifugation (5000 g, 15
min), resuspended in 50 mM Tris-HCl, 100 mM KCl, pH 8 (5 mL g-1 of cells), and
disrupted by sonication. The lysate was cleared by centrifugation (30000 g, 30 min), and
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the supernatant adjusted to 1% streptomycin from a 10% (w/v) stock. Solids were
removed by centrifugation (30000 g, 30 min), and the supernatant adjusted to 70%
saturation (472 g L-1) by the addition of solid ammonium sulfate over 30 min with
continuous stirring. After stirring overnight, solids were pelleted by centrifugation
(30000g, 10 min). The supernatant was applied in to a Phenyl Sepharose column (2.5 × 8
cm) equilibrated in 20 mM Tris-HCl, 1.5 M ammonium sulfate, pH 8 (Buffer B). The
column was washed with 5 CV of Buffer B and then developed with a linear gradient of
Buffer B to 20 mM Tris-HCl, pH 8 (Buffer C) (10 CV x 10 CV). Fractions containing
TdPurE2 were pooled and buffer exchanged into Buffer C with an Amicon ultrafiltration
device containing a YM30 membrane. The desalted TdPurE2 solution was then applied
to a hydroxyapatite column (2.5 × 3 cm) equilibrated in 10 mM phosphate, pH 8 (Buffer
A). The column was washed with 5 CV of Buffer A and developed with a linear gradient
of Buffer A to 500 mM phosphate, pH 8 (10 CV x 10 CV). Fractions containing TdPurE2
were pooled, buffer-exchanged into Buffer A, and concentrated to > 3 mg mL-1 with an
Amicon ultrafiltration device containing a YM30 membrane. The protein solution was
frozen by drop-wise addition to liquid N2 and stored at -80 °C.
PurE1 and PurE2-mediated Decarboxylation Assays. Continuous assays of PurE1- or
PurE2-mediated CAIR decarboxylation were performed according to a published
method.26 A final volume of 0.6 mL in a masked, 1 cm pathlength cuvette containing 50
mM Tris-HCl, pH 8 and 100 µM CAIR was incubated at 30 °C for at least 3 min.
Reactions were initiated by addition of either an AaPurE1 or TdPurE2 mutant (12-80 ng,
1.4-8.4 nM [subunits]). The initial velocity of CAIR decarboxylation to AIR (∆ε260
=8930 M-1 cm-1) was recorded at 260 nm, with a small background decarboxylation rate
subtracted. CAIR was quantitated by endpoint assay using the same method, except that
50 µg mL−1 TdPurE2 was the enzyme. A unit is defined as the amount of enzyme that
forms 1 µmol of product per minute.
Quantum Yield Determinations. Quantum yields of AaPurE1fwf and AaPurE1fwf-5FW
were determined according to a previously published protocol.4 Fluorescence emission
spectra were recorded at 25 °C using an excitation wavelength of 295 nm and slit widths
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of 1.5 nm (excitation) and 5 nm (emission). A buffer only-spectrum was subtracted from
as the background from all spectra. To calculate the quantum yield, the unobservable
portions of the spectra were estimated by obtaining a spectrum using a lower excitation
wavelength (280 nm) and normalizing the maxima to spectra obtained with an excitation
of 295 nm. These normalized 280nm spectra were then used to estimate the unobservable
area. The normalized spectra were superimposable with the spectra obtained from
excitation at 295 nm. The integrated fluorescence intensity was determined using the
peak analyzer module in Origin (OriginLab, Northampton, MA). Quantum yields were
determined using equation 3.1, where Φ and is the quantum yield, OD is the absorbance
at 295 nm, and ! is the refractive index of the solution, with the subscript R denoting the
reference sample.3,36
! !"! ! !

Φ = !!! ! !
!

!

!
!" !!

Equation 3.1

Quantum Yield Determinations with Ligands. Quantum yields of AaPurE1fwf and
AaPurE1fwf-5FW with citrate or AIR (present at 5 times Kd 0.014-1 mM citrate and 2.5-7
µM AIR) were determined according to above protocol for AaPurE1fwf-5FW with one
exception: citrate bound spectra were obtained in 50 mM potassium acetate, 100 mM
KCl, pH 4.6 at 25 °C. NATA emission spectra were recorded with each ligand and the
integrated fluorescence was corrected for any inner filter effect.
EcPurE1 Single-Trp Fluorescence Emission Spectra. Fluorescence emission spectra were
recorded using an excitation wavelength of 295 nm and slit widths of 2 nm (excitation)
and 5 nm (emission). Spectra were recorded in a 1 cm pathlength fluorometer cell that
contained 30 µM EcPurE1-W20F or EcPurE1-W151F (isolated by S. Tranchimand) in 50
mM Tris, pH 8 in a total volume of 2 mL.
Fluorescence Titrations. Spectra were obtained using a 1 cm pathlength fluorometer cell
that contained 2.0 mL prior to the titration. The excitation wavelength was 295 nm (2 nm
slit width) and emission spectra were collected from 305 to 450 nm (5 nm slit width). A
buffer only-spectrum was subtracted from as the background from all spectra. The
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intensity of the fluorescence emission F for each titration point was measured at 320 nm
and then corrected for dilution.
Citrate Titrations (0-25 mM final concentration, added from a 200 mM stock, pH 4.6)
were performed in 50 mM potassium acetate, 100 mM KCl, pH 4.6, with varying
amounts of AaPurE1 or TdPurE2 at 25 °C. Emission intensities at 320 nm (F) were
divided by the intensity at zero ligand (L) concentration (F0) to obtain fractional
saturation values. The AaPurE1 titration data were fit using gnuplot 4.4 and TdPurE2
were fit using Origin to a binding isotherm (equation 2.2) by allowing Kd and ΔF (the
value of F/F0 as [L] →∞) to vary.
!
!!

= 1 − ΔF!

[!]

Equation 3.2

[!]!!!

AIR titrations (0-25 µM final concentration, added from a 600 µM stock in 50 mM TrisHCl, pH 8) were performed in 50 mM Tris-HCl, pH 8 with varying amounts of AaPurE1
or TdPurE2 at 30 °C. Emission intensities at 320 nm (F) were divided by the intensity at
zero ligand (L) concentration (F0) to obtain fractional saturation values. The TdPurE2
data were fit using Origin to a binding isotherm (equation 3.2) by allowing Kd and ΔF
(the value of F/F0 as [L] →∞) to vary. AaPurE1 titration data were, with the exception of
AaPurE1fyw-H59N, fit using gnuplot 4.4 to a binding isotherm that accounts for ligand
depletion (equation 3.3) assuming that AIR binds to a maximum of half the enzyme
subunits (E =0.5[subunit]). The half-sites assumption is based upon the observation that
only four AIR molecules bind to a single face of the AaPurE1 octamer (PDB id 2fwj). 26
!
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CAIR titrations (0-25 µM final concentration, added from a 600 µM stock in 50 mM
Tris-HCl, pH 8) were performed in 50 mM Tris-HCl, pH 8 with varying amounts of
AaPurE1 at 30 °C. Emission intensities at 320 nm (F) were divided by the intensity at
zero ligand (L) concentration (F0) to obtain fractional saturation values. The titration data
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were, with the exception of AaPurE1fyw-H59N, fit using gnuplot 4.4 to a binding
isotherm that accounts for ligand depletion (equation 3.3).
Solution Studies of AaPurE1s. Solution aggregation state was determined on an AKTA
FPLC system (Amersham) using a Pharmacia G200-16/60 high-load column. The mobile
phase was 50 mM Tris-HCl, 100 mM KCl, pH 8 that was applied at 1 mL min-1.
Injections (100 µL) contained 0.5 mg of protein adjusted to 5% (v/v) glycerol. Protein
solution sizes and aggregation states were determined by comparison with protein size
standards (29-669 kDa; Sigma MW-GF-1000), blue dextran (2 MDa; Vo), and acetone
(60 Da, Vi) using the Kav partition coefficient method 37.
Crystallization of AaPurE1s. AaPurE1 forms intended for crystal production were buffer
exchanged into 5 mM Tris-HCl, 15 mM NaCl, pH 8 and concentrated to 10 mg mL-1
using Millipore Ultra spin columns (MWCO 30000). Crystals were grown by the hanging
drop vapor diffusion method using reservoir solutions containing 25-35% PEG 4000, 200
mM LiSO4, 100 mM Tris-HCl, pH 8.3.
X-ray Data Collection and Processing. Prior to data collection, crystals were placed
briefly into a cryoprotectant solution that consisted of artificial mother liquor with an
additional 2% PEG 4000 and 15% (v/v) ethylene glycol. Crystals were immediately
flash-cooled in liquid N2. X-Ray diffraction data were collected on either a MAR-225 or
MAR-300 CCD detector at the LS-CAT beamline (Advanced Photon Source - Argonne
National Laboratory). Diffraction data were indexed, integrated, and scaled with HKL2000.
Crystals used for subsequent mass spectrometric analysis were subjected to irradiation at
the LS-CAT beamline, by collecting 360 frames with a delta of 1 degree.
Structure Determination and Refinement. All crystals had the same space group with
similar unit cell parameters, previously observed in structures of AaPurE1.26,27 Molecular
replacement was performed using AutoMR/Phaser38 with the AaPurE1 monomer (PDB
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code 2fw1 chain A) as the search model. Structures for AaPurE1-Y154F, AaPurE1fwfY154F, and AaPurE1fwf-Y154L were determined by using the AaPurE1fwf monomer
(PDB code 4ycb) as the search model. First, 15 rounds of TLS with all B-factors set to 30
were performed followed by subsequent rounds using rigid body, TLS, Cartesian
coordinate optimization, individual isotropic temperature factor refinement, and
automatic water picking in PHENIX.39 Later rounds of refinement were performed using
Cartesian coordinate optimization, individual isotropic temperature factor refinement,
TLS, and occupancy refinement. Model building, manual inspection, and rebuilding were
performed using Coot.40 Coordinates and structure factors have been deposited in the
RCSB Protein Data Bank (PDB) with accession numbers 4ycb (AaPurE1fwf), 4ycc
(AaPurE1fwf-Y154L), 4ycd (AaPurE1fwf-Y154F), and 4ycj (AaPurE1-Y154F). Figures
were prepared using PyMOL.41
Previously deposited models of AaPurE1s lack a hydrogen bond between the Asn78
carboxamide oxygen and the Tyr154 phenol.26,27 For comparison with the newly obtained
structures, structure factors were obtained from EDS, the Asn78 side chain was flipped,
and a single round of one round of refinement performed using Cartesian coordinate
optimization, individual isotropic temperature factor refinement, and occupancy
refinement.
Mass Spectrometry of AaPurE1fwf. Each AaPurE1 form (0.8 mg) was dried and
resuspended in 50 µL of 70% (v/v) formic acid containing 0.5 M cyanogen bromide.
After 24 h at room temperature, the solvent was removed in a rotary evaporator. Solids
were dissolved in 80 µL of 50 mM ammonium bicarbonate and a portion (20 µL) was
mixed with trypsin (2 µg, Sigma proteomics grade from pig pancreas T6567) in a final
volume of 120 µL. After 18 h at 37 °C, 100 µL of 0.1% formic acid was added and the
reaction mixture was lyophilized, and stored at -80 °C. Dried peptide samples (~2 µg)
were resuspended in 25 µL of water:acetonitrile:trifluoroacetic acid (50:50:0.1 ratio) and
a portion was analyzed by LC-MS. Peptides were separated at 50 °C on a C18 column
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(Kinetex 1.7 µ, 50 x 2.10 mm; Phenomenex) that was developed at 0.5 mL min-1 in a
linear gradient of acetonitrile (5-65%) in 0.1% formic acid.
Mass Spectrometry of Dissolved AaPurE1fwf Crystals. Crystals of AaPurE1s were
prepared for mass spectrometric analysis by adapting a published method.42 Cryo-cooled
AaPurE1 and AaPurE1fwf crystals were washed twice with acetonitrile and dissolved in
10 mM potassium phosphate, pH 8. The dried protein was then digested and analyzed as
described above.

3.3

Results

Creation and Isolation of EcPurE1 Mutants. EcPurE1 single-Trp mutants were generated
by Yi Li and isolated by Sylvain Tranchimand to investigate the fluorescence response of
each individual Trp fluorophore upon ligand binding
Fluorescence Emission Spectra of EcPurE1 Single-Trp Mutants. EcPurE1 was previously
used to elucidate mechanistic details of the reaction catalyzed by PurE1.25 EcPurE1
contains two Trp residues per monomer and like AaPurE1 it would be advantageous to
use a single-Trp form.
Fluorescence emission spectra were obtained for single-Trp mutants of EcPurE1. The
single-Trp EcPurE1 forms have a 7 nm difference in λmax (EcPurE1-W20F λmax = 330 nm
and EcPurE1-W151F λmax = 337 nm) indicating the Trps occupy different local
environments (Figure 3.5). This does not occur with the corresponding AaPurE1 singleTrp mutants, which do not display significant shifts in λmax (Appendix Figures A1-A22).
Another caveat unique to the EcPurE1 single-Trp forms is the large amount of enzyme
necessary to produce adequate signal (30 µM subunit concentration). This concentration
is 40 times higher than used for wild-type EcPurE1 titrations.25 Therefore, we could not
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perform fluorescence titrations to determine the fluorescence response of each Trp to
ligand addition.
Creation of AaPurE1 Mutants. AaPurE1 Trp mutants were generated to investigate the
fluorescence response of each individual Trp fluorophore upon ligand binding. AaPurE1
Tyr mutants were generated in an effort to resolve the structural ambiguity observed in
the AaPurE1fwf structure. Quikchange site directed mutagenesis was successful in
generating a suite of combinatorial Trp and Tyr mutants (Table 3.3).
Purification of Recombinant AaPurE1s. The previously published isolation protocol26
was successfully used to isolate all AaPurE1 forms with varying specific activites and
high purity (Table 3.6, Figure 3.4 and Figure 3.5).
Identities of each AaPurE1 form were also established by MALDI analysis (Table 3.4).
Five full-length forms of AaPurE deviated from the excepted mass by more than 3 Da.
AaPurEwwf-H59N was 5 Da higher, AaPurEwwf-H59N,Y154F was 8 Da lower,
AaPurEyfw-H59N was 7 Da higher, AaPurEfyw was 8 Da lower, and AaPurEfyw-H59N was
4 Da higher than expected.
!
Physical Characterization of AaPurE1s. Analytical size exclusion chromatography was
used to determine the biological unit and relative stabilities of the AaPurE1 mutant forms.
Gel-filtration analyses confirmed the presence of the PurE1 octamer for all forms, but
also high molecular weight aggregate. The amount of aggregation roughly correlates to
the number of mutations in each form (Figures 3.8, 3.9, and 3.10). AaPurE1s lacking
Trp34 and Trp165 appear to be associated with increased aggregate, whether in a single
or multiple Trp form. Forms lacking Trp165 also appear to dissociate into tetramers as
evidenced by a peak at ~76 Da (Figure 3.9 and 3.10). Despite having an increased portion
of aggregate, it was possible to crystallize all forms with two exceptions: any proteins
lacking Trp97 and the quadruple mutant AaPurE1fwf-H59N, Y154F.
!
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Kinetic Parameters of AaPurE1s. All proteins containing the critical active site His retain
at least 50% of wild-type activity. The AaPurE1 forms that have lower relative specific
activites tend to dissociate in solution studies (Table 3.7 and Figures 3.8-3.10). The
W79Y AaPurE forms had the lowest activity, indicating this form is especially unstable.
Structure of AaPurE1fwf. The crystal structure of AaPurE1fwf was obtained to aid in
interpretation of single-Trp fluorescence data. This single AaPurE1fwf crystal resulted in
the highest resolution data set of any available PurE1 (PDB code 4ycb) (Table 2.8 and
2.9). At 1.35 Å, there is a great level of detail; the dimer in the asymmetric unit contains
25 residues with alternative conformations (including Trp97), a PEG molecule
coordinated to potassium, several ethylene glycols, and acetate.
The previously deposited AaPurE1 structure (PDB code 1ull) was aligned with
AaPurE1fwf and root-mean squared differences (RMSDs) calculated for all residues
within 10 Å of the all three Trp residues. No significant difference in the environment is
observed when the Trps are replaced by Phes: residue 34, 0.24 Å; residue 97, 0.22 Å; and
residue 165, 0.22 Å. Trp97 is present in both structures and has an RMSD between
structures that is equal or similar to the Phe34 and Phe165 replacements. The Phe/Trp
replacements do not appear to alter the surrounding structure (Figure 3.11). This is
beneficial for interpretation of single-Trp fluorescence data, because the environment
surrounding the Trp replacements has not been notably changed.
!
Another observation unique to the high resolution AaPurE1fwf structure is that the
orientation Asn78 side chains in previously deposited structures,

26,27

should be flipped.

This new orientation allows the Asn78 carboxamide to form a hydrogen bond with the
Gly76 backbone carbonyl oxygen. The Asn78 is likely a hydrogen bond acceptor for
Tyr154 from the same subunit, thus creating a “chain” of hydrogen bonds.
Tyr154s at the Dimer Interface. The most puzzling residues within AaPurE1fwf are two
Tyr154s, from adjacent subunits, that sit at the dimer interface. An iterative-build
simulated annealing composite omit map43 appears to contain continuous electron density
across the dimer interface and incomplete density for some Tyr154 atoms. Fo –Fc

!

68
difference maps show positive density peaks between the CE2 atoms at the interface, and
negative peaks for CD1, CE1, and OH of the phenol (Figure 3.12 panel C). Residue 68 is
the only other Tyr in AaPurE1, which has excellent electron density in both subunits
consistent with an unmodified residue (Figure 3.13). Any molecule that could be derived
from Tyrs at the dimer interface, which fits to the density, had unrealistic bond lengths
and angles (data not shown).
To study the ambiguous density at the dimer interface, mutations were introduced at
position 154. Structures were obtained for AaPurE1-Y154F (PDB code 4ycj), AaPurE1Y154L (PDB code 4ycc), and AaPurE1fwf-Y154F (PDB code 4ycd) (Table 2.8 and 2.9).
In stark contrast to Tyr154 structures, those containing a Phe at position 154 had clear
unambiguous density for the benzene ring with real space correlation coefficients
(RSCCs) near unity (Table 3.10 and Figure 3.12). The structure containing Leu154 was
less ordered and is populated by multiple rotamers (Figure 3.12 panel F).
A single deposited AaPurE1-H59F structure (PDB code 2fw9) contains Tyr154s that
superimpose on the Phe154s (PDB codes 4ycd and 4ycj) and make hydrogen bond
contacts with the Asn78s (Figure 3.12, panels B, D, and E). This structure and the Phe154
position provided the prototypal Tyr poses. In this prototypal pose, the Tyr phenols are
almost perpendicular in almost parallel planes with a dihedral of 87° between the Cβ-OH
axes. The phenol oxygen makes a hydrogen bond contact to the Asn78 carboxyamide as
discussed prior. In addition to the prototypal pose, each Tyr154 has an alternative
conformation. Tyr154 from subunit A reaches across the dimer interface and occupies the
density previously assigned to the cross-link. Tyr154 from subunit B is pointed out into
solvent (Figure 3.12, panel C).
The first assumption about the Tyr154 chemical identity was it might be a tyrosine
derived cross-link spanning the dimer interface. Dityrosine and isodityrosine crosslinks
are common structural features and oxidative stress markers in proteins44–48 and
formation of radiation-induced Tyr dimerization in solution has been observed.49 The
chemical structure consistent with the observed electron density in AaPurE1fwf is not
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dityrosine or isodityrosine. The crosslink is not evident in solution; the protein always
runs as a monomer on SDS-denaturing page gels (Figure 3.5), and LC-ESI-MS analyses
show the expected mass for non-cross-linked peptides of AaPurE1, AaPurE1-Y154F,
AaPurE1fwf, and AaPurE1fwf-Y154F (Figures 3.14-3.17).
Inspection of the AaPurE1 structures deposited in the PDB revealed that all contain some
extent of disorder at Tyr154 (Figure 3.23). Tyr154 RSCCs average 0.91 in all AaPurE1
models (Table 3.10). The source of radiation and crystallization conditions had no clear
effect on Tyr154 RSCC.
Fortunately, for direct comparison, two data sets were collected on a single AaPurE1fwf
crystal. The first data set was collected on home source and a second at the
synchronotron. Electron density was similar at the Tyr154 for both home source and
synchronotron data sets. In addition, comparison of early to late frames of synchrotron
data showed no difference in electron density (data not shown). Therefore, the “damage”
or density that spans across the subunit interface is always present regardless of the type
of energy the crystal is exposed to.
Crystals of AaPurE1 and AaPurE1fwf (radiated and un-radiated) were dissolved, run on
SDS-denaturing page, and visualized with silver staining. These ran exclusively as
monomers (Figure 3.18). LC-ESI-MS analysis of radiated crystals did not produce
useable signal (data not shown). LC-ESI-MS analysis of dissolved and digested unradiated crystals of AaPurE1 show no evidence of a cross-link, only peptides
corresponding to Tyr154 were observed (Figure 3.19).
Citrate Titrations of AaPurE1s. Citrate is a non-substrate active site ligand that binds
AaPurE1 weakly, under acidic conditions, leading to protein fluorescence quenching.26
While it has little resemblance to CAIR, citrate interacts with the protonated form of the
key His59 and all nucleotide-binding residues, except for the phosphate contact Ser32
and the exocyclic amine contacts in the 70s loop backbone. Therefore, titrations were
carried out in 50 mM potassium acetate, 100 mM KCl, pH 4.6 with all AaPurE1 forms to
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determine the fluorescence response of each mutant upon citrate addition. It is possible
that the acidic conditions destabilize the multiple-mutant variants more than others.
The fluorescence of all forms of AaPurE1s, with the exception of AaPurE1fyw-H59N, was
quenched by the addition of citrate (Table 3.7, Figure 3.20, and Appendix Figures A.1A.21). A comparison the single-Trp AaPurE1 mutants shows Trp34 and Trp165 have
opposing effects on fluorescence, and that most of the quenching is due to Trp97.
Interestingly, we do not observe the enhancement of Trp165 fluorescence unless an
inactive mutant is used.
The inactive AaPurE-H59N mutants show similar trends, but have lower citrate affinity
and a smaller quenching magnitude (Figure 3.20). The effect of H59N on fluorescence
quenching depends on the Trps present: H59N is associated with less quenching of Trp
fluorescence upon citrate binding, unless Trp97 and Trp165 are both present.
Surprisingly, AaPurE1 forms containing the Y154F mutation had diminished quenching
intensity, suggesting that it enhances the quenching of Trp97 fluorescence (Figure 3.12).
AIR Titrations of AaPurE1s. AIR is not a substrate for PurE1, it instead acts as a noncompetitive inhibitor.50 The addition of AIR to EcPurE1 does not result in an observable
fluorescence change,25 and it is small for AaPurE1 (C. Z. Constantine, unpublished
observations). This small increase in fluorescence proved to be the result of a fluorescent
species present in AIR (Chapter 2), which was derived from CAIR that had been
synthesized using LiOH mediated saponification procedure.28 To minimize the
contribution of the fluorescent species to saturation plots, titrations were performed using
an emission wavelength of 320 nm, which has less contribution from the fluorescent
species than at the AaPurE1 λmax of 338 nm.
AIR titrations were carried out in 50 mM Tris-HCl, pH 8.0 to determine the fluorescence
response of proteins containing only one Trp to determine which Trp fluorophore is the
most responsive to AIR addition.
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The addition of AIR to AaPurE1 or single-Trp AaPurE1 mutants had little or no effect on
fluorescence emission intensity (Table 3.7, Figure 3.21, and Appendix Figures A.1A.21).
A much larger change was observed for the addition of AIR to inactive forms containing
H59N (Figure 3.21). The H59N forms are impaired at binding AIR relative to active
AaPurE1s.

Single-Trp

AaPurE1-H59N

mutants

showed

approximately

equal

contributions from Trp34 and Trp97 to fluorescence enhancement, with Trp165 having a
smaller quenching response.
The obvious difference between the inactive and active forms is presence of His59. This
critical active site residue influences the overall fluorescence change and likely
camouflages the fluorescence enhancement seen in the inactive forms.
The AaPurE1 forms containing the Y154F mutation had no effect on AIR titrations
(Figure 3.21). Tyr154 has a slight effect with citrate and a marked effect with CAIR. The
electrostatic properties of the ligand may determine if Tyr154 has an effect on Trp97.
CAIR Titrations of Inactive AaPurE1s. CAIR is a substrate for the decarboxylation
reaction catalyzed by PurE1, and its addition results in an enhancement of AaPurE1H59N fluorescence.25 Conversely, CAIR addition to EcPurE1-H59N quenches
fluorescence. Therefore, CAIR titrations were carried out in 50 mM Tris-HCl, pH 8.0 to
determine the response of each AaPurE1 Trp fluorophore to CAIR addition.
The addition of CAIR to AaPurE1-H59N and single-Trp variants showed a similar trend
as the AIR titrations, with positive contributions from Trp34 and Trp97 and a quenching
contribution from Trp165 (Table 3.7, Figure 3.22, and Appendix Figures A.1, A.4-6, A.910, A.13, A.15, A.18-20).
Mutant AaPurE1 Kds were slightly higher than AaPurE1-H59N with the exception of
AaPurE1fyw-H59N. The increased Kds are likely associated with a decrease in stability.
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The Y154F mutation had a complicated effect, with enhancement relative to AaPurEH59N, suppression for two-Trp mutants, and elimination of the fluorescence
enhancement of AaPurEfwf-H59N (Table 3.7, Figure 3.22, and A.1, A.4-6, A.9-10, A.13,
A.15, A.18-20).
Identification of the Primary Emitter. A primary emitter is defined as the fluorophore that
is the most sensitive to ligand binding. There are three Trps within AaPurE1; however,
results indicate that Trp97 which, is not conserved in EcPurE1, is the primary
fluorophore. Therefore, further studies reported here will focus on Trp97 (or its
equivalent in TdPurE2).
Generation of AaPurE1fwf Containing 5FW. Incorporation on 5FW can be used to
determine the quenching mechanism associated with the primary emitter Trp97. The
addition of an electron-withdrawing fluorine to the indole ring of Trp raises the ionization
potential which should suppress quenching due to electron transfer.16 A diminution in
fluorescence! quenching upon incorporation of 5FW, would indicate if electron transfer
from the Trp indole is responsible.
Creation of AaPurE1fwf Plasmid with a T5 Promoter. AaPurE1 is normally produced
using a T7 system in BL21(DE3) cells, however this system does not tightly control
protein expression prior to induction. The successful incorporation of a 5FW analog into
AaPurE1fwf with a high yield requires tight expression control. Therefore, we created an
AaPurE1fwf plasmid with a T5 promoter to for protein expression in a DL41 Trp
auxotrophic strain. Standard molecular biology techniques were used to successfully
generate the AaPurE1fwf plasmid under the control of a T5 promoter (Table 3.3).
Expression and Isolation of AaPurE1fwf with 5FW. Control of induction is critical for
successful 5FW analog incorporation. The plasmid pCDFDuet, which contains the lacI
gene, was co-transformed with plasmid pJK698 to ensure AaPurE1fwf expression was
tightly controlled. Adding lacI cultures, which in addition were supplemented with
excess glucose (to suppress plasmid expression) and kept in log phase was necessary to
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control AaPurEfwf expression. These combined strategies allowed for the expression of
AaPurEfwf-5FW in DL41 cells without detectable protein expression until IPTG induction
(Figure 3.23).
AaPurE1fwf-5FW was successfully isolated using the previously published isolation
protocol26 with relatively high specific activity and purity (Figure 3.5-lane 21). To
confirm incorporation of 5FW, full-length proteins were analyzed by MALDI mass
spectrometry (Table 3.6). Only peaks corresponding to AaPurE1fwf-5FW were observed
and no signal corresponding to unlabeled AaPurE1fwf was identified (data not shown).
Absorbance and Fluorescence Emission Spectra of AaPurE1fwf. The incorporation of
5FW into AaPurE1fwf should have an effect on the absorbance and fluorescence emission
spectra. Absorbance spectra were obtained in 50 mM Tris-HCl, pH 8.0 containing either
AaPurE1fwf (168 µg mL-1) or AaPurE1fwf -5FW (123 µg mL-1) present and the same
solution was used to obtain fluorescence emission spectra with excitation at 295 nm.
AaPurE1fwf-5FW has shifted λmax values for both absorbance and fluorescence emission
spectra relative to AaPurE1fwf, with a large difference in the Stokes shift (AaPurE1fwf λmax
= 277

nm and 366 nm, and AaPurE1fwf -5FW λmax = 264 nm and 341 nm; for absorbance

and fluorescence respectively) (Figure 3.8). This indicates that 5FW was successfully
incorporated and suggests a difference in local environment for the residue at position 97,
or a small structural change in AaPurE1fwf-5FW. All attempts to obtain a crystal structure
of AaPurE1fwf -5FW resulted in poor diffraction.
Replacement of Trp with of 5FW analog typically results in a red shift of the
fluorescence emission spreturm.16,21,51 However, the AaPurE1fwf-5FW emission spectrum
is blue shifted by 5 nm. This change could be due to rearrangement of residues in close
proximity to the Trp or a conformational change somewhere else in AaPurE1fwf-5FW.
Quantum Yields of AaPurE1s. We obtained the λmax for absorbance and fluorescence
emission of AaPurE1fwf -5FW, next we wanted to obtain the other variable fluorescence
property, quantum yield. The AaPurE1fwf -5FW quantum yield was about twice that of
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AaPurE1fwf (Figure 3.9, Table 3.6). This was surprising, as the quantum yield of 5FW is
the same as the Trp in solution (Table 3.1).36 The environment surrounding 5FW in
AaPurEfwf may significantly enhance the quantum yield. Two possibilities exist to
enhance a quantum yield, either a positive charge is relocated near the benzene ring of
Trp97 or some intramolecular quenching group such as an amide is removed. However,
we do not have a crystal structure to examine either of these possibilities.
Quantum yields of AaPurE1s with Ligand Bound. If quenching of Trp97 fluorescence
occurs by electron transfer, then quantum yields with 5FW incorporated should be
diminished. Quantum yields for AaPurE1fwf and AaPurE1fwf -5FW were recorded in the
presence of either AIR or citrate (5 times the Kd). Citrate and AIR had no or very little
inner filter effect (0-4%) on the integrated fluorescence intensity of NATA (data not
shown). Quantum yields for AaPurE1fwf were determined using equation 3.1, after
correcting the integrated fluorescence values for any inner filter effect.
If ligand dependent quenching of Trp97 fluorescence is due to electron transfer, we
expect to see a lower quantum yield in AaPurE1fwf-5FW with citrate present. However,
the overall change in fluorescence observed in the presence of citrate is higher for
AaPurE1fwf-5FW (Table 3.11), indicating that fluorescence quenching does not occur by
electron transfer from the Trp indole.
We see the same effect when AIR is present (AaPurE1fwf-5FW quantum yield is not
diminished).
Citrate Titrations of AaPurE1fwf-5FW. AaPurE1fwf-5FW was quenched to about the same
extent as AaPurE1fwf. Incorporation of the 5FW analog produced very different binding
parameters, the citrate Kd for AaPurE1fwf-5FW is 88 times lower than AaPurE1fwf (Table
3.7 and Figure 3.26). Incorporation of 5FW may alter the environment of the active site,
which could lead to increased affinity.
AIR Titrations of AaPurE1fwf-5FW. Little increase in fluorescence occurred in
AaPurE1fwf-5FW upon AIR addition, which is consistent with data for other active PurE1
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forms (Figure 3.27). Incorporation of 5FW reduced the AaPurE1fwf-5FW Kd 2.8 times
lower than AaPurE1fwf (Table 3.7). Incorporation of 5FW alters the affinity of AaPurE1fwf
for both AIR and citrate. Again, indicating 5FW may alter the environment of the active
site, which may lead to increased affinity.
Mechanism of Ligand-Dependent Trp97 Fluorescence Quenching. The replacement of
Trp97 with 5FW was used to probe the mechanism of ligand-dependent fluorescence
quenching. No diminution in fluorescence upon ligand binding was observed in either
quantum yield determinations or titrations with AIR or citrate. The results indicate that
quenching occurs by non-radiative processes and not electron transfer.
Creation of TdPurE2-F79W Mutant. TdPurE2 does not contain any Trp residues.
Therefore, a TdPurE2 Trp introduction mutant (analogous to Trp97) was generated to
investigate the fluorescence response of the Trp fluorophore upon ligand binding.
Quikchange site directed mutagenesis repeatedly failed and instead cross-over PCR was
employed to generate the TdPurE2-F79W mutant. Sequencing confirmed that only the
intended mutations were obtained.
Purification of Recombinant TdPurE2 Tryptophan Introduction Mutant. The published
isolation protocol29 was successfully used to isolate TdPurE2-F79W with relatively high
specific activity and purity (Table 3.6. and Figure 3.28).
Citrate Titrations of TdPurE2-F79W. Citrate titrations have never been done before with
any TdPurE2. Therefore, titrations were carried out to determine if citrate binds to
TdPurE-F79W and has any effect on Trp79 fluorescence. The TdPurE2-F79W mutant
was quenched by the addition of citrate (Table 3.7 and Figure 3.29). The addition of
Trp79 to TdPurE2 produces fluorescence changes similar to AaPurE1fwf. However, there
is an obvious red shift in λmax that does not occur with AIR titrations of TdPurE2-F79W
(Figure 3.30). Citrate titrations are performed at pH 4.6, which may be destabilizing to
TdPurE2-F79W.
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AIR Titrations of TdPurE2-F79W. Unlike AaPurE1, AIR is a substrate for TdPurE2. AIR
titrations were carried out in 50 mM Tris-HCl, pH 8.0. TdPurE2-F79W showed little
change in fluorescence (8% ΔF/F0) upon addition of AIR, consistent with earlier studies
of active PurE1s (Table 3.7 and Figure 3.16).26,25 It was however, enough of a signal
change to obtain a Kd.
TdPurE2-F79W has an AIR affinity similar to AaPurE1 wild-type (Table 3.7). This is
slightly surprising because AIR is a substrate for TdPurE2, but is not a substrate for
AaPurE1. AIR inhibits AaPurE1 and PurK may serve to not only supply NCAIR, but to
also lower the concentration of AIR.
The single TdPurE2-F79W mutant is stable and is suitable for fluorescence titrations.
However, the addition of any additional mutations appears to destabilize the enzyme to
an extent that fluorescence titrations become impractical (Chapter 4).Therefore, TdPurE2
may prove to be unsuitable for fluorescence experiments. PurE2 from extremophilic
bacteria (that already contain a Trp residue) offer a potential alternative that may be
worth exploring.

3.4

Discussion

Initially this study had a single goal: to dissect the molecular basis of AaPurE1 and
TdPurE2 fluorescence responses to ligand binding using single-Trp forms. These forms
could then be used to monitor PurE1- and PurE2-medaited C C bond forming, in real
time. However, a single high-resolution AaPurE1fwf crystal structure revealed two
unexpected but relevant features: the primary emitter Trp97 adopts multiple rotamers and
a residue at the dimer interface (Tyr154), adopts multiple conformations and may be
chemically modified. This high-resolution structure led to the work discussed here: 1)
Investigation of changes in fluorescence induced by the binding of ligands to defined
single- and double-Trp forms of AaPurE1 and TdPurE2. 2) Characterization of the
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mutants of AaPurE1 position 154 to determine whether this disordered Tyr pair
contributes to net protein fluorescence and ligand-dependent fluorescence changes.
(1)

Investigation of fluorescence changes in single-Trp AaPurE1s and TdPurE2.

Trp97 is Responsible for the Differing Effects of CAIR on EcPurE1 and AaPurE1
Fluorescence. We determined that Trp97 is the primary fluorophore in AaPurE1. Our
initial hypothesis, based on simple sequence alignments, was that Trp97 would be
responsible for CAIR-dependent changes in the fluorescence of inactive H→N mutants
of EcPurE1 (fluorescence quenching) and AaPurE1 (fluorescence enhancement). No
evidence inconsistent with this hypothesis was found; Trp97 is therefore the best
candidate to explain the observed difference between highly homologous PurE1 forms.
Citrate Titrations Report on the Introduction of an Electron-Deficient Carbonyl Carbon
into the Carboxylate/CO2 Binding Pocket. Both PurE classes are proposed to generate a C
C bond using similar chemistry. We can monitor the C C bond forming reaction in
real-time using changes in intrinsic fluorescence that report upon electrostatic changes
within the active site. In order to follow these changes, and the reaction in real time, we
must first understand how AaPurE1 fluorescence is affected by the introduction of
electrostatics (electron-deficient carbonyl carbon of citrate or CO2 from CAIR and the
electron-rich aminoimidazole ring of AIR) into the active site.
Citrate is not a substrate for AaPurE1, but it binds to a region of the active site that
overlaps the nucleotide-binding site, leading to progressive quenching of protein
fluorescence.26
Citrate interacts with the critical active site His59 and several other residues that contact
the nucleotide portion of AIR or CAIR. In the wild-type AaPurE1 crystal structure with
citrate bound (PDB code 1u11), the pro-R arm of citrate interacts with Asp33 (the residue
that contacts the AIR 2’ and 3’ hydroxyls) and the central carboxylate forms a hydrogen
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bond with the protonated δ1-nitrogen of the His59 imidazole.26,27 The inactive AaPurE1H59N mutant binds citrate in a different position, with the pro-R arm occupying the
carboxylate/CO2 binding pocket and the pro-S arm interacting with Asp33. The central
carboxylate instead forms a hydrogen bond with the δ2-nitrogen of the Asn59.
Differences in citrate binding modes may account for some of the observed differences in
citrate Kds for active and inactive AaPurE1 mutants.
The addition of citrate (carrying an electron-deficient carbonyl carbon)52 appears to
quench the intrinsic fluorescence of TdPurE2-F79W and all AaPurE1 forms with one
exception, AaPurE1fyw-H59N. In the crystal structure of AaPurE1-H59N (PDB entry
2fwp) the indole ring of Trp165 is positioned near the central carboxylate of citrate
(Figure 3.1). The proximity of an electron-deficient carbonyl carbon to Trp165 may
slightly enhance its fluorescence unless His59 is also present. Since protonated His and
imidazole derivatives are known to quench indole fluorescence5,53,54 it seems possible
that a protonated His59 present in the active AaPurE1 forms might “mask” the
fluorescence-enhancing effect of Trp165. This apparent electrostatic effect may resemble
the effect of introducing an electron-deficient carbonyl carbon into the carboxylate/CO2
pocket during catalysis.
AIR Enhances Fluorescence in Inactive AaPurE1. Fluorescence enhancement is observed
upon the addition of AIR to inactive AaPurE1 forms but not to active AaPurE1 forms or
TdPurE-F79W.26 The only difference between these active and inactive AaPurE1 is the
active site His. Replacement of the positively charged His by the neutral Asn abrogates
catalytic activity, but may also alleviate intramolecular fluorescence quenching. This is
again consistent with the possibility that Trp97 fluorescence is sensitive to the
electrostatic environment within the active site pocket, with an effect proportional to the
net charge (i.e. more negative = more quenching).
Intramolecular quenching by a protonated His59 could explain the large fluorescence
enhancement upon AIR binding observed in inactive forms of AaPurE1. Protonated His
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contains an imidazolium ion capable of accepting an electron.14 Therefore, the His may
be an endogenous quencher of Trp97 fluorescence enhancement in the AIR bound
complex. There is some precedence for such an effect: the active site His in the wellstudied barnase has a similar intramolecular quenching effect. 55,56
Two rotamers of Trp97 were detected in the crystal structure of AaPurE1fwf, which are
present at about equivalent occupancies. The Trp97 A rotamer has a !1 = -83° while the
Trp97 B rotamer has a !1 = -97°. Both the rotamers have closer values for the !2 = -59 to
-65°. In the AaPurE1 structure bound to AIR (PDB code 2fwj), Trp97 adopts only the A
rotamer. Our working hypothesis is that the enhancement of AaPurE1 fluorescence upon
addition of AIR or CAIR is caused by increasing the contribution of the Trp97 A rotamer.
That is, a mixed population of Trp97 A and B rotamers may have lower fluorescence, but
the more florescent A rotamer predominates as AIR or CAIR binds.
CAIR Enhances AaPurE1 Fluorescence to a Lesser Extent than AIR. CAIR is a substrate
for AaPurE1 so binding equilibrium studies could only be performed using inactive
enzymes. Even in the “inactive” mutants, CAIR decarboxylates to the stable ternary
AIR•CO2 complex, directly detected in crystals of AaPurE1-H59N (PDB code 2fwp).26
Therefore, the fluorescence enhancement seen upon CAIR binding likely results from the
AIR•CO2 complex and not CAIR. To the extent that AIR binds to AaPurE1-H59N in the
presence or absence of CO2 - a somewhat controversial notion given that AIR is neither a
PurE1 substrate nor a particularly powerful competitive inhibitor – a comparison with
AIR titrations should give information on the net effect of CO2 in the active site.
The presence of CO2 could account for the differences in fluorescence enhancement
observed in titrations with AIR or CAIR. The results indicate that the additional presence
of CO2 leads to a smaller enhancement of protein fluorescence when AIR binds to a
given AaPurE-H59N form. Just as an electron-deficient carbonyl carbon (citrate)
quenches AaPurE1 fluorescence, the presence of CO2 in the CO2/carboxylate pocket may
suppress fluorescence enhancement due to AIR binding.
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AaPurE1fwf Fluorescence Quenching Does Not Occur by Electron Transfer. AaPurE1fwf5FW was used to determine if fluorescence quenching is the result of excited state
electron transfer from the Trp indole to a quenching moiety (Q = quenching moiety in
Figure 2.31). Indoles and indole derivatives such as Trp are good electron donors.14,15
However, the addition of a fluorine atom to the indole raises the ionization potential,
which should suppress ligand-dependent quenching caused by photoinitiated electron
transfer from the indole to an acceptor (quencher).16 If electron transfer is the mechanism
of quenching, one expects a smaller fluorescence change in a protein containing 5FW
instead of Trp.
The incorporation of 5FW did not affect the fluorescence changes linked to the binding of
either AIR or citrate, indicating that electron transfer from the Trp indole is not primarily
responsible in the observed fluorescence changes. Instead, the observed quenching of
fluorescence is likely due to some other form of radiationless energy transfer. However,
we cannot rule out that 5FW favors rotamer A since we have no structure.
TdPurE2-F79W is Not Suitable for Fluorescence Experiments. The long-term goal of this
project was to generate isostructural single-Trp forms of AaPurE1 and TdPurE2 to
monitor their C C bond forming reaction in real time, using stopped-flow spectroscopy.
This would provide a head-to-head comparison of the C C bond forming steps involved
in PurE1 and PurE2. Unfortunately, TdPurE2-F79W does not appear to be resilient
enough to mutations to permit a suitable comparison with AaPurE1.
While TdPurE-F79W appears to be stable enough for AIR fluorescence titrations, we it
eventually shows signs consistent with destabilization. A more significant problem is that
any additional mutation appears to create significantly less stable enzyme (Chapter 4).
Several purE2 genes have been recently annotated from thermophilic bacteria (Chapter
1), one or more of which may prove to be suitable for fluorescence studies comparing
PurE1 and PurE2.
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(2) Characterize the Tyr at the dimer interface of AaPurE1 and investigate its
contribution to fluorescence.
No Evidence for Formation of an Intersubunit Cross-Link in AaPurE1fwf. Collectively,
the results obtained from mass spectrometric and SDS-PAGE analyses indicate that no
more then ~10% of Tyr154 is modified, which places an upper limit on the fraction of
protein subunits that may be covalently linked. Since a cross-link has not been detected
by any means other than macromolecular crystallography, motional disorder and
conformational heterogeneity at this dimer interface is most probable cause for the
crystallographic findings. Refined crystal structures show that Tyr154 from each subunit
adopts two alternative conformations. One Tyr154 conformer in the AaPurEfwf structure
(PDB code 4ycb) closely resembles with the Phe154 conformer observed in both crystal
structures of Y154F mutants (PDB codes 4ycd and 4ycj).
Tyr154 has an Unexplained Contribution to Protein Fluorescence. Relative to Trp, Tyr is
not expected to have a large contribution to protein fluorescence. The excitation
wavelength used (295 nm) has little overlap with Phe and Tyr absorption spectra at
258nm and 275 nm, respectively. Tyr154 appears to relay information on ligand binding
to Trp97. The proximity of the phenol ring in each subunit could allow excited state
interactions between Tyr154 residues to red shift its excitation envelope.
AaPurE1 forms in which Trp97 is the sole fluorophore showed substantial difference
between AIR and CAIR titrations (Figures 3.20 and 3.21). The difference is particularly
pronounced for AaPurE1fwf-H59N,Y154F fluorescence, which was unchanged by the
addition of CAIR. The corresponding AaPurE1fwf-H59N still maintains moderate
fluorescence change in response to the addition of CAIR, indicting that the deletion of a
fluorophore (Tyr 154), which relays information on CAIR binding to Trp97 may be
responsible for the loss of AaPurE1fwf-H59N,Y154F fluorescence change. Alternatively,
the quadruple mutant AaPurE1fwf-H59N,Y154F may not stabilize the fluorescent Trp97
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A rotamer as well as other AaPurE1 forms. Therefore, we do not observe any
fluorescence enhancement upon CAIR addition.
The presence of CO2 within the PurE1•AIR•CO2 ternary complex and to a much lower
extent, the carboxylate of citrate in the CO2/carboxylate binding site appears to determine
if Tyr154 has any role in fluorescence response to ligand binding. If a protein is
engineered to contain Trp97 as the sole and primary fluorophore the presence of Tyr154
is required to elicit a fluorescence change in response to the electron deficient carbon in
the PurE1•AIR•CO2 complex.
Summary of Fluorescence Response in AaPurE1. Fluorescence changes that can be used
to monitor AaPurE1 kinetic parameters would be beneficial in investigating C

C bond

breakage and formation using real-time, using pre-steady state kinetics methods like
stopped-flow fluorescence spectroscopy.
Fluorescence quenching occurs from the addition of an electron-deficient carbonyl
carbon in citrate, and to a lesser extent of CO2 in the stable ternary AIR•CO2 complex.
Upon excitation, the electron density of the Trp is shifted from the pyrrole ring to the
benzene ring, increasing the permanent dipole moment of the indole (Figure 3.32). This
interaction of the electron-deficient carbonyl carbon (CO2 or citrate) in the
CO2/carboxylate pocket with the Trp indole may result in quenching of fluorescence.
Fluorescence enhancement results from the addition of AIR, unless His59 is present. Our
working hypothesis is that enhancement of fluorescence may result from a shift in a
mixed population of the fluorescent A and less-fluorescent B Trp97 rotamers to a
population predominated by the of the Trp97 A rotamer. Alternatively, enhancement of
fluorescence could result from the interaction of the electron-rich AIR aminoimidazole
with an endogenous quencher of the Trp indole such as a backbone amide.

!
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Quenching and enhancement of fluorescence is not due to electron transfer from the Trp
indole. It does appear that some form of resonance energy transfer is occurring between
the distant Tyr154 and the predominant fluorophore, Trp97.
The combined results indicate AaPurE1 and in some cases, AaPurE1fwf are the best forms
of PurE1 to use in future fluorescence studies. While AaPurE1fwf did not provide any
clear advantage over AaPurE1 in steady state fluorescence analysis, the single-Trp form
may be a cleaner reporter for pre-steady state analysis. A more stable PurE2 is needed for
future fluorescence studies

3.5

Future Directions

Acquisition of pre-steady state kinetic parameters with both active and inactive forms
should be done using stopped-flow with AaPurE1fwf and AaPurE1fwf-H59N.
A thermophilic PurE2 (preferably containing a Trp) should be characterized for future
experiments with the ultimate goal to compare C
class of PurE.

!
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Figures and Tables

Figure 3.1 AaPurE1 octamer with Trps and Tyr154 shown. (A) AaPurE1 (PDB code
2fwj) octamer shown along its four-fold symmetry axis (AIR depicted as spheres) and
each subunit shown in a different color. (B) Orientation of the AaPurE1 octamer shown
in cutaway in panel C. (C) AaPurE1 octamer presented in cutaway view to show Trp and
Tyr154 positions relative to AIR. Colors of subunits are the same as panels A and B. The
gray plane is the interior of the protein; all residues shown are between the plane and the
viewer. All distances (in Å) between AIR N3 and the nearest indole or phenol are
indicated.

Table 3.1 Fluorescence emission properties of Trp analogs.
Analog

λmax, nma

Φb

N-Acetyl-L-tryptophanamide

356

0.14

5-hydroxytryptophan

341

0.22

7-azatryptophan

415

0.01

5-fluorotryptophan

358

0.14

4-fluorotryptophan

na

≤0.0014

a
b

!

λmax values from literature 3,23
Φ; quantum yield values from literature measured in pH 7 water at 20 ºC.3,23
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Figure 3.2 Commonly used tryptophan analogs.
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Arg46&

Ala73&
Asp19&
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Figure 3.3 Structures of AaPurE1-H59N and EcPurE1-H45N with AIR•CO2 and CAIR
bound. Left: AaPurE1-H59N (PDB code 2fwp). and Right: EcPurE1-H45N (PDB code
2nsl) active sites are shown with active site contacts to AIR•CO2 and CAIR shown. CAIR
has different chemical outcomes between the PurE1s and might lead to different
fluorescence responses. The AIR and CO2 are not co-planar in AaPurE1, but are coplanar in EcPurE1. Electron density maps for 2Fo-Fc (blue mesh) are contoured at 1.0 σ
and have a carve radius of 2.0 Å.
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Figure 3.4 Illustration of cross-over PCR used to generate the TdPurE2-F79W mutant.

Table 3.2 E.coli strains used in this chapter.
Strain
DH5α

Description
F′ φ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1

Source
Lab stock

BL21(DE3)

F– ompT gal dcm lon hsdSB(rB- mB-)
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])

Lab stock

CC1215

F– ompT gal dcm lon hsdSB(rB- mB-) ΔpurE736::kan
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])

Lab stock

DL41

F-, λ-, metA28, trp

E. coli Genetic Stock
Center

!
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Table 3.3 Oligodeoxynucleotides (ODNs) used in this chapter.
a

ODN

Sequence (5’→3’)
2042
CCAGTCAGACTtcGAAACCATGCGCCA
AaPurE1-W34F
2043
TGGCGCATGGTTTCgaAGTCTGACTGG
AaPurE1-W34F
2044
CCTTGAAACATttCGCGCATTGCAG
AaPurE1-W165F
2045
CTGCAATGCGCGaaATGTTTCAAGG
AaPurE1-W165F
2048
GTTTCAGCAaATCGTACGCCAGACCGGTTGGC
AaPurE1-H59N
2049
CGTACGATtTGCTGAAACAATGAGGGTTTCATGCG
AaPurE1-H59N
2109
GTATGTGTGCGGCATatACACGCCTGCCCGTG
AaPurE1-W97Y
2110
CACGGGCAGGCGTGTATatGCCGCACACATAC
AaPurE1-W97Y
2170
GGGCCGGGTTAaACAGTGCAAGAATGG
AaPurE1-Y154F
2171
CCATTCTTGCACTGTtTAACCCGGCCC
AaPurE1-Y154F
2172
GCAAGGGCCGGGTTtaACAGTGCAAGAATGG
AaPurE1-Y154L
2173
CCATTCTTGCACTGTtaAACCCGGCCCTTGC
AaPurE1-Y154L
2174
GGCAAGGGCCGGGTTgatCAGTGCAAGAATGG
AaPurE1-Y154I
2175
CCATTCTTGCACTGatcAACCCGGCCCTTGCC
AaPurE1-Y154I
2329
GGTTGCACCTTTGACccAGCCATCAACAAAG
AaPurE1-F79W
2330
CTTTGTTGATGGCTggGTCAAAGGTGCAACC
AaPurE1-F79W
2410
CCGAGATCTCCCCGAAAAGTGCCACCTG
T5 promoter region
2411
GCTCATCATATGTTAATTTCTCCTCTTTAATGAATTC
T5 promoter region
a
Changes in the coding region that deviate from the genomic sequence are in lower case.

Table 3.4 Previously published plasmids used in this chapter.
Plasmid

Description

Source

Protein encoded

pET23a
pCDFDuet
acs1
pJK175
pJK283

Expression vector
Expression vector
acs1 in pQE80
purE1Aa in pET23a
purE1Aa-H59N in pET23a

Novagen
Novagen
Addgene

na
na
na
AaPurE
AaPurE-H59N

a!na-

!

not applicable!

26
26
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Table 3.5 Newly generated plasmids used in this chapter.
Plasmid
Three Trp
pJK601
pJK602
Two Trp
pJK506
pJK663
pJK510
pJK664
pJK505
pJK603
pJK509
pJK604
One Trp
pJK526
pJK666
pJK507
pJK508
pJK600
pJK559
pJK562
pJK525
pJK665
pJK698
pJK500
pJK501
pJK648

!

!

Description

Protein encoded

purE1Aa-Y154F in pET23a
purE1Aa-H59N,Y154F in pET23a

AaPurE-Y154F
AaPurE-H59N,Y154F

purE1Aa-W165F in pET23a
purE1Aa-Y154F,W165F in pET23a
purE1Aa-H59N,W165F in pET23a
purE1Aa-H59N,Y154F,W165F in pET23a
purE1Aa-W34F in pET23a
purE1Aa-W34F, Y154F in pET23a
purE1Aa-W34F, H59N in pET23a
purE1Aa-W34F,H59N,Y154F in pET23a

AaPurEwwf
AaPurE wwf-Y154F
AaPurEwwf-H59N
AaPurE wwf-H59N
AaPurEfww
AaPurE fww-Y154F
AaPurEfww-H59N
AaPurE fwwH59N-Y154F

purE1Aa-W97Y,W165F in pET23a
purE1Aa-H59N,W97Y,W165F in pET23a
purE1Aa-W34F, W165F in pET23a
purE1Aa-W34F, H59N, W165F in pET23a
purE1Aa-W34F,H59N,Y154F,W165F in pET23a
purE1Aa-W34F,Y154F,W165F in pET23a
purE1Aa-W34F,Y154L,W165F in pET23a
purE1Aa-W34F,W97Y in pET23a
purE1Aa-W34F,H59N,W97Y in pET23a
purE1Aa-W34F, W165F in pET23a with T5 promoter
purE1Ec-W20F in pET23a
purE1Ec-W20F in pET23a
purE2Td-F79W in pET23a

AaPurEwyf
AaPurE wyf-H59N
AaPurEfwf
AaPurEfwf-H59N
AaPurEfwf-H59N,Y154F
AaPurEfwf-Y154F
AaPurEfwf-Y154L
AaPurEfyw
AaPurE fyw-H59N
AaPurE fwf
EcPurE1-W20F
EcPurE-W151F
TdPurE-F79W
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Figure 3.5 Fluorescence emission spectra of EcPurE1-W20F and EcPurE1-W151F.
EcPurE1s were present at 30 µM [subunit]. The excitation wavelength was 295 nm. The
λmax EcPurE1-W20F is 330 nm and the λmax for EcPurE1-W151F is 337 nm.
!
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Table 3.6 Mass spectrometric analysis of AaPurE1 forms.
AaPurE1form

Observed Mass (Da)

Expected Mass (Da)a

Difference

Three Trp
18867b

18867

0

AaPurE1-H59N

18845

c

18844

-1

AaPurE1-H59N, Y154F

18827

18828

+1

AaPurE1-Y154F

18850

18852

+2

AaPurE1wwf

18829

18828

-1

AaPurE1wwf-Y154F

18812

18812

0

AaPurE1wwf-H59N

18810

18805

-5

AaPurE1wwf-H59N,Y154F

18790

18798

+8

AaPurE1fww

18830

18828

-2

AaPurE1fww-Y154F

18813

18812

-1

AaPurE1fww-H59N

18805

18805

0

AaPurE1fww-H59N, Y154F

18791

18789

-2

AaPurE1wyf

18802

18805

+3

AaPurE1wyf-H59N

18789

18782

-7

AaPurE1fwf

18790

18789

-1

AaPurE1fwf-H59N

18766

18766

0

AaPurE1fwf-H59N, Y154F

18752

18750

-2

AaPurE1fwf-Y154F

18774

18773

-1

AaPurE1fwf-Y154L

18739

18739

0

AaPurE1fyw

18797

18805

-8

AaPurE1fyw-H59N

18786

18782

-4

AaPurE1 (wild-type)

Two Trp

One Trp

AaPurE1fwf-5-FW
18804
18806
+2
Molecular masses ([M+H+]+) were determined by MALDI. Expected masses were calculated using
ExPaSy
ProtParam.
All
AaPurE1s
have
an
additional
N-terminal
Met26.
b
26
c
ESI-MS observed 18865 (expected 18865.7).
c
26
ESI-MS observed 18842 (expected 18842.7).
a
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Figure 3.6 SDS-PAGE analysis of a representative AaPurE1 Trp mutant (AaPurE1fwf)
isolation. A 12% polyacrylamide gel was loaded with 5 ug protein per lane: M, Sigma
biotinylated marker; S, soluble lysate; CL, cleared lysate; HA, hydroxyapatite input; and
ISO, isolated AaPurE1-S57V. Molecular weights (kDa) are denoted along the left side of
the gel.
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Figure 3.7 SDS-PAGE analysis of isolated AaPurE1 forms. A 12% polyacrylamide gel
was loaded with 5 ug protein per lane: M, Sigma biotinylated marker; AaPurE1 is
denoted by wt; 1, AaPurE1-H59N; 2, AaPurE1-H59N,Y154F; 3, AaPurE1-Y154F; 4,
AaPurE1wwf; 5, AaPurE1wwf-Y154F; 6, AaPurE1wwf-H59N; 7, AaPurE1wwf-H59N,Y154F;
8, AaPurE1fww; 9, AaPurE1fww-Y154F; 10, AaPurE1fww-H59N; 11, AaPurE1fwwH59N,Y154F; 12, AaPurE1wyf; 13, AaPurE1wyf-H59N; 14, AaPurE1fwf; 15, AaPurE1fwfH59N; 16, AaPurE1fwf-H59N,Y154F; 17, AaPurE1fwf-Y154F; 18, AaPurE1fwf-Y154L;
19, AaPurE1fyw; 20, AaPurE1fyw-H59N; and 21, AaPurE1fwf-5FW. Molecular weights
(kDa) are denoted along the left side of the gel.
!
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Figure 3.8 Gel-filtration analysis of AaPurE1 forms containing all three Trps. The traces
Figure S1: Gel-filtration analysis of AaPurE forms containing all three Trp residues.
are shifted 0.01 A . The PurE1 octamer elutes at ~57 mL and aggregate elutes within
Successive traces are280shifted 0.01 A280 . The completely excluded (Vo , 44.7 mL) and
the excluded volume. The completely excluded (Vo, 44.7 mL) and included (Vi, 113.6
included (Vi , 113.6 mL) volumes are indicated.
mL) volumes are indicated with arrows above.
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Table 3.7 Specific activities and dissociation constants for selected proteins.
ΔF

Kd (µM)

PurE1 or PurE2 form

rSAa

Citrateb

AIRc

CAIRc

Citrateb

AIRc

CAIRc

AaPurE1 (wild-type)

1.0d

-0.214

0.040

nae

275f

2.2

na

AaPurE1-H59N

~0d

-0.198

0.309

0.140

560g

0.61

0.96h

AaPurE1-H59N, Y154F

~0

-0.154

0.310

0.314

870

1.3

1.4

AaPurE1-Y154F

0.8

-0.214

-0.024

0.312

275

0.6

na

AaPurE1wwf

1.0

-0.319

~0

na

247

isi

na

AaPurE1wwf-Y154F

0.87

-0.366

~0

na

390

is

na

AaPurE1wwf-H59N

~0

-0.199

0.382

0.21

700

1.45

3.5

AaPurE1wwf-H59N,Y154F

~0

-0.294

0.302

0.078

530

1.36

1.4

AaPurE1fww

0.8

-0.326

-0.050

na

820

1.1

na

AaPurE1fww-Y154F

0.6

-0.234

-0.051

na

285

1.2

na

AaPurE1fww-H59N

~0

-0.326

0.337

0.33

820

1.57

2.8

AaPurE1fww-H59N, Y154F

~0

-0.177

0.290

0.24

780

1.57

4.8

0.54

-0.233

~0

na

220

Is

na

~0

-0.117

0.235

0.208

420

1.60

3.8

0.90

-0.368

-0.050

na

210

1.4

na

AaPurE1fwf-H59N

~0

-0.285

0.268

0.107

520

4.3

5.7

AaPurE1fwf-H59N, Y154F

~0

-0.221

0.236

~0

500

3.5

is

AaPurE1fwf-Y154F

0.7

-0.228

-0.062

na

283

1.3

na

AaPurE1fwf-Y154L

0.7

-0.213

-0.090

na

259

1.8

na

AaPurE1fyw

0.59

-0.170

~0

na

180

is

na

AaPurE1fyw-H59N

~0

0.088

-0.069 j

-0.051j

900

2.7

0.31j

AaPurE1fwf-5-FW

0.78

-0.393

-0.078

na

2.4

0.47

na

93

-0.240

-0.110

na

43

3

na

AaPurE1wyf
AaPurE1wyf-H59N
AaPurE1fwf

TdPurE2-F79W
a

rSA, specific activity relative to wild-type AaPurE1(39 units per mg protein, determined at 0.1 mM CAIR, pH 8, and °C).
b
Determined at pH 4.6 and 25 Representative spectra and fits to equation 3.1 are given in the Appendix as panels A and B of Figures A.1-A.22.
c
Determined at pH 8 and 30 °C Representative spectra and fits to equation 3.2 (except as noted) are given in the Appendix as panels C and D of Figures
A.1-A.22(AIR) and panels E and F of Appendix Figures A.1, A.4-6, A.9-10, A.13, A.15, A.18-20 (CAIR).
d
rSA, % specific activity in the CAIR decarboxylation reaction relative to wild-type AaPurE1 (39 U mg-1) and TdPurE2 (185 U mg-1) at 100 µM CAIR,
pH 8.0, 30 °C.
e
na, not applicable
f
0.4 mM reported previously.26
g
2 mM reported previously.26
h
0.78 µM reported previously.26
i
is, insufficient signal change.
j
Fit to equation 3.2.
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Figure 3.11 Electron density maps for the residues 34, 97, and 165 in AaPurE1.
Individual Phes and Trps and the residues within 10 Å are shown for AaPurE1 (PDB
code 1u11) in dark gray and AaPurE1fwf (PDB code 4ycb) in yellow. (A) Trp34 of
AaPurE1 shown. (B) Trp97 of AaPurE1 shown. (C) Trp165 of AaPurE1 shown. (D)
Phe34 of AaPurE1fwf shown. (E) Trp97 alt conformations of AaPurE1fwf shown. (F)
Phe165 of AaPurE1fwf shown. (G-I) The alignment of residue 34, Trp97, and residue 165
of AaPurE and AaPurE1fwf are shown. Electron density maps 2Fo-Fc (blue mesh) are
contoured at 1.8 σ and all maps have a carve radius of 2.0 Å.
!
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Table 3.8 X-ray data collection statistics.
AaPurE1fwf
Y154L
Y154F
PDB entry
4ycb
4ycc
4ycd
Beamline
21-ID-G
21-ID-F
21-ID-F
Wavelength (Å)
0.97856
0.97872
0.97872
Space group b
I422
I422
I422
Unit cell param.
a=b= 99.803,
a=b=99.458,
a=b=100.336,
(Å)
c= 164.409
c=165.567
c=165.712
Resolution (Å)
50-1.35
50-2.25
50–1.65
a
(2.29-2.25)
(1.68–1.65)
(1.37–1.35)
No. meas. refl.
1,319,978
158,696
419,831
No. unique refl.
90,070 (3925)
19,660 (950)
51,530 (2538)
Completeness (%) 99.2 (87.5)
98.9 (99.6)
100 (100)
Multiplicity
14.7 (22.9)
8.1 (20.7)
8.1 (20.3)
Rmerge (%) c
7.1 (52.3)
10.2 (22.8)
8.7 (53.8)
Mean I/σ (I)
48.1 (2.0)
37.2 (10.6)
26.8 (3.6)
VM (Å3 Da-1) d
2.49
2.49
2.53
Est. solvent (%)
50.5
50.6
51.5
a
Values in parenthesis are for the highest resolution shell.
b
All have α=β=γ=90°.
c

d

!

Rmerge =

!!!" !!!|!!! ! !!" ! !(!!") |
!!!" !!!! !! (!!")

!(ℎ!") is its mean value.
Matthews coefficient.

AaPurE1
Y154F
4ycj
21-ID-G
0.97856
I422
a=b= 99.761,
c= 165.008
50-1.84
(1.88-1.84)
429,790
35,774 (1748)
100 (100)
12.0 (11.7)
7.8 (55.1)
44.1 (5.4)
2.48
50.4

, where Ii (hkl) is the ith measurement of the intensity of reflection hkl and
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Table 3.9 Summary or refinement statistics.
4ycb
31.6-1.35
a
(1.37-1.35)

PDB entry
Resolution(Å)

AaPurE1fwf
Y154L
4ycc
49.7-2.24
(2.36-2.34)

No. reflections used
working
89999
19350
test set
3547
933
Completeness (%)
99.2
96.2
Rcrystb(%)
14.0 (23.43)
13.5 (14.3)
Rfreec(%)
14.9 (25.8)
17.2 (20.2)
No. of atoms
all atoms
2963
2554
protein atoms
2519
2328
solvent atoms
397
215
R.m.s. deviations from ideality
Bondlengths (Å)
0.011
0.008
Bond angles (°)
1.110
1.089
Average isotropic B factors (Å2)
protein atoms
13.8
26.7
ligand atoms
40.7
54.3
solvent atoms
35.7
27.9
Ramachandran plot statistics (%)
Residues in favored regions
99.1
98.8
Residues in allowed regions 0.7
1.3
Outliers
0.4
0.4
MolProbity score [percentile]
1.27 (94)
1.13 (100)
MolProbity clashscore
5.12(89)
3.35 (99)
[percentile]
a
Values in parenthesis are for the highest resolution shell.
!
!||!!
!|! !!"#! |
b
Rcryst = = !!" !"#
c

!

!!!" !|!!!"# !|

Y154F
4ycd
47.9-1.63
(1.67-1.63)

AaPurE1
Y154F
4ycj
35.5-1.84
(1.90-1.84)

49684
1966
96.0
15.6 (17.6)
17.4 (22.6)

34671
1481
95.8
13.5 (15.1)
15.4 (68.8)

2752
2341
396

2841
2446
355

0.006
1.091

0.007
0.985

14.1
45.9
31.2

20.6
49.6
38.8

98.8
1.2
0.4
1.03 (100)
5.50 (99)

98.8
0.7
0
1.07 (98)
2.79 (99)

Rfree is Rcryst with a test set of 5% of the reflections excluded from refinement.

104

Figure 3.12 Electron density at residue 154 in multiple AaPurE1 forms. Each panel
represents the pseudo two-fold NCS symmetry axis at the dimer interface; the axis runs
through each figure from the bottom right corner to the upper left corner between
residues 154A and 154B. Electron density maps (shown for residues 78 and 154) for 2FoFc (blue mesh) are contoured at 1.0 σ, Fo-Fc positive differences (green mesh) are
contoured at +3.0 σ, Fo-Fc negative differences (red mesh) are contoured at -3.0 σ, and all
maps have a carve radius of 2.0 Å. (A) AaPurE1 (PDB code 1u11). (B) AaPurE1-H59N
(PDB code 2fw9). (C) AaPurE1fwf (PDB code 4ycb). (D) AaPurE1fwf-Y154F (PDB code
4ycd). (E) AaPurE1-Y154F (PDB code 4ycj). (F) AaPurE1-Y154L (PDB code 4ycc).

!

105

Figure 3.13 Electron density at Tyr68 in both AaPurE1fwf subunits. (PDB code 4ycb)
Electron density maps for 2Fo-Fc (blue mesh) are contoured at 1.0 σ, Fo-Fc positive
differences (green mesh) are contoured at +3.0 σ, Fo-Fc negative differences (red mesh)
are contoured at -3.0 σ, and all maps have a carve radius of 2.0 Å around residue 68. (A)
Tyr68 from subunit A. (B) Tyr68 from subunit B.
Table 3.10 R-Factors and RSCC154 values for AaPurE1 structures.

a
b

!

PDB entry

AaPurE1

dmin (Å)

Rwork (%)

Rfree (%)

RSCC154b

Ref.

1u11a

WT

1.55

16.2

17.7

0.785/0.785

27

2fw1a

WT

2.00

17.3

18.1

0.869/0.875

26

2fw6a

H59N

1.85

16.3

17.9

0.856/0.813

26

2fw7a

H59N

1.75

16.1

17.5

0.856/0.860

26

2fw8a

H89G

1.75

16.7

18.8

0.904/0.820

26

2fw9a

H59F

1.75

16.4

18.6

0.890/0.856

26

2fwaa

H89N

1.90

17.4

19.3

0.799/0.821

26

2fwba

H89F

2.00

17.3

19.0

0.885/0.866

26

2fwia

H59D

1.94

16.6

18.1

0.872/0.843

26

2fwja

WT

1.95

16.1

18.7

0.815/0.869

26

2fwpa

H59N

1.85

17.3

20.1

0.827/0.858

26

4ycb

fwf

1.35

16.2

17.3

0.877/0.816

This study

4ycd

fwf-Y154F

1.65

14.8

18.2

0.981/0.976

This study

4ycc

fwf-Y154F

2.25

15.6

17.4

0.948/0.954

This study

4ycj

Y154F

1.84

15.7

16.9

0.979/0.969

This study

Previously deposited-RSCC values are computed after the Asn78 flip was completed.
Values are for subunit A and B, respectively.
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Figure 3.14 LC-MS analysis of AaPurE1 peptide from solution. (A) Total ion count
chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from LC that
contain masses corresponding to the peptide of interest (666 and 999 m/z). (E) Mass
spectrum from elutions (4.88-4.99 min) that contains the expected masses for the +2 (999
Da) and +3 (666 Da) peptide of interest.
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+3

+2

NAALLAASILALFNPALAAR

Figure 3.15 LC-MS analysis of AaPurE1-Y154F peptide from solution. (A) Total ion
count chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from
LC that contain masses corresponding to the peptide of interest (661 and 991 m/z). (E)
Mass spectrum from elutions (5.28-5.36 min) that contains the expected masses for the
+2 (991 Da) and +3 (661 Da) peptide of interest.
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+3

NAALLAASILALYNPALAAR

+2

Figure 3.16 LC-MS analysis of AaPurE1fwf peptide from solution. (A) Total ion count
chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from LC that
contain masses corresponding to the peptide of interest (666 and 999 m/z). (E) Mass
spectrum from elutions (6.73-6.93 min) that contains the expected masses for the +2 (999
Da) and +3 (666 Da) peptide of interest.

!

109
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Figure 3.17 LC-MS analysis of AaPurE1fwf-Y154F peptide from solution. (A) Total ion
count chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from
LC that contain masses corresponding to the peptide of interest (661 and 991 m/z). (E)
Mass spectrum from elutions (7.04-7.29 min) that contains the expected masses for the
+2 (991 Da) and +3 (661 Da) peptide of interest.
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Figure 3.18 SDS-PAGE analysis of irradiated and dissolved AaPurE1 crystals. A 12%
polyacrylamide gel was loaded with 25 ng protein per lane and visualized with silver
staining. AaPurE1 is labeled on the left gel and AaPurE1-Y154F is on the right gel. Key
to symbols: M, Sigma wide molecular weight marker; S, protein from solution; C,
dissolved crystals; and IR, irradiated and dissolved crystals. Molecular weights (kDa) are
denoted along the left side of the gel.
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Figure 3.19 LC-MS analysis of dissolved AaPurE1 crystals. (A) Total ion count
chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from LC that
contain masses corresponding to the peptide of interest (666 and 999 m/z). (E) Mass
spectrum from elutions (5.15-5.23 min) that contains the expected masses for the +2 (999
Da) and +3 (666 Da) peptide of interest.

!

112

Figure 3.20 Fluorescence titrations of wild-type and inactive AaPurE1 forms with citrate.
Observed fluorescence emission intensity at 320 nm, as a function of AIR is represented
by the symbols: AaPurE1 (black filled circles), AaPurE1-H59N (red open circles),
AaPurE1wyf-H59N (cyan filled triangles), AaPurE1fwf-H59N (green filled diamonds),
AaPurE1fwf-H59N, Y154F (blue open diamonds), and AaPurE1fyw-H59N (purple filled
inverted triangles). Solid lines are the observed data fit using gnu plot with equation 3.2
!

Figure 3.21 Fluorescence titrations of wild-type and inactive AaPurE1 forms with AIR.
Observed fluorescence emission intensity at 320 nm, as a function of AIR is represented
by the symbols: AaPurE1 (black filled circles), AaPurE1-H59N (red open circles),
AaPurE1wyf-H59N (cyan filled triangles), AaPurE1fwf-H59N (green filled diamonds),
AaPurE1fwf-H59N, Y154F (blue open diamonds), and AaPurE1fyw-H59N (purple filled
inverted triangles). Solid lines are the observed data fit using gnu plot with equation 3.3,
with the exception of AaPurE1.
!
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Figure 3.22 Fluorescence titrations of inactive AaPurE1 forms with CAIR. Observed
fluorescence emission intensity at 320 nm, as a function of CAIR is represented by the
symbols: AaPurE1-H59N (red open circles), AaPurE1wyf-H59N (cyan filled triangles),
AaPurE1fwf-H59N (green filled diamonds), AaPurE1fwf-H59N, Y154F (blue open
diamonds), and AaPurE1fyw-H59N (purple filled inverted triangles). Solid lines are the
observed data fit with equation 3.3.
!
Pre/IPTG# Post/IPTG#
##M########C#########S#########C#########S#
58#
39#
29#
20#

14#

Figure 3.23 SDS-PAGE analysis of AaPurE1fwf-5FW and pCDFDuet expression in
DL41. A 12% polyacrylamide gel was loaded with 5 µg protein per lane: M, Sigma
biotinylated marker; C, crude lysate; and S, soluble lysate. The Pre-IPTG samples were
taken before washing steps and the post-IPTG samples were taken after final harvest of
cells. Molecular weights (kDa) are denoted along the left side of the gel.
!
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Figure 3.24 Absorbance spectra and fluorescence emission spectra for AaPurE1fwf and
AaPurE1fwf-5FW. AaPurE1fwf absorbance spectra are shown in red and fluorescence
emission spectra (Excitation at 295 nm) are shown in dark red. AaPurE1fwf -5FW
absorbance spectra are shown in light blue and fluorescence emission spectra are shown
in dark blue. The λmax for absorbance and fluorescence spectra of AaPurE1fwf and
AaPurE1fwf-5FW are Abs = 277 nm, F = 366 nm and Abs = 264 nm, F = 341 nm;
respectively.
!
Table 3.11 Quantum yields for AaPurE1fwf and AaPurE1fwf-5FW.
Sample
NATA
L-Trp
AaPurE1fwf
AaPurE1fwf -5FW
a
not determined.
b
value from literature36

!
!

!

Unliganded
Quantum yield
nda
0.14b
0.039 ± 0.004
0.088 ± 0.002

Quantum yield
with AIR
nd
0.14
0.042
0.096

Quantum yield
with citrate
nd
0.14
0.039
0.083

Conc. Protein
(µg mL-1)
9.0
8.4
168
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Figure 3.25 Fluorescence emission spectra used to determine quantum yields for
AaPurE1fwf and AaPurE1fwf-5FW. Emission spectra of NATA, L-Trp, AaPurE1fwf and
AaPurE1fwf-5FW with excitation at 295 nm. All solutions had an absorbance of 0.06 AU
and quantum yield values are listed in Table 2.5.
!
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Figure 3.26 Fluorescence titrations with AaPurE1fwf-5FW with citrate. Excitation
wavelength was 295 nm. Citrate titrations were performed with 0.2 µM [subunit] in 50
mM acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values
are given in Table 3.7. (A) Fluorescence emission spectra with increasing amounts of
citrate. (B) Recorded emission at 320 nm upon citrate addition was plotted as a function
of [citrate] and data were fit using equation 3.5 using gnu plot. The Kd values are listed in
Table 3.7.
!
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Figure 3.27! AIR Fluorescence titrations with AaPurE1fwf-5FW. Excitation wavelength
was 295 nm. AIR titrations were performed with 0.18 µM [subunit] in 50 mM Tris-HCl,
pH 8 at 30 °C and data were fit to equation 3.2. Kd values are given in Table 3.7. (A)
Fluorescence emission spectra with increasing amounts of AIR. (B) Recorded emission at
320 nm upon AIR addition was plotted as a function of [AIR] and data were fit using
equation 3.6 using gnu plot. The Kd values are listed in Table 3.7.
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Figure 3.28 SDS-PAGE analysis of isolated TdPurE2 Trp introduction forms. A 12%
polyacrylamide gel with 5 ug protein loaded per lane: 12% polyacrylamide gel was
loaded with 5 ug protein per lane: M, Sigma biotinylated marker. Each mutation in Ser 38
is indicated by the one letter code directly above each lane. Each mutation to introduce a
Trp into TdPurE2 is indicated above the solid line. Molecular weights (kDa) are denoted
along the left side of the gel.
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Figure 3.29 Citrate fluorescence titrations of TdPurE2-F79W. Excitation wavelength was
295. Citrate titrations were performed with 0.4 µM [subunit] in 50 mM potassium acetate,
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.5. Kd values are given in
Table 3.7. (A) Fluorescence emission spectra of TdPurE2-F79W recorded in 50 mM
potassium acetate, 100 mM KCl, pH 4.6 at 25 °C with an excitation of 295 nm. (B)
Fluorescence emission intensity at 320 nm was plotted as a function of [citrate] and data
were fit using equation 3.5 using Origin software. The Kd values are listed in Table 3.7.

A"

B"

Figure 3.30 AIR fluorescence titrations of TdPurE2-F79W. Excitation wavelength was
295 AIR titrations were performed with 0.56 µM [subunit] in 50 mM Tris-HCl, pH 8 at
30 °C. (A) Fluorescence emission spectra with increasing amounts of AIR. (B) Recorded
emission at 320 nm upon AIR addition. Titrations were performed with [subunit] of 0.4
µM. Fluorescence emission intensity at 320 nm was plotted as a function of [AIR] and
data were fit using equation 3.5 using Origin software. The Kd values are listed in Table
3.7.
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Figure 3.31 Scheme for excited state electron transfer from the Trp indole to a quenching
moiety (Q). Q could be the ligand or some other intramolecular quenching group in the
protein (e.g. a backbone amide).
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Figure 3.32 Electron density of the Trp indole in the excited state. The teal circles
represent the relative electron density in Trp at the ground state or excited state. When
excited, the electron density shifts from the pyrrole ring to the benzene ring and creates a
temporary dipole.
!
!

!

!

119

CHAPTER 4 ROLE OF THE CONSERVED ACTIVE SITE SERINE RESIDUE IN
PURE1 AND PURE2
!
!
!
4.1

Introduction

PurE1 and PurE2 have similar structures and similar active sites. Crystal structures of
PurE1 and PurE2 with AIR bound (PDB codes 2fwj and 3rgg)1,2 reveal that the
universally conserved Ser is the sole polar contact between the substrate aminoimidazole
ring and any PurE side chain. Due to its strict conservation in both PurE classes, Ser was
thought to have a similar role in both enzymes.
PurE1 and PurE2 Carbon-Carbon Bond-Forming Chemistry is Conserved. PurE1 and
PurE2 appear to form a new C−C bond, the conversion of PurE•AIR•CO2 to PurE•CAIR,
the same way (Figure 4.1).3 An absolute difference is the source of CO2: PurE1 acquires
it by decarboxylation of bound NCAIR (or CAIR), while PurE2 binds it directly.
PurE1 converts either NCAIR or CAIR to a PurE•AIR•CO2 ternary complex from which
CO2 does not escape (brackets in Figure 4.1). Confining CO2 in PurE1 preserves the
investment made by PurK, which uses ATP to activate bicarbonate (Chapter 1). A strong
electrostatic interaction between the polarized C4 of AIR and CO2 may help PurE1 to
achieve quantitative retention of the transiently formed CO2 within the active site.
Hydrogen bonds involving AIR N3 with the conserved 40s loop Ser and the 70s loop
backbone carbonyls with the exocyclic amine N6 may further polarize AIR and promote
the reaction between AIR C4 and CO2.
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The 40s Loop Ser May Have Different Roles in Each PurE Class. The PurE1 and PurE2
active sites differ most in two active site loops (Figure 4.2).4,5 The 40s loop contains a
class-specific motif, SAH[R/K] in PurE1 and PurE2, respectively. The conserved active
site His serves as the general acid/general base catalyst and is essential for activity.1,2,6
The 40s loop Ser is proposed to serve as a hydrogen bond donor to AIR N3 and is the
sole polar contact between the substrate aminoimidazole ring and any side chain of PurE1
and PurE2 (Figure 4.2).1,2
Decarboxylation of CAIR gives a ternary PurE•AIR•CO2 complex, which only
dissociates from PurE2. In contrast, the PurE1 reaction continues with an aminoimidazole
ring flip and NCAIR formation. Ser may provide a hydrogen bond to AIR N3 and, in
PurE1 only; function as a pivot-point for the aminoimidazole ring to rotate and position
either AIR C4 or N6 of the exocyclic amine for attack on the bound CO2 to form either
NCAIR or CAIR, respectively (Figure 4.1).6
!
The pH rate profiles for PurE1 are bell-shaped and the basic arm (pK2) is unambiguously
assigned to the active site His.1,6 The acidic pK1 likely corresponds to the protonation of
CAIR N3, which is mutually exclusive with protonation at C4 (Figure 4.2). Ser may
function as a hydrogen bond donor to (C)AIR N3, favoring protonation by the conserved
His at C4 instead of N3. This would be an example of “negative catalysis” in that the
hydrogen bonding interaction prevents an unproductive event but is not itself required.
This contrasts with a conclusion based on non-enzymatic model studies, where the N3
protonation occurs first and the proton is transferred to the C4 position for
decarboxylation to occur.7,8 While, N3 protonation is inhibitory for PurE1, it may allow
PurE2 to do different chemistry at low pH.
In PurE2, an increase in velocity at acidic pH (pK1) has been proposed to correspond to a
change in polarity in the hydrogen bond formed between Ser and the aminoimidazole
N3.2 At low pH, Ser could accept a hydrogen bond from the protonated N3. Furthermore,
the order of CAIR protonation and decarboxylation events may be reversed by this
interaction, as C4 protonation would pose serious electrostatic barriers (two positive
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charges on the aminoimidazole ring). Instead, decarboxylation may lead to formation of a
nitrogen ylide of AIR (yAIR), which is a proposed intermediate for decarboxylation of
CAIR ribonucleoside.8 Similar intermediates have been proposed for both 3aminopicolinic acid decarboxylation and orotidine 5’-monophosphate decarboxylase.9,10
Characteristics of PurE1 and PurE2 Examined in this Chapter. This chapter details the
kinetic and structural analysis of Ser mutants from Acetobacter aceti (AaPurE1) and
Treponema denticola (TdPurE2). Several functional mutants have pH-dependent activity
that indicates a class-divergent role for this residue. The requirement a hydrogen bond
donor at the Ser position is more important for PurE2 function. Our working hypothesis
is that the hydrogen bond provided by Ser is important to ensure efficient C4 protonation
and without it decarboxylation may occur through a different mechanism beginning with
N3 protonation.

4.2

Materials and Methods

Materials. Chemicals were obtained from Sigma or Fisher in the highest purity available
unless otherwise noted. CAIR was prepared from 5-aminoimidazole-4-carboxamide
ribonucleotide (Toronto Research Chemicals, catalogue number: A611705) as described
previously.11 AIR was generated enzymatically from CAIR using Treponema denticola
PurE2 (TdPurE2) and quantitated by Bratton-Marshall assay as described previously.2
Oligodeoxynucleotides (ODNs) were obtained from Integrated DNA Technologies and
used without further purification. Restriction endonucleases, Vent polymerase, Q5 DNA
polymerase, CIP, T4 PNK, and T4 DNA ligase were obtained from New England
Biolabs. Mutagenesis was accomplished using Quikchange Mutagenesis using kits
(Agilent). Phenyl sepharose CL-6B was obtained from Sigma. Hydroxyapatite (Bio-Gel
® HT) and Bradford reagent were obtained from Bio-Rad. PD-10 desalting columns were
obtained from GE Health Care. Protein concentrations were determined by the method of
Bradford with bovine serum albumin as the standard.12 Solution makeup was determined
on an AKTA FLPC system (Amersham). Small-scale centrifugation steps were
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performed using an Eppendorf 5424 centrifuge. All other centrifugation steps were
performed using a Beckman Avanti J-E centrifuge with a JLA-10.5 or JA-20 rotor. Cell
disruption was performed by sonication using a Fisher Scientific Dismembrator 550 at
25% output for 3 cycles (1 min each with 1 min cooling periods in-between) at 4 °C.
Spectroscopic measurements were recorded on a Varian CARY-100 UV/Vis
spectrophotometer thermostated by a Cary Dual Peltier Accessory temperature controller.
Steady state fluorescence measurements were recorded on a Horiba Fluoromax-3
fluorometer thermostated with a Peltier Accessory and a Wavelength Electronics
temperature controller. . Data were analyzed using Origin (OriginLab, Northampton,
MA) or using gnuplot 4.4 by T. J. Kappock. Plasmid DNA was sequenced by the staff of
the Purdue University Genomics Core Facility. Full-length protein masses were
determined by Matrix-assisted laser desorption/ionization mass spectrometry (MALDIMS) on a Voyager-DE PRO mass spectrometer (Applied Biosystems, Framingham, MA)
by Connie Bonham.
Standard Conditions for Vent PCR. Standard PCRs (50 µL final volume) contained Vent
DNA polymerase (1 unit), two ODNs (50 nmol each, Table 4.2), template DNA (14 ng),
dNTPs (25 nmol each), MgCl2 (2 mM), and 1x thermopol buffer (20 mM Tris-HCl, 10
mM (NH4)2SO4, 10 mM KCl, 0.1% Trition® X-100, pH 8.8). PCR products were
amplified with standard conditions: annealing temperature of 52 °C with a 30 s hot start
followed by melting, annealing, and extension times of 30 s, 60 s, and 30s for 25 cycles
with a final extension time of 5 min.
Generation of Protein Production Strain CC1215. Strain CC1215 was created using a
previously published protocol.13 P1 lysates [W3110] were a gift of Dr. Ronald
Somerville. The Keio strain JW0512 served as the donor and BL21(DE3) served as the
recipient strain.
P1 Lysate Preparation: JW0512 cells were grown overnight on LB-Kan plates and a
single colony was used to inoculate a 5 mL overnight LB-Kan culture. A portion of the
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saturated overnight culture (50 µL) was mixed with 2.5 mL of molten top agar and plated
onto LB soft agar plates supplemented with CaCl2 (2.5 mM). P1 [W3110] lysate (50 µL)
was spotted onto the solidified top agar and grown overnight. Lytic plaques were excised
from the top agar with a nickel spatula and transferred to 0.5 mL of LB in a sterile 15 mL
falcon tube. Tubes were then vortexed and incubated at room temperature for 30 min. A
portion of saturated overnight JW0512 culture (100 µL) was added to each tube and
incubated at room temperature for an additional 30 min. A control incubation was carried
out lacking any P1 lysate. Molten top agar (2.5 mL) was added to each tube, mixed
gently, and then poured on top of LB soft agar plates supplemented with CaCl2 (2.5 mM).
Plates were grown at 37 °C for 8 h until they had a “lacey” appearance. After 8 h, the
plates were flooded with 3-5 mL of LB and placed at 4 °C overnight. Lysate was pipetted
off, transferred into sterile glass screw-cap vials, and chloroform (~100 µL) was added.
The tubes were shaken forcefully and then centrifuged (2000 g, 10 min) at 4 °C to pellet
bacteria. Lysates (P1 [JW0512]) were then decanted into sterile glass screw-cap vials for
storage at 4 °C. Portions of the lysates were streaked onto LB plates to ensure the lysate
had no bacterial contamination.
P1 Transduction: BL21(DE3) cells were grown overnight on LB plates and a single
colony chosen to inoculate a 5 mL overnight LB culture. A 10 mL LB culture was
inoculated at 1:100 and grown at 37 °C, shaking for 2-3 h to reach log phase (OD600=0.30.7). The cells were centrifuged (5000 g, 15 min) at 4 °C, the resulting supernatant
discarded, and cells resuspended in 1 mL of LB. Donor strain lysate, P1 [JW0512], was
mixed with an equal volume of sterile 0.85% (w/v) saline (1 mL) in a 60 x15 mm petri
dish. The dish was placed ~30 cm under a UV-lamp (254 nm), with the lid removed, and
incubated for 5 min. Transductions were carried out in duplicates: 1 mL irradiated lysate,
0.05 mL CaCl2 (0.5 M stock), and 0.1 mL of concentrated log phase BL21(DE3) cells.
Control transductions contained 0.1 mL of LB in place of irradiated lysate. The
transductions were incubated at 37 °C for 20 min and then a portion (0.1 mL) was plated
undiluted, 1:3, and 1:15 on LB Kan plates. The resulting colonies were streaked onto M9
minimal media plates lacking exogenous purines and grown overnight at 37 °C to test for
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purine autotrophy. Kan cassette insertion from the donor strain JW0512 into BL21(DE3)
was confirmed by PCR with ODNs 1161 and 1164.
Construction of AaPurE1 Plasmids for Protein Expression. Plasmid pJK175, which
encodes the wild-type AaPurE1, was used as a template for the generation of serine
mutants.1 Mutants were generated using Quikchange II mutagenesis kits (with standard
PCR conditions outlined in in Chapter 3) with plasmid pJK175 (25 ng) as template, and
the appropriate ODNs (Table 4.2) to create plasmids pJK582 (AaPurE1-S57A), pJK583
(AaPurE1-S57C),

pJK584

(AaPurE1-S57T),

pJK608

(AaPurE1-S57D),

pJK677

(AaPurE1-S57V), and pJK686 (AaPurE1-S57N).
Construction of TdPurE2 Plasmids for Protein Expression. Plasmid pJK376, which
encodes the wild-type TdPurE2, was used as a template for the generation of serine
mutants.2 Mutants were generated using Quikchange II mutagenesis kits (with standard
PCR conditions outlined in in Chapter 3) with plasmid pJK376 (25 ng) as template, and
the appropriate ODNs (Table 4.2) to create plasmids pJK607 (TdPurE2-S38C), pJK617
(TdPurE2-S38A), pJK684 (TdPurE2-S38V), and pJK685 (TdPurE2-S38N).
Construction of TdPurE2–S38T Construct Plasmid pJK643. The general cloning strategy
is illustrated in Chapter 3 (Figure 3.4). A 0.21 kb primary PCR product containing purE2
was amplified using standard Vent PCR conditions from template pJK376 (14 ng), using
ODNs 2124 and 2316. The crude product was digested with DpnI and purified using a
Qiagen PCR purification kit. A 0.55 kb product containing purE2 was amplified using
standard Vent PCR conditions from template pJK376 (14 ng), using ODNs 2125 and
2317. The crude product was digested with DpnI and purified using a Qiagen PCR
purification kit. Cross-over PCR product was obtained using standard Vent PCR
conditions, with a single exception: the annealing time was increased to 1 min, from a
mixture containing primary PCR products (25 ng each) and ODNs 2124 and 2125. The
0.79 kb cross-over was digested with NdeI and XhoI, and ligated into the same sites of the
destination vector pET23a to yield TdPurE2-S38T expression plasmid pJK643.
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Construction of TdPurE2–S38D Construct Plasmid pJK644. A 0.21 kb primary PCR
product containing purE2 was amplified using standard Vent PCR conditions from
template pJK376 (14 ng), using ODNs 2124 and 2320. The crude product was digested
with DpnI and purified using a Qiagen PCR purification kit. A 0.55 kb product
containing purE2 was amplified using standard Vent PCR conditions from template
pJK376 (14 ng), using ODNs 2125 and 2321. The crude product was digested with DpnI
and purified using a Qiagen PCR purification kit. Cross-over PCR product was obtained
using standard Vent PCR conditions, with a single exception: the annealing time was
increased to 1 min, from a mixture containing primary PCR products (25 ng each) and
ODNs 2124 and 2125. The 0.79 kb cross-over product was digested with NdeI and XhoI,
and ligated into the same sites of the destination vector pET23a to yield TdPurE2-S38D
expression plasmid pJK644.
Construction of TdPurE2–S38T,F79W Construct Plasmid pJK653. A 0.21 kb primary
PCR product containing purE2 was amplified using standard Vent PCR conditions from
template pJK648 (14 ng), using ODNs 2124 and 2316. The crude product was digested
with DpnI and purified using a Qiagen PCR purification kit. A 0.55 kb product
containing purE2 was amplified using standard Vent PCR conditions from template
pJK648 (14 ng), using ODNs 2125 and 2317. The crude product was digested with DpnI
and purified using a Qiagen PCR purification kit. Cross-over PCR product was obtained
using standard Vent PCR conditions, with a single exception: the annealing time was
increased to 1 min, from a mixture containing primary PCR products (25 ng each) and
ODNs 2124 and 2125. The 0.79 kb cross-over product was digested with NdeI and XhoI,
and ligated into the same sites of the destination vector pET23a to yield TdPurE2S38T,F79W expression plasmid pJK653.
Construction of TdPurE2–S38C,F79W Construct Plasmid pJK659. A 0.21 kb primary
PCR product containing purE2 was amplified using standard Vent PCR conditions from
template pJK648 (14 ng), using ODNs 2124 and 2366. The crude product was digested
with DpnI and purified using a Qiagen PCR purification kit. A 0.55 kb product
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containing purE2 was amplified using standard Vent PCR conditions from template
pJK648 (14 ng), using ODNs 2125 and 2367. The crude product was digested with DpnI
and purified using a Qiagen PCR purification kit. Cross-over PCR product was obtained
using standard Vent PCR conditions, with a single exception: the annealing time was
increased to 1 min, from a mixture containing primary PCR products (25 ng each) and
ODNs 2124 and 2125 The 0.79 kb cross-over product was digested with NdeI and XhoI,
and ligated into the same sites of the destination vector pET23a to yield TdPurE2S38C,F79W expression plasmid pJK659. !
Construction of T. denticola purE2–H17W,S38T Construct Plasmid pJK692. A 0.651 kb
product containing pur2E was amplified using standard Q5 PCR conditions from
template pJK643 (14 ng), using ODNs 2125 and 2393 with a extension time of 1 min.
The PCR product was digested with NdeI and XhoI, and ligated into the same sites of the
destination vector pJK643 to yield TdPurE2-H17W,S38T expression plasmid pJK692.
Construction of TdPurE2–M15W,S38T Construct Plasmid pJK697. The general cloning
strategy is illustrated in Figure 3.6. ODNs 2398 and 2399 (100 nmol each) were
phosphorylated, annealed, and ligated at a 1:20 molar ratio of vector: linker into the NheI
and BamHI sites of destination vector pJK692 to yield TdPurE2-M15W,S38T expression
plasmid pJK697.
Cell Growth Media. M9 minimal media plates (1 L) contained: 750 mL H2O autoclaved
with 20 g of agar, was mixed with 200 mL sterile 5x M9 salts, 20 mL sterile 20%
glucose, 10 mM thiamine, 100 ug mL-1 Amp and 70 ug mL-1 Kan (30 mL media per
plate). A control set of plates was supplemented with hypoxanthine (0.1 mM) as an
exogenous source of purines. Autoinduction media (ZYM-5052) used for expression of
TdPurEs was prepared as previously published.14
Functional Complementation of JW0512. Plasmids containing AaPurE1-S57X and
TdPurE2-S38X mutants and pET23a (negative control) were transformed into Keio strain
JW0512 (ΔpurE) and assessed for their ability to restore purine prototrophy on solid M9
minimal media. Cells were grown for 16 h on LB-Amp/Kan plates and a single colony
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was used to inoculate a 5 mL LB-Amp/Kan culture that was then grown to log phase
(OD600=0.3-0.7) at 37 °C. Cultures were back-diluted to OD600=0.0005 and 10 µL was
applied to solid M9 minimal media. A duplicate set of plates was grown in a high CO2
environment. This high CO2 environment was achieved by placing the plates along with a
lit candle into a desiccator. The desiccator was sealed and the candle was allowed to
extinguish. The desiccator was then placed into a large 37 °C incubator.
Mutant AaPurE1 Overexpression and Isolation. AaPurE1-S57X mutants were
overexpressed and isolated like wild-type AaPurE11 (Chapter 3), with a single exception:
the buffers used to isolate AaPurE1-S57C contained 20 mM 2-mercaptoethanol. Fresh
column media were used for each mutant to avoid any possibility of cross-contamination.
AaPurE1 mutants were concentrated to >3 mg mL-1 with an Amicon ultrafiltration device
containing a YM30 membrane. The protein solutions were frozen by drop-wise addition
to liquid N2 and stored at -80 °C.
Mutant

TdPurE2

Overexpression

and

Isolation.

TdPurE2-S38X,F79W

was

overexpressed and isolated like wild-type TdPurE2 (Chapter 3),2 with two exceptions: the
lysis buffer contained PMSF (1 mM) and the buffers used to isolate TdPurE2-S38C
contained 20 mM 2-mercaptoethanol. Fresh column media were used for each mutant to
avoid any possibility cross-contamination. TdPurE2 mutants were concentrated to >3 mg
mL-1 with an Amicon ultrafiltration device containing a YM30 membrane. The protein
solution was frozen by drop-wise addition to liquid N2 and stored at -80 °C.
Quantitation of Free Sulfhydryl Groups in AaPurE1-S57C. AaPurE1-S57C was
incubated with 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB, Ellman’s reagent) to
determine the oxidation state of two Cys, one Cys (Cys97) near the surface and the active
site Cys mutant. DTNB reactions were performed according to a previous protocol.15 A 1
cm path length cuvette contained (final volume of 0.5 mL) 100 mM Tris-HCl, pH 8 with
DTNB (10 mM) added immediately prior to the start of the experiment. Reactions were
initiated by the addition of AaPurE1 or AaPurE1-S57C (10 nmoles, 20 µM) and the
absorbance at 412 nm was monitored. The number of unmodified Cys (free thiols) was
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determined by using the observed absorbance at 412 nm (ε412 = 14,150 M-1 cm-1).
Proteins were quantified by the method of Bradford12 with bovine serum albumin as the
standard.
PurE1 and PurE2-Mediated Decarboxylation Assays. Continuous assays of PurE1 and
PurE2-mediated CAIR decarboxylation were performed according to a published
method.1 A final volume of 0.6 mL in a masked, 1 cm pathlength cuvette containing 50
mM Tris-HCl, pH 8 and 100 µM CAIR was incubated at 30 °C for at least 3 min. High
concentrations of CAIR (>100 µM) required the use of a 0.5 cm cuvette. Reactions were
initiated by addition of either an AaPurE1 or TdPurE2 mutant (12-80 ng, 1.4-8.4 nM
[subunits]). The initial velocity of CAIR decarboxylation to AIR (∆ε260 =8930 M-1 cm-1)
was recorded at 260 nm, with a small background decarboxylation rate subtracted. CAIR
was quantitated by endpoint assay using the same method, except that 50 µg mL−1
TdPurE2 was the enzyme. A unit is defined as the amount of enzyme that forms 1 µmol
of product per minute.
PurE1 and PurE2 CAIR Decarboxylation pH-Rate Profiles. The initial rates of reaction
for

AaPurE1-S57C,

AaPurE1-S57A,

TdPurE2-S38C

and

TdPurE2-S38D

were

determined as above, except that a triple buffer system (100 mM Tris-HCl, 50 mM MES,
50 mM acetic acid) was used across different pHs, and various ∆ε260 values for
CAIR→NCAIR were used.1 Reactions contained variable amounts of CAIR (2-200 µM)
and variable amounts of AaPurE1 and TdPurE2 (12-80 ng, 1.4-8.4 nM [subunits]).
Velocity (units mg-1) at each pH was plotted as a function of [CAIR] and the data fit to an
alternative Michaelis-Menten equation (equation 4.1) where j = (Vmax/Km). Values of kcat
and kcat/Km were plotted as a function of pH and fit to equation 4.2 (or equation 4.3 for
AaPurE1-S57C kcat, which accounts for two ionizations). AaPurE1-S57A kcat and kcat/Km
were fit to equation 4.4, which accounts for two ionizations.
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Determination of Extinction Coefficients for SAICAR at Varying pH. The extinction
coefficient is known for SAICAR at pH 7.5, which allows for the computation of ∆ε282
for CAIR→SAICAR at various pHs. SAICAR solutions (350-500 µM) were obtained
from AIR carboxylation assays in which the reaction was allowed to go to completion.
SAICAR solutions were diluted into varying buffers at different pHs (triple buffer at pH
6, 6.5, 7, 7.5, 8, and 9) and recorded in at least triplicate and corrected for background
ATP contribution at 282 nm. The recorded A282 was used to calculate a ∆ε282 for each pH
(with the known SAICAR ∆ε282 = 8607 M-1 cm-1 at pH 7.5). Calculated ∆ε282 values were
plotted against pH and fit to a linear equation.
AaPurE1 NCAIR→CAIR pH-Rate Profiles. Continuous assays of PurE1-mediated CAIR
carboxylation were performed according to a published method.16 Assays were carried
out at 23 °C in in a final volume of 0.7 mL, 1x triple buffer (100 mM Tris-HCl, 50 mM
MES, 50 mM acetic acid) of varying pH, 10 mM MgCl2, 2 mM PEP, 0.5 mM ATP, 10
mM L-aspartate, 1 mM KHCO3, 1.2 units of pyruvate kinase (477 units mg-1, Sigma
P9136), 5 units of H6PurK (isolated by Jesse Murphy), 4 units of H6PurC (isolated by
Jesse Murphy), and varying amounts of AaPurE1s. After pre-incubation for 3 min the
reaction was initiated by the addition of AIR (12.5-500 µM) and SAICAR formation
monitored directly (∆ε282 = 128.04 x pH + 7684.4, units of M-1 cm-1). Velocity (units mg1

) at each pH was plotted as a function of [CAIR] and the data were fit to equation 4.1.

Values of kcat and kcat/Km were plotted as a function of pH and fit to equation 4.4.
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Fluorescence Titrations. Spectra were obtained using a 1 cm pathlength fluorometer cell
that contained 2.0 mL prior to the titration. The excitation wavelength was 295 nm (2 nm
slit width) and emission spectra were collected from 305 to 450 nm (5 nm slit width). A
buffer only-spectrum was subtracted from as the background from all spectra. The
intensity of the fluorescence emission F for each titration point was measured at 320 nm
and then corrected for dilution.
Citrate Titrations (0-25 mM final concentration, added from a 200 mM stock, pH 4.6)
were performed in 50 mM potassium acetate, 100 mM KCl, pH 4.6, with varying
amounts of AaPurE1 or TdPurE2 at 25 °C. Emission intensities at 320 nm (F) were
divided by the intensity at zero ligand (L) concentration (F0) to obtain fractional
saturation values. The AaPurE1 titration data were fit using gnuplot 4.4 to a binding
isotherm (equation 4.2) by allowing Kd and ΔF (the value of F/F0 as [L] →∞) to vary.
!
!!

= 1 − ΔF!
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Equation 4.5

AIR titrations (0-25 µM final concentration, added from a 600 µM stock in 50 mM TrisHCl, pH 8) were performed in 50 mM Tris-HCl, pH 8 with varying amounts of AaPurE1
at 30 °C. Emission intensities at 320 nm (F) were divided by the intensity at zero ligand
(L) concentration (F0) to obtain fractional saturation values. The data were fit using
Origin to a binding isotherm (equation 4.5) by allowing Kd and ΔF (the value of F/F0 as
[L] →∞) to vary.
Solution Studies of AaPurE1s. Solution aggregation state was determined on an AKTA
FPLC system (Amersham) using a Pharmacia G200-16/60 high-load column. The mobile
phase was 50 mM Tris-HCl, 100 mM KCl, pH 8 applied at 1 mL min-1. Injections (100
µL) contained 0.5 mg of protein adjusted to 5% (v/v) glycerol. Protein solution sizes and
aggregation states were determined by comparison with protein size standards (29-669
kDa; Sigma MW-GF-1000), blue dextran (2 MDa; Vo), and acetone (60 Da, Vi) using the
Kav partition coefficient method 17.
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Crystallization and Soaking of AaPurE1s. AaPurE1 forms intended for crystal production
were buffer-exchanged into 5 mM Tris-HCl, 15 mM NaCl, pH 8 and concentrated to 10
mg mL-1 using Millipore Ultra spin columns (MWCO 30000). Crystals were grown by
the hanging drop vapor diffusion method using reservoir solutions containing 25-35%
PEG 4000, 200 mM LiSO4, 100 mM Tris-HCl, pH 8.3. To generate nucleotide bound
complexes, AaPurE1 crystals were soaked for 1-3 h in artificial mother liquor containing
5 mM CAIR.
Crystallization of TdPurE2s. TdPurE2 forms intended for crystal production were buffer
exchanged into 5 mM Tris-HCl, 20 mM KCl, pH 8 and concentrated to 10 mg mL-1 using
Millipore Ultra spin columns (MWCO 30000). Crystals were grown by the hanging drop
vapor diffusion method using reservoir solutions containing 14-16% PEG 1000, 100mM
MgCl2, 100 mM imidazole, pH 8.
X-ray Data Collection and Processing. Prior to data collection, AaPurE1 crystals were
placed briefly into a cryoprotectant solution that consisted of artificial mother liquor with
an additional 2% PEG 4000 and 15% (v/v) ethylene glycol. TdPurE2 crystals were placed
briefly into a cryoprotectant solution that consisted of artificial mother liquor and 20%
(v/v) ethylene glycol. Crystals were immediately flash-cooled in liquid N2. X-Ray
diffraction data were collected on either a MAR-225 or MAR-300 CCD detector at the
LS-CAT beamline (Advanced Photon Source - Argonne National Laboratory).
Diffraction data were indexed, integrated, and scaled with HKL-2000..
Structure Determination and Refinement. All crystals had the same space group with
similar unit cell parameters, previously observed in structures of AaPurE1.1,18 Molecular
replacement was performed using AutoMR/Phaser19 with AaPurE1 monomer (PDB code
2fw1 chain A) as the search model. Structures for AaPurE1-S57A, AaPurE1-S57C,
AaPurE1-S57T, AaPurE1-S57D, AaPurE1-S57N, and AaPurE1-S57V were determined
by using the AaPurE1fwf monomer (PDB code 4YCB chain A) as the search model. The
TdPurE2-S38D crystal had the same space group with similar unit cell parameters, t to a
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previous TdPurE2 structure.2 Early rounds of refinement were performed using rigid
body, simulated annealing, Cartesian coordinate optimization, individual isotropic
temperature factor refinement, and automatic water picking in PHENIX 20. Later rounds
of refinement were performed using Cartesian coordinate optimization, individual
isotropic temperature factor refinement, automatic water picking, automatic outlier
correction, and occupancy refinement. Model building, manual inspection, and rebuilding
were performed using Coot 21. Coordinates and structure factors have been deposited in
the RCSB Protein Data Bank (PDB) with accession numbers TBD (AaPurE1-S57A),
TBD (AaPurE1- S57C), TBD (AaPurE1-S57T), TBD (AaPurE1-S57V), TBD (AaPurE1S57N), TBD (AaPurE1-S57D), and TBD (TdPurE1- S38D). Figures were prepared using
PyMOL.22

4.3

Results

!
Construction of CC1215 Strain. Recombinant PurE expression was carried out in
BL21(DE3) cells that contain an endogenous copy of EcPurE1. The generation of the
CC1215 strain ensures there is no contamination of endogenous EcPurE1 in recombinant
PurE1 and PurE2 isolations.
The Keio strain JW0152 contains an in-frame replacement of the purE1 gene with a
kanamycin resistance cassette.23 The use of P1 phage transduction to transfer the
kanamycin cassette to the BL21(DE3) strain was straightforward and successful on the
first attempt.
Creation of AaPurE1 and TdPurE2 Mutants. AaPurE1-S57X and TdPurE2-S38X
mutants were generated to investigate the role of the absolutely conserved active site
serine.
The most stable AaPurE1 mutant, Ser→Thr was chosen as the background to test the
stability of Trp introduction mutants. TdPurE2-M15W,S38T; TdPurE2-H17W,S38T;
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TdPurE2-F79W; TdPurE2-F79W,S38T; and TdPurE2-F79W,S38C mutants were
generated to determine if an intrinsic fluorophore (Trp) could be introduced into TdPurE2
for obtaining kinetic parameters by fluorescence methods.
Quikchange site directed mutagenesis was successful in generating the AaPurE1-S57X
mutants and some TdPurE2-S38X mutants (Table 4.4). TdPurE2 mutants proved to be
very difficult to generate by standard Quikchange mutagenesis. Therefore, cross-over
PCR was employed to generate most TdPurE2 mutants. Cross-over PCR was performed
using standard techniques with a single addition to the protocol, a DpnI digestion step
was introduced after the primary PCR to ensure the parental plasmid did not contaminate
the secondary PCR. This extra step significantly decreased the amount of false-positive
colonies (data not shown). Finally, a cassette carrying the M15W mutation was generated
from synthetic oligonucleotides and ligated into a plasmid encoding TdPurE2H17W,S38T to replace the H17W mutation. Multiple molecular cloning techniques were
used to generate TdPurE2 plasmids because Quikchange repeatedly failed. Sequencing
confirmed all the intended mutations were obtained.
Functional Complementation of JW0512. Ser mutants were assessed for the ability to
restore prototrophy to the Keio strain JW012 (ΔpurE1). Only wild-type PurE1 and PurE2
complement a ΔpurE1 strain under normal atmospheric conditions. This is consistent
with the low specific activites obtained for all S57X and S38X mutants (Tables 4.4 and
4.6).
Of the AaPurE1-S57X mutants, only AaPurE1-S57T complemented under high CO2
conditions. Under high CO2 levels, TdPurE2-S38T complemented almost as well as wildtype TdPurE2. While this mutant has the highest residual activity in vitro, it did not
produce crystals and its combination with any additional mutation (M15W, H15W, or
F97W) was highly destabilizing. There may be enough activity in TdPurE2-S38T to
support growth on minimal media, or some component in vivo such as a chaperone may
help to stabilize TdPurE2-S38T. Cells producing either TdPurE2-S38A or TdPurE2S38C grow after 120 h (Table 4.4).
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Purification of Recombinant AaPurE1-S57X Mutants. The previously published isolation
protocol1 was successfully used to isolate all AaPurE1 forms with varying specific
activites and high purity (Table 4.9, Figure 4.5, and Figure 4.7).
Purification of Recombinant TdPurE2-S38X Mutants. The previously published isolation
protocol2 was successfully used to isolate all TdPurE2 forms with varying specific
activites and high purity (Table 4.9, Figure 4.6, and Figure 4.7).
Purification of Recombinant TdPurE Tryptophan Introduction Mutants. The previously
published isolation protocol2 was successfully used to isolate all TdPurE2 forms with
varying specific activites and high purity (Table 4.9 and Figure 4.8).
Forms not suitable for further analyses were: TdPurE2-S38T,F79W (activity is lost when
diluted and cannot be stored), TdPurE2-H17W,S38T (retains only 4% of TdPurE-S38T
activity), and TdPurE2-M15W,S38T (precipitates out of solution during isolation). It
appears the addition of multiple mutations to TdPurE2 creates an unstable protein.
Solution Studies of AaPurE1 Forms. Analytical size exclusion chromatography was used
to determine the biological unit and relative stability of each AaPurE1-S57X mutant. Gelfiltration analyses confirmed the presence of the PurE octamer for all AaPurE1 forms, but
also showed formation of some high molecular weight aggregates (Figure 4.9). AaPurE1S57V has a peak at ~76 mL that corresponds to dissociation into tetramers.
!
Citrate Titrations of AaPurE1-S57X Mutants. Citrate is a non-substrate active site ligand
that binds AaPurE1 weakly, under acidic conditions, leading to protein fluorescence
quenching.1 While it has little resemblance to CAIR, citrate interacts with the protonated
form of the key His59 and all nucleotide-binding residues, except for the phosphate
contact Ser32 and the exocyclic amine contacts in the 70s loop backbone. Therefore,
titrations were carried out in 50 mM potassium acetate, 100 mM KCl, pH 4.6 with all
AaPurE1-S57X forms to determine the fluorescence response of each mutant upon citrate
addition.
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The fluorescence of all AaPurE1-S57X mutants was quenched by the addition of citrate.
Mutation of Ser decreases the affinity for citrate (Table 4.9 and Figure 4.10), indicating
that the hydrogen bond provided by Ser is likely involved in binding citrate. The inactive
mutant AaPurE1-S57D does bind citrate and, along with crystal structures, indicates that
the active site is intact (Figure 4.17).
AIR Titrations of AaPurE1-S57X Mutants. AIR is not a substrate for PurE1, it instead acts
as a inhibitor.24 The addition of AIR to active AaPurE1 forms results in small increase as
result of a fluorescent species present in AIR (Chapter 2). AIR titrations were carried out
in 50 mM Tris-HCl, pH 8.0.
The addition of AIR to AaPurE1-S57X mutants had little or no effect on fluorescence
emission intensity, consistent with earlier studies of active PurE1s (Table 4.9 and Figure
4.11).1,6 AaPurE1-S57A did have enough signal to obtain a Kd which was similar to wildtype, indicating that Ser may not be involved in substrate binding. Alternatively, the
replacement of Ser57 with a smaller side chain, could allow an adventitious water to
provide a hydrogen bond to the AIR N3.
Crystallization of AaPurE1-S57X Mutants. Structures were obtained for all six Ser
mutants (Tables 4.7- 4.8 and Figure 4.12). The structures of AaPurE1-S57X mutants
confirm that the active sites are intact, with the exception of AaPurE-S57C (Figure 4.13).
The electron density surrounding the Cys57 residues clearly indicates the oxidized
species are cysteine sulfenic and cysteine sulfinic acid, even before the acids are
introduced into the model (Figure 4.13). The oxidation could be due to radiation damage
or components (PEG 4000) in the crystallization solution.
The existence of oxidized cysteines in the AaPurE1-S57C active site was examined using
DTNB. AaPurE1-S57C isolated without 2-mercaptoethanol present was used to
determine the oxidation state of the active site cysteine. AaPurE1 was used to determine
the background formation of TNB (Cys94 is buried, but may still react with DTNB).
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Five independent replicates were performed with each form of AaPurE1 and the average
amount of TNB formation was calculated. The amount of TNB formation for AaPurE1 is
0.1 ± 0.01 thiol/subunit and the amount of TNB formation for AaPurE-S57C is 1.12 ±
0.04 thiol/subunit. These results indicate Cys94 is largely inaccessible to DTNB and that
a 1:1 molar relationship of TNB to the active site Cys57 exists. Therefore, the AaPurES57C mutant is not oxidized in solution.
Mass Spectrometric Analysis of AaPurE1-S57C. MALDI Mass Spectrometric analysis
was performed with AaPurE-S57C to determine if Cys57 is oxidized in solution. The
mass for AaPurE1-S57C is consistent with the presence of cysteines and not the oxidized
form(s) (Table 4.6).
Crystallization of TdPurE2-S38X mutants. Crystals of TdPurE2-S38X mutants were
harder to obtain and most resulted in modest diffraction at ~6-8 Å. However, a 1.69 Å
structure was obtained for TdPurE2-S38D (Tables 4.7-4.8 and Figure 4.14). A model of
the Asp38 mutant, with AIR transferred from the TdPurE2•AIR structure (PDB code
3rgg)2, reveals a steric clash between the Asp carboxylate and AIR N3. In addition, the
active site His appears to be displaced by 2.0 Å in the S38D structure (Figure 4.14). The
S38D mutant is active therefore; it is likely that a conformational change occurs in S38D
that allows CAIR to bind and decarboxylation to occur.
Kinetic Characterization of AaPurE1-S57X Mutants at pH 8. Kinetic constants (Km and
kcat) for CAIR decarboxylation were obtained for all active forms of AaPurE1-S57X
mutants. Of the mutants tested, only Thr, Ala, Val, and Cys mutants had detectable
catalytic activity. Asn and Asp mutants had no detectable activity.
We then wondered if AaPurE1-S57D might be active at low pH, which could allow
protonation of this more acidic residue. AaPurE1-S57D did not have activity at pH 6,
indicating that protonation of the Asp may not be sufficient to allow catalysis. Both Asp
and Asn are may be too bulky (and negatively charged in the case of the Asp) to permit
CAIR binding. All active mutants, with the exception of AaPurE1-S57V, could be
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saturated with substrate under assay conditions (Table 4.9 and Figure 4.15). The higher
Km of AaPurE1-S57V may indicate that Val inhibits CAIR binding.
The Kms of AaPurE1-S57X mutants (with the exception of S57V) are relatively
unchanged relative to wild-type. This observation suggests that Ser57 is not essential for
substrate binding, but that loss of the hydrogen bond provided by Ser does negatively
affect catalysis.
Kinetic Characterization of TdPurE2-S38X Mutants at pH 8. All Ser mutants retained a
low level of activity, lower than the corresponding AaPurE1-S57X mutants, with the
exception of TdPurE2-S38V. Of the mutants tested, only Thr, Ala, Val, Cys, and Asn had
detectable activity. Asp mutants had no detectable activity at pH 8. However, TdPurE2S38D had detectable activity at pH 6 (Figure 4.16).
Kinetic constants (Km and kcat) for CAIR decarboxylation were only obtained for the
TdPurE2-S38C mutant at pH 8 (Table 4.8 and Figure 4.16, panel A). Comparison of the
TdPurE2 and TdPurE2-S38C kinetic parameters suggests that both binding and catalysis
are affected by the loss of a hydrogen bond normally provided by Ser57.
At low substrate concentration, both TdPurE2-S38T and TdPurE2-S38A mutants had
slightly sigmoidal saturation curves (Figure 4.16, panels B and C). These mutations
appear to destabilize TdPurE2; crystals of either mutant were not obtained. Both
TdPurE2-S38T and TdPurE2-S38V mutants show substrate inhibition above 100 µM
CAIR, indicating that CAIR may act as an inhibitor at high concentrations (Figure 4.16,
panels B and D).
While mutation of the universal Ser appears to destabilize both AaPurE1 and TdPurE2,
the mutation of Ser38 impacts TdPurE2 activity more profoundly. AaPurE1 demonstrates
heat and acid stability beyond a protein from a mesophilic bacterium.1 We have
uncovered that TdPurE2 cannot tolerate mutations as well as AaPurE1.
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pH Rate Profiles. By determining the velocity of a reaction at varying pH we can obtain
the pKa(s) of ionizable groups on the enzyme and substrate necessary for binding and
catalysis to occur. We can also determine the proton stoichiometry of the ionizable
groups involved. However, assigning the pKa values to a specific residue or a chemical
moiety of the substrate is difficult. We generated pH rate profiles of AaPurE1-S57X and
TdPurE2-S38X mutants to gain insight into the ionizations that occur when Ser57 is
replaced by an ionizable residue. A triple buffer system was used to ensure constant ionic
strength for each pH tested.
The log kcat/Km versus pH rate profile reports on ionizations within the free enzyme and
free substrate. Changes in the kcat/Km across pHs are suggestive of ionizations required for
productive binding of substrate. The log kcat versus pH rate profile reports on ionizations
within the Michaelis complex (ES). Changes in the kcat across pHs are suggestive of
ionizations required in the ES complex for catalysis.
CAIR Decarboxylation pH Rate Profiles for AaPurE1-S57X Mutants. To further
investigate the effect of protonation at the Ser position in PurE1, pH rate profiles were
constructed using the AaPurE1-S57C ionizable mutant. pH rate profiles were constructed
with AaPurE1-S57A to examine the effect of pH without an ionizable residue at the Ser
position. We expected the effect of pH on AaPurE1-S57A activity to match that of wildtype but with lower activity.
AaPurE1-S57A initial velocity data from each pH were fit using equation 4.4. Both the
log kcat/Km versus pH and log kcat versus pH data produced bell shaped profiles consistent
with two pKas. The likely origin of pK1 is the N3 of CAIR and pK2 is His59.1,6 AaPurE1S57C initial velocity data from each pH were fit to equations 4.2 and 4.3. The log kcat/Km
versus pH data produced a log-linear fit with a slope near negative unity and the log kcat
versus pH produced a fit consistent with two indistinguishable pKas.
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kcat/Km pH Rate Profiles. The log kcat/Km versus pH profiles for both wild-type and
AaPurE1-S57A are similar bell-shaped curves with comparable pKas (pK1 = 6.0 ± 0.1 and
5.9 ± 0.1, respectively; pK2 = 7.2 ± 0.1 and 8.3 ± 0.2, respectively) (Figure 4.17, panel
A), indicating similar ionizations are required for CAIR binding in both AaPurE1 and
AaPurE1-S57A.1
The log kcat/Km versus pH profile for AaPurE1-S57C demonstrates log-linear dependence
on pH, fit to equation 4.2 yielded a slope of -0.86 ± 0.03, indicating that a single
ionizable proton is required for the free enzyme or free substrate to bind CAIR (Figure
4.17, panel A). The proton required may be located on the active site His or on the ribose
5’-phosphate (pKa = 6.3),24 but could be located on any ionizable group involved in
CAIR binding.
kcat pH Rate Profiles. The log kcat versus pH profiles for both wild-type and AaPurE1S57A are similar bell-shaped curves with comparable pKas (pK1 = 5.1 ± 0.2 and, = 5.8 ±
0.1 respectively; pK2 = 8.4 ± 0.1 and 8.6 ± 0.1, respectively)1 (Figure 4.17, panel B).
The log kcat versus pH profile for AaPurE1-S57C fit to a model in which two protons
with indistinguishable pKas (averaging ~6.7) are required for activity. One of the pKas is
likely associated with the active site His. The other pKa may be associated with the active
site Cys, however, this would require the pKa be lowered to around 7.
CAIR Decarboxylation pH Rate Profiles of TdPurE2-S38X Mutants. To further
investigate the effect of protonation at the Ser position in PurE2, pH rate profiles were
constructed using the TdPurE2-S38C and TdPurE2-S38D ionizable mutants. TdPurE2S38C and TdPurE2-S38D initial velocity data from each pH were fit to equation 4.2. All
the log kcat/Km versus pH and log kcat versus pH data produced log-linear fits.
kcat/Km pH Rate Profiles. The log kcat/Km versus pH profiles for wild-type TdPurE2 is a
bell-shaped curve with pK1 = 5.7 ± 0.2 and pK2 = 7.3 ± 0.1 (Figure 4.18, panel A).2
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The log kcat/Km versus pH profiles for TdPurE2-S38C and TdPurE2-S38D did
demonstrate log-linear dependence on pH, fits to equation 4.2 yielded a slopes of -0.21 ±
0.06 and -0.90 ± 0.04, respectively (Figure 4.18, panel A). The Asp pKa is much lower
than that of the Cys, indicating that Asp protonation is likely required for CAIR binding.
kcat pH Rate Profiles. The log kcat versus pH profile for wild-type TdPurE2 is a bellshaped curve with pK1 = 5.9 ± 0.5 and pK2 = 8.4 ± 0.1 (Figure 4.18 panel B).2
The log kcat versus pH profiles for TdPurE2-S38C and TdPurE2-S38D demonstrate loglinear dependence on pH, fits to equation 4.2 yielded slopes of -0.52 ± 0.09 and -1.5 ±
0.08, respectively. This difference in slopes (exactly -1) of the two S38X mutants is
likely due to the protonation of the Asp.
NCAIR→CAIR pH Rate Profiles of AaPurE1 and AaPurE1-S57C. . To further investigate
the effect of protonation at the Ser position in PurE1, pH rate profiles were constructed in
the biosynthetic direction (NCAIR→CAIR) with AaPurE1 and AaPurE1-S57C.
AaPurE1 and AaPurE1-S57C initial velocity data from each pH were fit to equation 4.4.
The AaPurE1 log kcat/Km versus pH data produced a bell shaped profile consistent with
two pKas, while the AaPurE1-S57C log kcat/Km versus pH data produced a log-linear fit.
The log kcat versus pH data for AaPurE1 and AaPurE-S57C produced log-linear fits.
kcat/Km pH Rate Profiles. The binding of CAIR to AaPurE1 requires His57 to be
protonated and AIR to de deprotonated. However, due to the microequilibria, a small
mole fraction will be present in the reverse protonation state. If this reverse protonation
state is the “correct” protonation state for AaPurE1 to bind NCAIR, then the pKas
obtained by fitting the log kcat/Km versus pH will be opposite relative to the pH rate
profile constructed from CAIR decarboxylation assays.
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The log kcat/Km versus pH profile for AaPurE1 fit to equation 4.4 results in is a bellshaped curve with pK1 = 8.8 and pK2 = 5.45, indicating a reverse protonation mechanism
in the forward direction (Figure 4.19, panel A).
The log kcat/Km versus pH profile for AaPurE1-S57C did not demonstrate log-linear
dependence on pH, fit to equation 4.2 yielded slopes -0.094 ± 0.079, indicating that
protonation is not required for the free enzyme or free substrate to bind NCAIR.
kcat pH Rate Profiles. The log kcat versus pH profiles for wild-type and AaPurE1-S57C
did not demonstrate log-linear dependence on pH, fits to equation 4.4 yielded slopes of
-0.12 ± 0.09 and -0.05 ± 0.12, respectively (Figure 4.19, panel B). The lack of
dependence on pH indicates that protonation is not important for catalysis in the
NCAIR→CAIR direction for either wild-type AaPurE1 or AaPurE1-S57C.

4.4

Discussion
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Our initial hypothesis was that Ser assists in catalysis, but would not be as important as
the absolutely conserved His acid-base catalyst.3 Our results show, however, that Ser→X
mutants have substantially diminished activity in both PurE1 and PurE2, indicating that a
hydrogen bond formed between Ser and N3 is very important for catalysis.
Ser could support PurE1 and PurE2 function in one or more ways:
1) In PurE1 and PurE2 (at high pH), Ser has been proposed to provide a
hydrogen bond to (C)AIR N3 thereby directing protonation to C4.1,6 This
would be an example of “negative catalysis”, whereby the Ser itself does not
participate in catalysis but deters protonation of the N3.
2) In PurE1, Ser57 has been proposed to provide a pivot-point that allows AIR in
the AIR•CO2 ternary complex to “ring flip” to position either AIR C4 or N6
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for attack on the retained CO2 to produce CAIR or NCAIR, respectively. No
similar behavior is suspected for PurE2, which cannot accommodate NCAIR
(Figure 4.1).
3) In PurE2, Ser38 may switch hydrogen bond polarity at low pH to become a
hydrogen bond acceptor for a protonated N3.2 This role is not suspected for
PurE1, since the active site is closed and N3 protonation is associated with
inhibition of activity.
Not one of these functions is mutually exclusive, so Ser could play any or all of these
roles. To differentiate between these possibilities, ionizable mutants were used to
construct pH rate profiles.
A simple conclusion from site-directed mutagenesis is that Ser is indeed involved in
hydrogen bonding, as the mutants with the highest detectable activity are able to supply a
hydrogen bond. The Ser→Ala mutants may allow an adventitious water to perform this
function. The pH rate profiles indicate that protonation at the Ser position is important for
catalysis.
pH Rate Profiles of PurE1 and PurE2 are Consistent with Different Mechanisms of CAIR
Decarboxylation . pH rate profiles indicate that replacement of the Ser with an ionizable
residue changes the shape of the pH profile, except for the AaPurE1-S57A mutant.
AaPurE1-S57A does not posses an ionizable residue at the Ser57 position, but
nevertheless has pK values similar to wild-type, indicating that both enzyme forms use
the classic C4 protonation mechanism proposed! for CAIR decarboxylation3 (Figure 4.3,
panel A).
A log-linear pH dependence was observed in AaPurE1-S57C log kcat/Km, TdPurE2-S38C
(log kcat/Km and log kcat), and TdPurE2-S38D (log kcat/Km and log kcat) pH rate profiles.
The different shape of Ser mutant pH rate profiles versus wild-type suggests a change in
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mechanism of CAIR decarboxylation. Loss of the hydrogen bond provided by the Ser
hydroxyl may “break” the classic C4 protonation mechanism. A weaker hydrogenbonding partner provided by the Cys may actually facilitate protonation at AIR N3,
allowing decarboxylation by the ylide (N3 protonation) mechanism (Figure 4.3, panel B).
While this reaction may be slower, the Ser→X mutants are still able to catalyze CAIR
decarboxylation.
If decarboxylation occurs through the ylide mechanism, it may explain why we do not
observe a pKa in the Ser→X mutant pH rate profiles. We know the pKa of N3 for CAIR
and AIR in solution (~5.9 and ~6.05, respectively), but the pKa of the ylide intermediate
N3 could be much higher.
An observation unique to the AaPurE1-S57C mutant is that the log kcat pH profile shows
loss of the inhibitory pK1, the one associated with N3 protonation of CAIR in wild-type
AaPurE1. The shape of the S57C profile resembles the TdPurE2 log kcat versus pH
profile, which could indicate that AaPurE1-S57C uses a PurE2-like mechanism. The Cys
mutant cannot form a strong hydrogen bond with AIR N3, which may facilitate (or at
least allow) N3 protonation and decarboxylation through the ylide reaction manifold.
The Replacement of Ser with Asp or Cys May Have Electrostatic Effects on CAIR C4. In
addition to diminishing the polarity of the Ser-N3 hydrogen bond, the effect of Cys and
Asp may be to diminish the negative character of C4 (Figure 4.20). Our working
hypothesis is that N3 protonation is favored over C4 protonation unless something
decreases the likelihood of the former. If N3 is protonated, decarboxylation could occur
by the proposed ylide mechanism.
Mutagenesis and kinetic analysis versus pH both indicate that the polarized hydrogen
bond provided by the Ser hydroxyl is important for C4 protonation. Therefore, this
suggests the primary role for Ser is to direct protonation to C4 in both PurE1 and PurE2
by thwarting N3 protonation.
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The Asp in TdPurE2-S38D May Directly Participate in Catalysis. The pH rate profile for
TdPurE2-S38D suggests that Asp38 may participate in catalysis (S38D retains 96% of
wild-type activity at pH 5.8). Asp38 could share a proton with N3 and decarboxylation
could proceed by the ylide mechanism. The AaPurE1 active site His mutant, AaPurE1H59D, is also a surprisingly efficient enzyme at low pH.2 This non-conservative mutation
appears to support catlysis at either the Ser or His position.
AaPurE1 NCAIR→CAIR Conversion Uses a Reverse Protonation Mechanism. The
mechanism of CAIR decarboxylation requires a protonated His59 (its acid form) and a
deprotonated AIR N3 (its basic form).26 At the optimal pH for CAIR decarboxylation, a
small mole fraction of AaPurE1 is present in the reverse protonation state. Enzymes,
which use a reverse protonation mechanism, are commonly associated with one direction
of a reversible enzyme reaction.25, PurE1 catalyzes the fully reversible interconversion of
NCAIR⇌CAIR and the reverse protonation state appears to be the “correct” protonation
state for activity in the NCAIR→CAIR direction.
The AaPurE1 log kcat/Km versus pH profile is a bell-shaped curve with two distinct pKas.
The pKas obtained for the forward direction are opposite relative to the CAIR
decarboxylation pKas (Figure 4.17 and Figure 4.19). The basic pK1 is likely associated
with a deprotonated His and the acidic pK2 may be associated with the N3 position or the
carbamate of NCAIR. These protonation states are required for NCAIR binding.
However, the AaPurE1 log kcat pH profile is not dependent upon pH, indicating
protonation is not required for catalysis.
The replacement of the conserved Ser with Cys abrogates any detectable ionization
within the pH range tested. The AaPurE1-S57C log kcat/Km and log kcat pH profiles are
not dependent upon pH, indicating the presence of a proton is not required for NCAIR to
bind to the Cys mutant or for catalysis (Figure 4.19).
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4.5

Future Directions

Acquisition of pH rate profiles in the forward direction with both S57X and S38X
mutants should be done to determine if the loss of a hydrogen bond at the Ser position
causes a switch to the irreversible ylide (N3 protonation) mechanism.
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Figure 4.1 CAIR decarboxylation reaction catalyzed by PurE1 and PurE2. Reactions are
shown in the nonphysiological CAIR decarboxylase direction because CAIR is a
substrate for both PurE1 and PurE2. (A) CAIR decarboxylation (R = R5P) begins with
protonation at C4 by an essential His residue.1,2 Decarboxylation gives a ternary complex
containing AIR and CO2, which only dissociates from PurE2. The PurE1 reaction
continues with an aminoimidazole ring flip and NCAIR formation.6
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TdPurE2
AfPurE2
HumanE2
AaPurE1
EcPurE1

70

RIGSAHKTAE
RIASAHKTPE
RVTSAHKGPD
LIVSAHRTPD
EVVSAHRTPD

A"

YITIAGRSNALSG
F V T V A G R S N A L S G class2
FVAVAGRSNGLGP
IIAGAGGAAHLPG
I I A G A G G A A H L P G M class1

B"
Ala58&
Arg60&

Ala39&

Lys41&

Ser57&

2.8&Å&

2.6&Å&

His40&

His59&

Asp33&

Gly85&

Ser38&

Asp14&

Ser69&
Gly67&

Figure 4.2 PurE1 and PurE2 sequence alignment and active site structures with AIR
bound. (A) Sequence alignment of the conserved residues in the active site of PurE2 and
PurE1 (T. denticola numbering). Bold residues are conserved across the different classes;
the red boxes are conserved among PurE2s and the blue boxes are conserved among
PurE1s. The critical active site acid/base catalyst His is denoted by a star. Residues that
are hydrogen bond acceptors are indicated by, ▲ and hydrogen bond donors ▼. (B)
AaPurE1 (PDB code 2FWJ) (C) TdPurE2 (PDB code 3RGG) active site is shown with
contacts to the AIR nucleotide shown. The hydrogen bond between the N3 of AIR and
Ser is colored in salmon. Electron density maps for 2Fo-Fc (blue mesh) are contoured at
1.0 σ and have a carve radius of 2.0 Å around the AIR ligand. “Place holder” waters that
bind in the carboxylate/CO2 pocket are shown as cyan spheres.
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Figure 4.3 Proposed mechanisms for decarboxylation by PurE1 and PurE2. Reactions are
shown in the reverse biosynthetic direction. (A) Classic C4 protonation mechanism
proposed for PurE1 and PurE2 (at high pH).1,2 (B) Ylide (N3 protonation) mechanism
proposed for low pH decarboxylation in PurE2.2
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Figure 4.4 Illustration of the protocol using synthetic oligonucleotides to generate
TdPurE2-M15,S38T.
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Table 4.1 Description of bacterial strains used in this chapter.
Strain
DH5α

Description
F′ φ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1

Source
Lab stock

BL21(DE3)

F– ompT gal dcm lon hsdSB(rB- mB-)
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])

Lab stock

CC1215

F– ompT gal dcm lon hsdSB(rB- mB-) ΔpurE736::kan
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])

This study

JW0512

F- Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) ΔpurE736::kan, λ-, rph-1
Δ(rhaD-rhaB)568, hsdR514

CGSG

W3110

LAM- ln(rrnD-rrnE)1 rph-1

Lab stock
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Table 4.2 Oligodeoxynucleotides (ODNs) used in this chapter.a
ODN
1161
1164
2124
2125
2203
2204
2205
2206
2207
2208
2285
2286
2316
2317
2320
2321
2235
2236
2345
2346
2355
2356
2366
2367

Sequence (5’→3’)
CGGATGACGTTGAGCTGATTCATTTTCC
Sequencing
CAGCTCACCTAAACGATCAAACAC
Sequencing
TAATACGACTCACTATAGGG
T7 promoter
GCTAGTTATTGCTCAGCGG
T7 terminator
GCGTACGATGTGCTGcAACAATGAGGG
AaPurE1-S57A
CCCTCATTGTTgCAGCACATCGTACGC
AaPurE1-S57A
CTGGCGTACGATGTGCgcAAACAATGAGGG
AaPurE1-S57C
CCCTCATTGTTTgcGCACATCGTACGCCAG
AaPurE1-S57C
GGCGTACGATGTGCTGtAACAATGAGGG
AaPurE1-S57T
CCCTCATTGTTaCAGCACATCGTACGCC
AaPurE1-S57T
CATGAAACCCTCATTGTTgtAGCACATCGTACGCCAG
AaPurE1-S57V
CTGGCGTACGATGTGCTacAACAATGAGGGTTTCATG
AaPurE1-S57V
CCGCTGTTTTATGCGCGGtACCGATGCGAATGGCATAC
TdPurE2-S38T
GTATGCCATTCGCATCGGTaCCGCGCATAAAACAGCGG
TdPurE2-S38T
GCTCCGCTGTTTTATGCGCGtcGCCGATaCGtATGGCATACTC
TdPurE2-S38D
GAGTATGCCATaCGtATCGGCgaCGCGCATAAAACAGCGGAGC
TdPurE2-S38D
GCGTACGATGTGCgtcAACAATGAGGG
AaPurE1-S57D
CCCTCATTGTTgacGCACATCGTACGC
AaPurE1-S57D
CATTCGCATCGGCgTCGCGCATAAAACAG
TdPurE2-S38A
CTGTTTTATGCGCGAcGCCGATGCGAATG
TdPurE2-S38A
CATTCGCATCGGCGtnGCGCATAAAACAG
TdPurE2-S38V
CTGTTTTATGCGCnaCGCCGATGCGAATG
TdPurE2-S38V
CGCATCGGCTgCGCGCATAAAACAGCtGAGCATGTAGTGTC
TdPurE2-S38C
CGTCTGAATTGAAAACTTTTGGTATTGAGTATGCCATTCGCATC TdPurE2-S38C
GGCTgCG
2374
CCGCTGTTTTATGCGCGtTACCGATGCGAATGGCATAC
TdPurE2-S38N
2375
GTATGCCATTCGCATCGGTAaCGCGCATAAAACAGCGG
TdPurE2-S38N
2376
GGCGTACGATGTGCGTtAACAATGAGGG
AaPurE1-S57N
2377
CCCTCATTGTTaACGCACATCGTACGCC
AaPurE1-S57N
2393
GATATACATATGCGTCCGCTGGTGATTATCCTTATGGGatcCAGT TdPurE2-H17W
TCAGATATGGGTtggGCCGAGAAAATTGCtagcGAATTGAAAAC
2398
GatcCAGTTCAGATtgGGGgCAtGCCGAGAAAATTG
TdPurE2-M15W
2399
ctaGCAATTTTCTCGGCaTGcCCCcaATCTGAACTG
TdPurE2-M15W
a
Changes in the coding region that deviate from the genomic sequence are in lower case.
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Table 4.3 Previously published plasmids used in this study.
Plasmid
pJK175

Description

Source

Protein encoded

purE1Aa in pET23a

1

AaPurE

Table 4.4 Plasmids used in this chapter.
Plasmid

Description

Protein encoded

pJK582
pJK583
pJK584
pJK608
pJK643
pJK644
pJK653
pJK659
pJK677
pJK684
pJK685
pJK686
pJK692
pJK697

purE1Aa-S57A in pET23a
purE1Aa-S57C in pET23a
purE1Aa-S57T in pET23a
purE1Aa-S57D in pET23a
purE2Td-S38T in pET23a
purE2Td-S38D in pET23a
purE2Td-S38T, F79W in pET23a
purE2Td-S38C, F79W in pET23a
purE1Aa-S57V in pET23a
purE2Td-S38V in pET23a
purE2Td-S38N in pET23a
purE1Aa-S57N in pET23a
purE2Td-H17W, S38T in pET23a
purE2Td-M15W, S38T in pET23a

AaPurE-S57A
AaPurE-S57C
AaPurE-S57T
AaPurE-S57D
TdPurE-S38T
TdPurE-S38D
TdPurE-S38T,F79W
TdPurE-S38C,F79W
AaPurE-S57V
TdPurE-S38V
TdPurE-S38N
AaPurE-S57N
TdPurE-H17W,S38T
TdPurE-M15W,S38T

!
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Table 4.5 Results of functional complementation of JW0512 (ΔpurE) Keio strain.
MMa +
MM+ CO2 b+
Plasmid (PurE form)
hypoxanthine
MM
hypoxanthine
MM + CO2
pET23a
+++c!
$!
++++!
$!
pJK175 (purE1Aa)
+++!
+++!
++++!
+++!
pJK283 (purE1Aa-H59N)
+++!
$!
++++!
$!
pJK582 (purE1Aa-S57A)
+++!
$!
++++!
$!
pJK583 (purE1Aa-S57C)
+++!
$!
++++!
$!
pJK584 (purE1Aa-S57T)
+++!
$!
++++!
+!
pJK677 (purE1Aa-S57V)
+++!
$!
++++!
$!
pJK686 (purE1Aa-S57N)
+++!
$!
++++!
$!
pJK608 (purE1Aa-S57D)
+++!
$!
++++!
$!
pJK376 (purE2Td)
+++!
++!
++++!
++++!
pJK392 (purE2Td-H40N)
+++!
$!
++++!
$!
pJK617 (purE2Td-S38A)
+++!
$!
++++!
+!
pJK607 (purE2Td-S38C)
+++!
$!
++++!
+!
pJK643 (purE2Td-S38T)
+++!
$!
++++!
+++!
pJK684 (purE2Td-S38V)
+++!
$!
++++!
$!
pJK685 (purE2Td-S38N)
+++!
$!
++++!
$!
pJK644 (purE2Td-S38D)
+++!
$!
++++!
$!
a
minimal media described above in experimental details
b
plates grown in a candle jar.
c
symbols:++++, large colonies at 24 h +++, small colonies at 24 h;, ++, small colonies at 48 h; +, small
colonies at 120 h; -, no growth observed at 144 h.

M SL SS HA ISO
M"""S"""CL""HA"ISO"

25kDa
25"
677P
15kDa
15"

!
Figure 4.5 SDS-PAGE analysis of a representative AaPurE1-S57X (X = V) isolation. A
12% polyacrylamide gel was loaded with 5 ug protein per lane: M, Sigma biotinylated
marker; S, soluble lysate; CL, cleared lysate; HA, hydroxyapatite input; and ISO, isolated
AaPurE1-S57V. Molecular weights (kDa) are denoted along the left side of the gel.
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M"""C""""S""CL"""AS""HA""ISO"

25"
20"

!
Figure 4.6 SDS-PAGE analysis of a representative TdPurE2-S38X (X = A) isolation. A
12% polyacrylamide gel was loaded with 5 ug protein per lane: M, Sigma biotinylated
marker; S, soluble lysate; CL, cleared lysate; AS, ammonium sulfate supernatant; ; HA,
hydroxyapatite input; and ISO, isolated TdPurE2-S38A. Molecular weights (kDa) are
denoted along the left side of the gel.
!
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AaPurE15S57X#

TdPurE25S38X#

##M#####wt###A#####C######T#####V#####N#####D##############M####wt##A####C####T####V#####N####D#
#

39#
29#

14#

!
Figure 4.7 SDS-PAGE analysis of isolated AaPurE1-S57X and TdPurE2-S38X forms. A
12% polyacrylamide gel was loaded with 5 ug protein per lane: M, Sigma biotinylated
marker; AaPurE1 is denoted by wt; and each mutation in Ser57 or Ser 38 is indicated by
the one letter code. Note the slightly decreased mobility of S57D, which is presumably
due to the addition of a negatively charged residue. Molecular weights (kDa) are denoted
along the left side of the gel.
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F79W# H17W#

####M######S####T#####C#####T#

S38X#

39#
29#

14#
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Figure 4.8 SDS-PAGE analysis of isolated TdPurE2 Trp introduction forms. A 12%
polyacrylamide gel with 5 ug protein loaded per lane: 12% polyacrylamide gel was
loaded with 5 ug protein per lane: M, Sigma biotinylated marker. Each mutation in Ser 38
is indicated by the one letter code directly above each lane. Each mutation to introduce a
Trp into TdPurE2 is indicated above the solid line. Molecular weights (kDa) are denoted
along the left side of the gel.
!
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Figure 4.9 Gel-filtration analysis of AaPurE1-S57X mutants. The traces are shifted 0.1
A280. The AaPurE1 octamer elutes at ~57 mL and aggregate elutes at the excluded
volume (Vo). The completely excluded volume (Vo, 44.7 mL) and included volume (Vi,
113.6 mL) volumes are indicated with arrows. A small peak at (~76 mL) observed in
AaPurE1-S57V is likely due to the formation of tetramers.
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Figure 4.10 Fluorescence titrations of AaPurE1-S57X mutants with citrate. (A)
Fluorescence emission spectra of AaPurE1-S57C were recorded in 50 mM potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C with an excitation at 295 nm. (B) Fluorescence
emission intensity at 320 nm plotted as a function of [citrate] for AaPurE1-S57T (black
filled squares), AaPurE1-S57A (red filled circles), AaPurE-S57C (blue filled triangles),
AaPurE1-S57V (pink filled inverted triangles), and AaPurE1-S57D (green filled
diamonds). Titrations were performed with [subunit] of 0.4 µM, 1.29 µM, 0.4 µM, 0.4
µM and 0.4 µM, respectively. Data were fit to equation 4.5 in Origin to obtain Kd values
(Table 4.9).
!
!

Figure 4.11 Fluorescence titrations of AaPurE1-S57A with AIR. (A) Fluorescence
emission spectra of AaPurE1-S57A were recorded in 50 mM potassium acetate, 100 mM
KCl, pH 4.6 at 25 °C with excitation at 295 nm. (B) Fluorescence emission intensity at
320 nm, plotted as a function of [AIR]. Titrations were performed with [subunit] of 0.4
µM. Data were fit to equation 4.6 using Origin to obtain Kd values (Table 4.9).
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Figure 4.12 Active sites AaPurE1-S57X mutants with AIR modeled in from the 2fwj
structure. (A) EcPurE1•CAIR complex (PDB code 2NSL). (B) AaPurE1•AIR complex
(PDB code 2FWJ). (C) AaPurE1 (PDB code 1U11). (D) AaPurE-S57T (PDB code
TBD). (E) AaPurE1-S57A (PDB code TBD). (F) AaPurE1-S57C (PDB code TBD). (G)
AaPurE1-S57V (PDB code TBD). (H) AaPurE1-S57N (PDB code TBD). (I) AaPurE1S57D (PDB code TBD). An electron density map (final 2Fo−Fc, blue mesh) is shown for
AIR atoms and residue 57 with a 1.0 σ contour and 2.0 Å carve. The Fo−Fc map is
contoured at +3 σ (green mesh) and –3 σ (red mesh). Note the two “placeholder waters”
shown as cyan spheres. These oxygen atoms occupy the same location as those in CO2
or CAIR carboxylate in PurE1 structures.
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Figure 4.13 Oxidized cysteines in the AaPurE1-S57C structure. (A) The density in
subunit A is not consistent with Cys57. (B) The density in subunit B not consistent with
Cys57. (C) The density in subunit A is consistent with the oxidized cysteine sulfinic acid.
(D) The density in subunit B is consistent with the oxidized cysteine sulfenic acid. (E)
Possible chemical structures for Cys57. An electron density map (final 2Fo−Fc, blue
mesh) is shown for residue 57 with a 1.8 σ contour and 2.0 Å carve. The Fo−Fc map is
contoured at +3 σ (green mesh) and –3 σ (red mesh).
!
Table 4.6 Mass spectrometric analysis of AaPurE1 forms.
PurE1

Observed Mass (Da)

Expected Mass (Da)a

AaPurE1 (wild-type)

18869c

18867

AaPurE1-S57C

18880

18882

a

Molecular masses ([M+H+]+) were determined by MALDI., Expected masses were
calculated using ExPaSy ProtParam. All AaPurE1s have an additional N-terminal Met2
b
Difference in mass between expected and observed.
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Figure 4.14 Active sites of TdPurE2 and the TdPurE2-S38D mutant. (A) TdPurE2 with
AIR bound (PDB code 3rgg). (B) TdPurE2 (PDB code 3rg8) with AIR modeled in from
alignment with the 3rgg structure. (C) TdPurE2-S38D (PDB code TBD) with AIR
modeled in from alignment with the 3rgg structure. An electron density map (final
2Fo−Fc, blue mesh) is shown for AIR atoms and residue 57 with a 1.0 σ contour and 2.0
Å carve. The Fo−Fc map is contoured at +3 σ (green mesh) and –3 σ (red mesh). Note the
two “placeholder waters” shown as cyan spheres.
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Table 4.7 X-ray data collection statistics.

PDB entry
Beamline
Wavelength (Å)
Space group b
Unit cell param.
(Å)
Resolution (Å)

S57A_4
TBD
21-ID-D
0.97872
I422

209_S57C
TBD
21-ID-F
0.97856
I422

a=b= 99.775,
c= 165.021

a=b=99.430,
c=164.168

a=b=99.803,
c=164.409

50-1.75
a
(1.78–1.75)
611,211
41,986 (2080)

50-1.98
(2.01-1.98)
275154
29106 (1430)

50–2.00
(2.03–2.00)
360568
28501 (1390)

No. meas. refl.
No. unique refl.
Completeness
100 (100)
99.3 (99.9)
100 (100)
(%)
Multiplicity
14.6 (14.7)
9.5 (8.7)
12.7 (12.4)
Rmerge (%) c
8.7 (86.6)
10.3 (30.9)
12.2 (80.2)
Mean I/σ (I)
45.2 (2.9)
46.4 (9.8)
34.0 (3.9)
VM (Å3 Da-1) d
2.49
2.48
2.48
Est. solvent (%)
50.7
50.4
50.4
a
Values in parenthesis are for the highest resolution shell.
b
All have α=β=γ=90°.
c
d

Rmerge =

AaPurE1
S57V2
TBD
21-ID-F
0.97872
I422

S57T_6
TBD
21-ID-D
0.97856
I422

!!!" !!!|!!! ! !!" ! !(!!") |
!!!" !!!! !! (!!")

206_S57N
TBD
21-ID-F
0.97872
I422

S57D_102
TBD
21-ID-F
0.97856
I422

a =b=!99.803,
c=!164.409

a =b=!99.981
c=!164.716

a =b=!99.703
c=!165.606

50-1.80
(1.83-1.80)
751400
37948 (1871)

50-1.79
(1.82-1.79)
1130009
39536 (1958)

50-2.75
(2.80-2.75)
124466
11217 (535)

TdPurE2
207_S38D
TBD
21-ID-F
0.97872
C2221
a= 84.084
b=!154.958
c=!89.130
50-1.70
(1.73-1.70)
950714
64883 (3188)

100 (100)

100 (100)

99.8 (99.4)

99.9 (100)

19.8 (18.7)
9.3 (44.2)
61.1 (10.7)
2.47
50.3

28.6 (28.0)
9.3 (83.5)
51.7 (6.3)
2.50
50.8

11.1 (10.9)
8.9 (63.9)
25.3 (3.4)
2.50
50.7

14.7 (14.3)
7.0 (50.4)
55.3 (5.3)
2.71
54.6

, where Ii (hkl) is the ith measurement of the intensity of reflection hkl and !(ℎ!") is its mean value.

Matthews coefficient.
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Table 4.8 Summary or refinement statistics.

PDB entry
Resolution (Å)
No. reflections used
working
test set
Completeness (%)
Rcrystb(%)
Rfreec(%)
No. of atoms
all atoms
protein atoms
solvent atoms
R.m.s. deviations from ideality
Bondlengths (Å)
Bond angles (°)
Average isotropic B factors (Å2)
protein atoms
ligand atoms
solvent atoms
Ramachandran plot statistics (%)
Residues in favored regions
Residues in allowed regions
Outliers
MolProbity score [percentile]
MolProbity clashscore
[percentile]
a
b
c

S57A_4
TBD
29.4-1.99
(2.06-1.99)

209_S57C
TBD
43.1-1.99
(2.06-1.99)

AaPurE1
S57V2
TBD
42.7-1.81
(1.86-1.81)

206_S57N
TBD
43.2-1.79
(1.85-1.79)

S57D_102
TBD
48.0-2.73
(3.00-2.73)

TdPurE2
207_S38D
TBD
44.6-1.69
(1.72-1.69)

40297
1608
95.9
18.1 (19.8)
18.8 (24.8)

27738
1391
96.9
16.2 (15.9)
18.6 (20.5)

27435
1369
94.6
16.1 (18.1)
18.2 (24.9)

37370
1863
98.4
16.0 (17.4)
17.6 (22.1)

38493
1531
97.3
15.5 (17.0)
17.4 (26.9)

10484
505
91.9
17.3 (21.2)
21.3 (29.3)

63737
3189
97.5
19.5 (25.9)
22.3 (31.8)

2460
2303
337

2577
2347
221

2549
2336
203

2971
2351
293

2637
2328
309

2321
2312
9

5198
4716
482

0.007
1.008

0.007
0.997

0.007
1.011

0.006
1.002

0.007
1.009

0.008
1.051

0.006
1.097

26.5
37.1

22.5
48.5
35.7

24.6
49.9
38.1

17.1
31.9

17.9
32.0

47.7
45.1

27.3
33.9

98.7
1.3
0
1.02 (100)
0.64 (100)

98.8
1.3
0
0.92 (100)
1.26 (100)

99.4
0.6
0
0.71 (100)
0.64 (99)

99.1
0.9
0
1.08 (100)
2.3 (99)

99.8
1.3
0
1.9 (100)
1.03 (100)

98.4
1.6
0
1.49 (100)
1.14 (100)

98.2
1.6
0.2
2.84 (99)
1.07 (100)

Values in parenthesis are for the highest resolution shell.
!
!||!!
!|! !!"#! |
Rcryst = = !!" !"#
!!!" !|!!!"# !|

Rfree is Rcryst with a test set of 5% of the reflections excluded from refinement
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S57T_6
TBD
35.6-1.75
a
(1.81-1.75)
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Figure 4.15 Saturation curves of active AaPurE1-S57X mutants. All data were collected
in 50 mM Tris-HCl, pH 8 at 30 °C. The velocity (units mg-1) for CAIR decarboxylation
of active AaPurE-S57X mutants was plotted against [CAIR] and fit to the MichaelisMenten equation in Origin, with the exception of AaPurE1-S57V, which was fit to a
linear equation. Data for each active AaPurE-S57X mutant is shown above: A, AaPurE1S57C; B, AaPurE1-S57T; C, AaPurE1-S57A; and D, AaPurE1-S57V.
!
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Figure 4.16 Saturation curves of active TdPurE1-S38X mutants. All data were collected
in 50 mM Tris-HCl, pH 8 at 30 °C. The velocity (units mg-1) for CAIR decarboxylation
of active AaPurE-S57X mutants was plotted against [CAIR] and the TdPurE-S38C data
fit to the Michaelis-Menten equation in Origin. Data for each active TdPurE-S38X
mutant is shown above: A, TdPurE2-S38C; B, TdPurE2-S38T; C, TdPurE2-S38A; and
D, TdPurE2-S38V.
!
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Table 4.9 Kinetic parameters for PurE1 and PurE2 Ser→X mutants at pH 8.
PurE form

rSAa

rel.
kcat/Km b

kcat/Km (M1 -1
s )

kcat (s-1)

Km
(µM)

Kd citrate
(µM) c

Kd AIR
(µM) d

AaPurE1

100

100

1.5 x 106

12.6

11

275

2.2

AaPurE1-S57T

10

20

3.0 x 105

1.5

5

141

ise

AaPurE1-S57A

1.4

1.2

1.8 x 104

0.2

11

133

is

AaPurE1-S57C

0.03

0.02

2.8 x 102

3.9 x 103

14

102

is

AaPurE1-S57V

0.03

0.2

2.9 x 103

ndf

nd

132

is

AaPurE1-S57D

~0

nag

na

na

na

63

is

AaPurE1-S57N

~0

na

na

na

na

nd

is

TdPurE2

100

100

7.2 x 106

65

9

nd

na

TdPurE2-S38Th

9

nd

nd

nd

nd

nd

na

TdPurE2-S38T,F79W

9

nd

nd

nd

nd

nd

nd

TdPurE2-H17W,S38T

0.4

nd

nd

nd

nd

nd

nd

TdPurE2-S38A

0.05

nd

nd

nd

nd

nd

na

TdPurE2-S38C

0.05

0.00002

1.13

5.7 x 102

51

nd

na

TdPurE2-S38C,F79W

0.11

nd

nd

nd

nd

237

6

TdPurE2-S38Vh

0.05

nd

nd

nd

nd

nd

na

TdPurE2-S38D

~0

na

na

na

na

na

na

TdPurE2-S38N

0.02

nd

nd

nd

nd

nd

na

TdPurE2-S38C,F79W

0.11

nd

nd

nd

nd

237

6

a

rSA, % specific activity relative to wild-type AaPurE1 (39 units per mg protein) or TdPurE2 (185 units
per mg protein), determined at 100 µM CAIR, pH 8, 30 °C.
b
rel. kcat/Km, % kcat/Km relative to wild-type AaPurE1 or TdPurE2.
c
Citrate titrations carried out in 50 mM potassium acetate, 100 mM KCl, pH 4.6 at 25 °C.
d
AIR titrations carried out in 50 mM Tris-HCl, pH 8.0 at 30 °C.
e
is, insufficient signal.
f
nd, not determined.
g
na, not applicable.
h
Saturation curves show substrate inhibition above 100 µM CAIR.
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Figure 4.17 pH-rate profiles for AaPurE1 CAIR decarboxylation. The wild-type (black
circles) 2, AaPurE1-S57A (green circles), and AaPurE1-S57C (blue circles) kcat/Km and
kcat data are shown above with fits to the data shown in the same color. (A) The log
kcat/Km versus pH profiles are similar bell-shaped curves for both wild-type and S57A
(pK1 = 6.0 ± 0.1 and 5.9 ± 0.1, respectively; pK2 = 7.2 ± 0.1 and 8.3 ± 0.2, respectively).
The log kcat/Km versus pH profile for S57C has a log-linear dependence on pH with a
slope of -0.86 ± 0.03. (B) The log kcat versus pH profiles for wt2 and S57A are similar
bell-shaped curves (pK1 =5.1 ± 0.2 and, = 5.8 ± 0.1 respectively; pK2 = 8.4 ± 0.1 and 8.6
± 0.1, respectively). The log kcat versus pH profile for S57C has two pKas averaging ~6.7.
Data for pHs 8.5 and 9.0 were excluded from the fit.
!
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Figure 4.18 pH-rate profiles for TdPurE2 CAIR decarboxylation. The wild-type (black
circles)2, TdPurE2-S38D (red circles), and TdPurE2-S38C (blue circles) kcat/Km and kcat
data are shown above with fits to the data shown in the same color. (A) The log kcat/Km
versus pH profile for wt is bell-shaped curve with pK1 = 5.7 ± 0.2 and pK2 = 7.3 ± 0.1.
The log kcat/Km versus pH profile for both S38C and S38D has a log-linear dependence on
pH with slopes of -0.21 ± 0.06 and -0.90 ± 0.04, respectively. (B) The log kcat versus pH
profile for wt is bell-shaped curve with pK1 = 5.9 ± 0.5 and pK2 = 8.4 ± 0.1. The log kcat
versus pH profile for both S38D and S38C has a log-linear dependence on pH with slopes
of -1.5 ± 0.08 and -0.52 ± 0.09, respectively.
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Figure 4.19 pH-rate profiles for AaPurE1 NCAIR→CAIR conversion. The wild-type
(black circles) and AaPurE1-S57C (blue circles) kcat/Km and kcat data are shown above
with fits to the data shown in the same color. (A) The log kcat/Km versus pH profile for wt
is a bell-shaped curve with pK1 = 8.8 and pK2 = 5.45. The log kcat/Km versus pH profile
for AaPurE1-S57C has a log-linear dependence on pH with a slope of -0.09 ± 0.08. (B)
The log kcat versus pH profiles for wt or AaPurE1-S57C have log-linear dependence on
pH with a slopes of -0.12 ± 0.09 and -0.05 ± 0.12, respectively.
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Figure 4.20 The replacement of Ser with Asp or Cys may have electrostatic effects. The
strong hydrogen bond provided by Ser is important for C4 protonation. The electrostatic
effects of Cys and Asp may diminish the negative character of C4, making C4 more
difficult to protonate.
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CHAPTER 5 ROLE OF THE CONSERVED ACTIVE SITE LYSINE RESIDUE IN
PURE2 FROM TREPONEMA DENTICOLA
!
!
5.1

Introduction

In Chapter 4 we examined the role of the universally conserved active site Ser. Crystal
structures of PurE1 and PurE2 with AIR bound (PDB id 2fwj and 3rgg) reveal that the
Ser makes similar contacts with the substrate and would appear to have similar roles.
Surprisingly, this conserved residue appears to have different roles between PurE1 and
PurE2. In this chapter we examine the role of the class-specific active site Lys in PurE2
to determine if it has different roles in PurE1 and PurE2.
The 40s Loop Basic Residue is Differentially Conserved. The strictly conserved 40s loop
sequence SAH[R/K] contains a single absolute, class-linked divergence. The
differentially conserved basic residue, Arg in PurE1 and Lys in PurE2, contacts the
phosphate moiety of the nucleotide and appears to be involved in high affinity substrate
binding.

1–3

The E. coli PurE1-R46K mutant, which replaces the class-specific Arg, is

active, as expected for a residue that is mainly involved in substrate bidning.3 It is
therefore, curious why there are no known exceptions to the class-linked divergence in
the basic residue.
Lys May Play a Role Beyond Substrate Binding. An absolute difference between PurE1
and PurE2 is the source of CO2: PurE1 acquires it by decarboxylation of bound NCAIR
(or CAIR), while PurE2 binds it directly from solution. The challenging acquisition of
CO2 by PurE2 has been hypothesized to involve intermediate formation of an Ncarboxylated carbamate species on the conserved Lys. This function would be unique to
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PurE2 and not necessary in PurE1, as the carbamate moiety of NCAIR serves a similar
role as a CO2 carrier.
The ability to form a carbamate is limited to Lys or the N-terminus. Both urease and
Rubisco reactions require the formation of a Lys-carbamate within the active site, and
hemoglobin uses an N-terminal carbamate to carry CO2.4–6 PurE2 may instead use a Lyscarbamate as a source of substrate. Formation of a Lys-carbamate could also function as a
CO2 concentrating mechanism, which would be advantageous in environments with
limited CO2 availability (Figure 5.1A).
Alternatively, the AIR carbanion could directly attack the fixed carbonyl of the Lyscarbamate (Figure 5.1B). In this scenario, the Lys-carbamate would play a role analogous
to N-carboxybiotin in the reaction catalyzed by acetyl-CoA carboxylase, in which the
acetyl-CoA carbanion attacks carboxybiotin to form malonyl-CoA and biotin (Figure
5.1C).7 While this “deactivates” CO2 as an electrophile, it would confer an potentially
compensatory entroptic advantage relative to collisional capture of a gaseous substarte.
This chapter tests the hypothesis that formation of a Lys-carbamate is an obligatory
intermediate in TdPurE2 catalysis. We show that the TdPurE2-K41R mutant retains both
AIR carboxylase and CAIR decarboxylase activities, indicating that a N-carboxylated
Lys is not a required intermediate in the TdPurE2 reaction. We cannot however, rule out
a role for Lys-carbamate in other PurE2s under low CO2 conditions.

5.2

Materials and Methods

Materials. Chemicals were obtained from Sigma or Fisher in the highest purity available
unless otherwise noted. CAIR was prepared as described in Chapter 2.8 AIR was
generated enzymatically from CAIR using TdPurE2 and quantitated by Bratton-Marshall
assay as described previously.2 Oligodeoxynucleotides (ODNs) were obtained from
Integrated DNA Technologies and used without further purification. Restriction
endonucleases, Q5 DNA polymerase, CIP, and T4 DNA ligase were obtained from New
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England Biolabs. Phenyl Sepharose CL-6B was obtained from Sigma. Hydroxyapatite
(Bio-Gel® HT) and Bradford reagent were obtained from Bio-Rad. PD-10 desalting
columns were obtained from GE Health Care.
Methods. Protein concentrations were determined by the method of Bradford with bovine
serum albumin as the standard.9 Small-scale centrifugation steps were performed using an
Eppendorf 5424 centrifuge. All other centrifugation steps were performed using a
Beckman Avanti J-E centrifuge with a JLA-10.5 or JA-20 rotor. Cell disruption was
performed by sonication using a Fisher Scientific Dismembrator 550 at 25% output for 3
cycles (1 min each separated by 1 min cooling intervals) at 4 °C. Spectroscopic
measurements were recorded on a Varian CARY-100 UV/Vis spectrophotometer
thermostated by a Cary Dual Peltier Accessory temperature controller. Data were
analyzed using gnuplot 4.4 by T. J. Kappock. Plasmid DNA was sequenced by the staff
of the Purdue University Genomics Core Facility.
Construction of TdPurE–K41M Construct Plasmid pJK687. The general cloning strategy
is illustrated in Chapter 3 (Figure 3.4) A 0.21 kb primary PCR product containing purE2
was amplified using standard Q5 PCR conditions from template pJK376 (14 ng), using
ODNs 2124 and 2362. The crude product was digested with DpnI and purified using a
Qiagen PCR purification kit. A 0.55 kb primary PCR product containing purE2 was
amplified using standard Q5 PCR conditions from template pJK376 (14 ng), using ODNs
2125 and 2363. The crude product was digested with DpnI and purified using a Qiagen
PCR purification kit. Cross-over PCR product was obtained using standard Q5 PCR
conditions, with a single exception: the annealing time was increased to 1 min, from a
mixture containing primary PCR products (25 ng each) and ODNs 2124 and 2125. The
0.723 kb cross-over product was digested with NdeI and XhoI, and ligated into the same
sites of the destination vector pET23a to yield TdPurE2-K41M expression plasmid
pJK687.
Construction of TdPurE2–K41R Construct Plasmid pJK688. A 0.21 kb primary PCR
product containing purE2 was amplified using standard Q5 PCR conditions from
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template pJK376 (14 ng), using ODNs 2124 and 2364. The crude product was digested
with DpnI and purified using a Qiagen PCR purification kit. A 0.55 kb primary PCR
product containing purE2 was amplified using standard Q5 PCR conditions from
template pJK376 (14 ng), using ODNs 2125 and 2365. The crude product was digested
with DpnI and purified using a Qiagen PCR purification Cross-over PCR product was
obtained using standard Q5 PCR conditions, with a single exception: the annealing time
was increased to 1 min, from a mixture containing primary PCR products (25 ng each)
and ODNs 2124 and 2125.The product was digested with NdeI and XhoI, and ligated into
the same sites of the destination vector pET23a to yield TdPurE2-K41R expression
plasmid pJK688.
Mutant TdPurE2 Overexpression and Isolation. TdPurE2-K41M was overexpressed and
isolated as detailed for wild-type TdPurE2 (Chapter 3).2 TdPurE2-K41R was expressed
using the same TdPurE2 protocol,2 but isolated using the AaPurE1 isolation protocol
(Chapter 3).1 Fresh column media were used for each mutant to avoid any possibility of
cross-contamination. TdPurE2 mutants were concentrated to >3 mg mL-1 with an Amicon
ultrafiltration device containing a YM30 membrane. The protein solution was frozen by
drop-wise addition to liquid N2 and stored at -80 °C.
PurE2-mediated Decarboxylation Assays. Continuous assays of PurE2-mediated CAIR
decarboxylation were performed according to a published method.1 A final volume of 0.6
mL in a masked, 1 cm pathlength cuvette containing 50 mM Tris-HCl, pH 8 and 100 µM
CAIR was incubated at 30 °C for at least 3 min. Reactions were initiated by addition of
either TdPurE2-K41X (12-24 ng, 1.4-2.8 nM [subunits]). The initial velocity of CAIR
decarboxylation to AIR (∆ε260 =8930 M-1 cm-1) was recorded at 260 nm, with a small
background decarboxylation rate subtracted. CAIR was quantitated by endpoint assay
using the same method, except that 50 µg mL−1 TdPurE2 was the enzyme. A unit is
defined as the amount of enzyme that forms 1 µmol of product per minute. Kinetic
constants were determined by fitting the plotted concentration versus velocity (units mg1

!

) to the standard Michaelis-Menten equation.
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PurE2-mediated AIR Carboxylation Assays. Continuous assays of PurE2-mediated AIR
carboxylation were modified from published method for PurE1 NCAIR→CAIR
carboxylation assays.10 Assays were carried out at 23 °C in in a final volume of 0.7 mL,
1x triple buffer (100 mM Tris-HCl, 50 mM MES, 50 mM acetic acid) pH 7.5, 10 mM
MgCl2, 2 mM PEP, 0.5 mM ATP, 10 mM L-aspartate, 1 mM KHCO3, 1.2 units of
pyruvate kinase (477 units mg-1, Sigma P9136), 4 units of H6PurC (isolated by Jesse
Murphy), AIR (100 µM), and varying amounts of TdPurE2s at 10 °C. After preincubation for 3 min, the reaction was initiated by addition of CO2 (variable amounts of a
53 mM solution in water, generated by constant bubbling of gas released from dry ice
through nanopure water at 10 °C) and SAICAR formation monitored directly (∆ε282 =
8607 M-1 cm-1) with a correction for PurE2-independent SAICAR formation. Reactions
containing all assay components except PurE2 were performed to determine a
background velocity for PurE2-independent SAICAR formation.

5.3

Results

Creation of TdPurE2-K41X Mutants. TdPurE-K41R mutants were created to investigate
the role of the class-specific Lys in the TdPurE2 reaction. TdPurE2 mutants could not be
created by standard Quikchange mutagenesis. Therefore, cross-over PCR was employed
to generate both TdPurE2-K41X mutants. Sequencing confirmed that only the intended
mutations were obtained.
Purification of the Recombinant TdPurE2-K41M Mutant. The published isolation
protocol2 was successfully used to isolate TdPurE2-K41M with relatively high specific
activity and purity (Table 5.4 and Figure 5.2).
Purification of the Recombinant TdPurE2-K41R2 Mutant. TdPurE2-K41R could not be
isolated using the published TdPurE2 protocol.2 Unexpectedly, the published AaPurE1
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isolation protocol1 was successfully used to isolate TdPurE2-K41R with relatively high
activity and purity (Table 5.4 and Figure 5.2).
Kinetic Characterization of the TdPurE2-K41R Mutant at pH 8. Kinetic constants (Km
and kcat) for CAIR decarboxylation were obtained for the TdPurE2-K41R mutant to
determine if the diminished activity of K41R is due to binding, catalysis, or both. The
substitution of Lys with either the positively charged Arg or uncharged Met residue does
not abrogate activity in either K41X mutant (Table 5.4 and Figure 5.3). Formation of a
Lys-carbamate is therefore not an obligatory catalytic intermediate in TdPurE2 catalysis.
This does not exclude a role in CO2 enhancement or off-pathway formation of Lyscarbamate in PurE2s.
The Km of TdPurE2-K41R is ~3.6 times higher than TdPurE, indicating that the
Lys→Arg mutation may impair CAIR binding.
The observed TdPurE2-K41R AIR carboxylase activity is very low compared to wildtype TdPurE2 (Table 5.4), but may be an underestimate, because the AIR carboxylase
activity of TdPurE-K41R was likely recorded below its AIR Km. We did not obtain
kinetic parameters for AIR carboxylation by TdPurE2-K41R, but we assume the mutant
should have a higher AIR Km relative to wild-type.

5.4

Discussion

TdPurE2 Activity Does Not Require Formation of a Lys-Carbamate Intermediate. PurE2
acquires CO2 directly from solution and this challenging acquisition was suggested to
require the intermediate formation of an N-carboxylated species on the active site Lys.
Therefore, we tested the hypothesis that formation of a Lys-carbamate is necessary for
PurE2 function by replacing it with residues that are unable to form carbamates. We
found that TdPurE2-K41R retains substantial activity and is capable of both CAIR
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decarboxylation and CAIR generation from AIR and CO2, indicating the formation of a
Lys-carbamate is not an obligatory intermediate in TdPurE2 catalysis.
The Differentially Conserved Residue Appears to Have the Same Role in Both PurE1 and
PurE2. Logic would dictate that the single differentially conserved side chain contact to
the substrate should have different roles in each class. However, the observation that both
EcPurE1-R46K3 and TdPurE2-K41R mutants retain activity suggests that this residue has
a relatively simple role in substrate binding.
The Conserved Basic residue is Not Critical for Catalysis. Perhaps the most
unanticipated result in this chapter is that the non-conservative TdPurE2-K41M mutant
retains substantial activity. We and others have thought that the electrostatic interaction is
important for catalysis, as neither PurE form reacts with the AIR and CAIR nucleosides.
Evidently an interaction between the phosphate moiety of the substrate and a positively
charged residue is not essential for PurE2 function.
Lys Could Have a Role Beyond Simple Substrate Binding. TdPurE2 is from the
mesophilic bacterium T. denticola, which occupies an microaerophilic subgingival niche
that may provide sufficient CO2 for catalysis. While formation of a Lys-carbamate is not
obligatory for TdPurE2 it could be required for PurE2s from other organisms that face
larger challenges in acquiring CO2.
Under limiting CO2 conditions the formation of the Lys-carbamate could either 1) react
directly with the AIR carbanion or 2) serve as a CO2 concentrating mechanism. (Figure
5.1). We consider these possibilities separately, although they are not necessarily
mutually exclusive.
The first case, is analogous to the reaction catalyzed by acetyl-CoA carboxylase, in which
the Lys-carbamate would be attacked by the AIR carbanion to form CAIR. However,
examination of the PurE2•AIR crystal structure (PDB id 3rgg) suggests that a large
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protein rearrangement would have to occur to allow the Lys-carbamate to position itself
within range of AIR C4. There is no evidence for large-scale rearrangement of any PurE
form.
In the second case, formation of a Lys-carbamate as a CO2 concentrating mechanism
could confer an advantage by increasing the local concentration of CO2 under low CO2
conditions. This possibility is directly addressed by the results reported here.
Environmental Constraints May Have Affected the Strict Conservation of Lys in PurE2.
Environmental CO2 availability is influenced by a number of factors including CO2
partial pressure, pH and most important, temperature. CO2 solubility is greatly
diminished at high temperatures (Figure 5.4).
If we assume that PurE2 evolved under warm, anaerobic, conditions on early Earth,11,12
then the presence of abundant CO2 makes the ability to concentrate CO2 superfluous.
However, as primitive organisms left the immediate vicinity of geological CO2 sources
(e.g. deep ocean sediments)14 and as O2 appeared in the atmosphere, the ability to
concentrate CO2 from the environment might have become advantageous.
Under low CO2 conditions, a Lys acquired by mutation might have conferred a selective
advantage in organisms that inherited a purE2 gene. Its strict conservation could be a
consequence of its early evolutionary importance in these low CO2 environments. Lys
could still be required in hot, low CO2 environments, which could explain the retention of
purE2 genes in a small number of mostly thermophilic organisms (Chapter 1).
Increasing the local CO2 concentration would also increase the substrate specificity for
CO2 over the smaller, more reactive O2. In particular, this would have helped PurE2 avoid
the fate of Rubisco, which evolved a catalytic strategy under anaerobic conditions that
has liabilities under the modern oxic conditions (Chapter 6).
Conserved Residues Have Different Roles and Differentially Conserved Residues Do Not.
In PurE, the differentially conserved basic residue appears to have similar roles in ligand
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binding. In contrast, the universally conserved Ser residue appears to have different roles
in PurE1 and PurE2 (Chapter 4). Crystal structures of PurE1 and PurE2 with AIR bound
(PDB id 2fwj and 3rgg) reveal that the Ser makes similar contacts with the substrate and
would appear to have similar roles. Ser is usually associated with donation of a hydrogen
bond, but is also capable of accepting a hydrogen bond, which may occur at low pH in
the PurE2 reaction.
Mutation of a single residue in either PurE class does not generate a PurE of the other
class. We hypothesize that several amino acid changes occurred during the evolutionary
divergence of one class of PurE from another. These are likely to occur in the other three
loops surrounding the substrate: the P loop, the 70s loop, and the P loop from an
neighboring subunit.
!
5.5

Future Directions

!
The presence of a purE2 gene in a small number of thermophilic bacteria may require the
intermediate formation of a Lys carbamate. This can be tested by the expression,
isolation, and characterization of a monofunctional PurE2 from the thermophilic bacteria
discussed in Chapter 1.
!

!
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5.7

Figures and Tables

Figure 5.1 Potential roles for the Lys-carbamate in the PurE2 reaction. (A) The
reversible formation of a Lys-carbamate would increase the local CO2 concentration in
the PurE2 reaction. (B) The AIR C4 carbanion may directly attack the carbonyl of the
Lys-carbamate to form CAIR. (C) The acetyl-CoA carbanion directly attacks the
carbonyl of enzyme-bound carboxybiotin to form malonyl-CoA.
!
Table 5.1 Description of bacterial strains used in this chapter.
Strain
DH5α

Description
F′ φ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1

Source
Lab stock

CC1215

F– ompT gal dcm lon hsdSB(rB- mB-) ΔpurE736::kan
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])

This study

Table 5.2 Oligodeoxynucleotides (ODNs) used in this chapter.a
ODN
Sequence (5’→3’)
2124
TAATACGACTCACTATAGGG
T7 promoter
2125
GCTAGTTATTGCTCAGCGG
T7 terminator
2362
GACACTACATGCTCaGCTGTcaTgTGCGCGGAGCCGATG
TdPurE2-K41M
2363
CATCGGCTCCGCGCAcAtgACAGCtGAGCATGTAGTGTC
TdPurE2-K41M
2364
GACACTACATGCTCaGCTGTTcTATGCGCGGAGCCGATG
TdPurE2-K41R
2365
CATCGGCTCCGCGCATAgAACAGCtGAGCATGTAGTGTC
TdPurE2-K41R
a
Changes in the coding region that deviate from the genomic sequence are in lower case.
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Table 5.3 Description of Plasmids used in this chapter.
Plasmid

Description

Source

pJK687
pJK688

purE2Td-K41M in pET23a
purE2Td-K41R in pET23a

This study
This study

!
!
K41!
!!!!M!!!!R!!!M!
58!
39!
29!
20!

14!

Figure 5.2 SDS-PAGE analysis of isolated TdPurE2-K41X forms. A 12%
polyacrylamide gel was loaded with 3 µg protein per lane: M, Sigma biotinylated marker;
R, TdPurE-K41R; and M, TdPurE-K41M. Note the slightly increased mobility of K41M,
which is presumably due to the deletion of a positively charged residue. Molecular
weights (kDa) are denoted along the left side of the gel.
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Figure 5.3 Saturation curve of TdPurE2-K41R. All data were collected in 50 mM TrisHCl, pH 8 at 30 °C and fit to the Michaelis-Menten equation.
!
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Table 5.4 Kinetic parameters for TdPurE2-K41X mutants at pH 8.
rSAa

rel. kcat/Km b

kcat/Km (M-1 s-1)

kcat (s-1)

Km (µM)

rSA
AIR→CAIR c

TdPurE2d

100

100

7.2 x 106

65

9

100

TdPurE2-K41R

25

74

5.3 x 105

17.5

33

1.2

TdPurE2-K41M

16

nde

nd

nd

nd

nd

a

rSA, % specific activity in the CAIR decarboxylation reaction relative to wild-type TdPurE2 (185 U mg-1)
at 100 µM CAIR, pH 8.0, 30 °C.
b
rel. kcat/Km, % kcat/Km relative to wild-type TdPurE2 (7.2 x 106).
c
rSA, % specific activity in the AIR carboxylase reaction relative to wild-type TdPurE2 (195 U mg-1) at
100 µM CAIR, pH 7.5, 10 °C.
d
Published values.2
e
nd; not determined.

!

Figure 5.4 Dissolved CO2 at various temperatures. CO2 availability in water decreases as
temperature increases. 13
!
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CHAPTER 6 OXYGENASE ACTIVITY IN AN “INACTIVE” MUTANT PURE
FROM TREPONEMA DENTICOLA
!
!
!
6.1

Introduction

In both PurE1 and PurE2, the active site His provides the essential proton to CAIR C4 for
C C bond scission.1–3 However, crystallography shows that the His is not required for
CAIR cleavage. A CAIR-soaked crystal of the completely inactive A. aceti PurE1-H59N
mutant (PDB code 2fwp) contained AIR and CO2 in the active site (Figure 3.2, Chapter
3), mimicking the ternary PurE•AIR•CO2 complex. This crystal structure was the first
evidence that if the proton source is deleted, decarboxylation still occurs, indicating that
PurE1, and possibly the PurE2 His mutants are not truly inactive. In this chapter we
discuss an initial examination of oxygenase activity in the “inactive” TdPurE2-H40N
mutant.
PurE2 and Rubisco are the most abundant CO2-dependent carboxylases on the planet that
do not require substrate activation by ATP or other energy inputs. Why these two
enzymes have such different reactivities with O2 or CO2 is also considered in this chapter.
CO2 Abundance Determines Rubisco Specificity. Most CO2 removed from the
atmosphere is converted to carbohydrates by Rubisco (ribulose-1,5-bisphosphate
carboxylase/oxygenase) during photosynthesis.4 Rubisco has a limited ability to promote
reactions with CO2 over O2, a smaller, more abundant, and more reactive gas, leading to
an “inevitable,” apparently wasteful oxygenase reaction.5 Rubisco generates a reactive
ribulose-1,5-bisphosphate enediol(ate) that attacks either CO2 or O2 (Figure 5.1). Rubisco
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is therefore under pure kinetic control, with reaction outcomes determined by the relative
gas concentrations and ratio of specificity constants (kcat/Km).6
Enzymes, including Rubisco that form a carbanionic intermediate often catalyze reactions
with O2. Oxygenase activity can be the primary7,8 or a secondary (promiscuous)
function.9,10
PurE1 and PurE2 Do Not React with O2. PurE1 has no detectable oxygenase activity.10
This is not surprising, as PurE1 supplies CO2 stoichiometrically from either of its
substrates and scrupulously prevents transiently produced CO2 from escaping the active
site. O2 therefore has no opportunity to gain access to the AIR carbanion intermediate. In
addition, the proximity of the electron-deficient carbon in CO2 may be required to
stabilize the AIR carbanion.
PurE2 encounters essentially the same situation as Rubisco. Unlike PurE1, it must expose
a portion of its active site, including Lys 41 and AIR C4 to small molecules. The “CO2
portal” (Chapter 1) is a consequence of the need for CO2 to enter (or exit) after AIR,
which comprises a large part of the gas-binding site and is probably required to ensure
CO2 binds to PurE2 at all.
Inspection of the proposed mechanisms for PurE2 and Rubisco shows they have a critical
difference in the required sequence of deprotonation and C C bond formation. Rubisco
encounters CO2 after carbon deprotonation. PurE2 flips the sequence of steps in C C
bond formation: its substrate reacts with CO2 before carbon deprotonation (Figure 6.1).!
This apparently fundamental chemical difference in CO2 fixation appears to have been
overlooked. This seemingly small difference in chemical strategy would bypass both
sluggish carbon deprotonation and greatly improve CO2/O2 selectivity
A Catalytically Inactive Form of PurE2 May React with O2. The TdPurE2-H40N mutant,
which lacks the key His, was generated with the expectation that it would be inactive.3
Surprisingly, functional complementation experiments in ∆purK and ∆purE1 E. coli
strains (a functional PurE2 should complement both deletions) revealed that TdPurE2-
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H40N was not simply inactive but caused a growth defect: a ∆purK strain grew worse
than a vector-only control on solid minimal medium. We wanted to know if the growth
defect could be explained if TdPurE2-H40N were somehow capable of destroying AIR,
CAIR, or both.
An X-ray crystal structure of the TdPurE2•AIR binary complex shows good electron
density for all parts of AIR (Figure 6.2A).3 In contrast, a higher-resolution crystal
structure of TdPurE2-H40N co-crystallized with CAIR provides clear evidence that the
aminoimidazole ring is disrupted by the “inactive” mutant TdPurE2-H40N (Figure 6.2B).
The ligand contains an acyclic moiety of ≥3 non-H atoms that were tentatively modeled
as 5-phosphoribofuranosylurea (PRU, Figure 6.2C).
PRU is not the only ligand consistent with the observed electron density, but it is
anticipated to be more stable than alternatives that fit in the difference electron density
maps. While the oxygen atom is not well modeled, it is necessary to avoid highly labile
structures such as am iminoamine substituent (R5P-NHCH=NH2+). We can however,
infer that the terminal atom is a hydrogen bond donor based on proximity to backbone
carbonyls.
This chapter details the discovery of a very low level of oxygenase activity in the
“inactive” PurE2 mutant, TdPurE2-H40N.

6.2 Materials and Methods
!
Materials. Chemicals were obtained from Sigma or Fisher in the highest purity available
unless otherwise noted. CAIR was prepared as described in Chapter 2.11 AIR was
generated enzymatically from CAIR using TdPurE2 and quantitated by Bratton-Marshall
assay as described previously.3 Phenyl Sepharose CL-6B was obtained from Sigma.
Hydroxyapatite (BioGel®-HT) and Bradford reagent were obtained from Bio-Rad. PD10 desalting columns were obtained from GE Health Care.
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Methods. Protein concentrations were determined by the method of Bradford with bovine
serum albumin as the standard.12 Small-scale centrifugation steps were performed using
an Eppendorf 5424 centrifuge. All other centrifugation steps were performed using a
Beckman Avanti J-E centrifuge with a JLA-10.5 or JA-20 rotor. Cell disruption was
performed by sonication using a Fisher Scientific Dismembrator 550 at 25% output for 3
cycles (1 min each with 1 min cooling periods in-between) at 4 °C. Spectroscopic
measurements were recorded on a Varian CARY-100 UV/Vis spectrophotometer
thermostated by a Cary Dual Peltier Accessory temperature controller.
PurE1 and PurE2 Overexpression and Isolation. AaPurE1 and AaPurE1-H59N were
overexpressed and isolated as detailed for wild-type AaPurE1 (Chapter 3).1 TdPurE2 and
TdPurE2-H40N were overexpressed and isolated as detailed for wild-type TdPurE2
(Chapter 3).3
Aerobic AIR Destruction Assays. A reaction mixture (0.55 mL total) contained 50 µM
AIR in 50 mM Tris-HCl (pH 8.0). The reaction mixture was incubated at room
temperature for 3 min prior the addition of AaPurE1 (60 µM, 620 µg), TdPurE2 (60 µM,
564 µg), AaPurE1-H59N (60 µM, 620 µg), or TdPurE2-H40N (60 µM, 564 µg). Controls
lacking enzyme and containing BSA (1 mg mL-1) were performed in parallel. Aliquots
(0.1 mL) were removed at 0 min, 1 h, 3h, 5h, and 8 h and immediately quenched by
addition to 0.2 mL of pre-mixed 665 mM potassium phosphate in 10% TCA (w/v) and
NaNO2 0.05% (w/v). Reactions were then derivatized by the Bratton-Marshall Assay,9
which is highly specific for diazotizable amines, and the absorbance spectra recorded.
Anaerobic AIR Destruction Assays. These experiments were performed in an anaerobic
chamber (N2 atmosphere, ≤5 ppm O2) but were otherwise identical to above protocol for
aerobic AIR destruction assay. After Bratton-Marshall derivatization samples were
removed from the anaerobic chamber and absorbance spectra were recorded.

!

188
6.3

Results

TdPurE2-H40N has detectable oxygenase activity. In all of our experiments, no evidence
was obtained for any Bratton-Marshall reactive species other than AIR. AIR
concentrations decreased in the presence of TdPurE2-H40N, with a half-life of about 4 h.
No decomposition was observed in reaction mixtures prepared without enzyme (not
shown), in the presence of small amounts of either AaPurE1 (6.7 nM, 68 ng) or TdPurE2
(1.4 nM, 13 ng) (not shown), BSA, AaPurE1-H59N (±O2), or TdPurE2-H40N maintained
in an anaerobic environment (Figure 6.3). We concluded that TdPurE2-H40N has a
function not previously described: it catalyzes the irreversible, O2-dependent destruction
of AIR to an unknown product. This low level of AIR oxygenase activity is the only
known reaction performed by TdPurE2-H40N.
!
6.4

Discussion

PurE1 and PurE2 Do Not Have Detectable Oxygenase Activity. AIR is an inhibitor of
PurE1,13 but binds in the same orientation as in PurE2. PurE1 was previously shown to
lack oxygenase activity10 and our results confirm this. Neither AaPurE1 nor AaPurE1H59N had detectable oxygenase activity when incubated with AIR. This is likely due to
one of two things: either 1) PurE1 disallows access of O2 to AIR or 2) an AIR carbanion
is only formed when AIR•CO2, delivered by NCAIR or CAIR, are confined together. In
addition, a crystal structure of AaPurE1-H59N•AIR•CO2 (PDB code 2fwp) contains no
additional room for an O2 to enter the vicinity of AIR.
The PurE2 reaction with CO2 is reversible, but the proposed reaction with O2 involves
several irreversible steps. The first three steps are similar to the Rubisco oxygenation
reaction, with the aminoimidazole ring opening being the first irreversible step. This is
followed by a second hydrolysis step, which closely resembles 2′-deoxy-PRU formation
in damaged DNA8 to produce diformamide and PRU (Figure 6.4).
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In its solvent-exposed active site, Rubisco generates a reactive carbanion that irreversibly
reacts with either O2 or CO2. PurE2, like Rubisco, generates a reactive carbanion in a
solvent-exposed active site but catalyzes a reversible reaction with CO2. Although we
cannot detect any reaction with O2, it is possible that active PurE2 still allows O2 to react
with the AIR carbanion, but acts to prevent the subsequent irreversible steps including
ring opening which would be required to detect products of the oxygenase reaction
(boxed steps in Figure 6.4). Aminoimidazole ring opening would require a sterically
demanding rearrangement within the rigid PurE2 active site, which cannot accommodate
NCAIR or other analogs.14
The Critical Active Site His May Shield the AIR Carbanion. The “inactive” TdPurE2H40N has oxygenase activity that has never been detected in wild-type TdPurE2 or any
other PurE2 form. Wild-type PurE2 contains the general acid/general base His in the
active site, which is located near the site of AIR carbanion formation at AIR C4. This
residue could also serve to shield the reactive AIR carbanion from O2, an effect lost when
Asn replaces His. Asn is smaller and cannot donate a proton, although it could provide a
hydrogen bond; this difference may be enough to allow a slow reaction with O2.
Our working hypothesis for CO2 selectivity, for both PurE1 and PurE2, is that the AIR
carbanion does not form in the absence of CO2. The AIR•CO2 complex may be required
to stabilize the AIR carbanion; therefore, without CO2 present, AIR does not form the
reactive intermediate and is unavailable to react with O2 (Figure 6.1).
Did PurE1 and PurE2 Evolve in an Anaerobic Environment with Accidental and Inherent
Selectivity for CO2? PurE1, PurE2, and Rubisco developed in an anoxic environment.
Modern Rubisco cannot suppress oxygenase activity without the support of carbon
concentrating mechanisms within carboxysomes of CO2 fixing bacteria15 and CO2
concentrating accessory systems in higher plants (C4 and crassulacean acid metabolism).
All of these require specialized anatomy or extra catalysts that support CO2 fixation. The
complete lack of associated carbon concentration mechanisms suggests that PurE1 and
PurE2 always had the ability to selectively react with CO2 over O2.
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Chemical considerations and phylogenetic analyses do not indicate if PurE1 evolved
from PurE2 or vice versa (Chapter 1). Results presented in this thesis deepen the mystery
of which came first, as it is clear that a point mutant in the differentially conserved 40s
loop has no functional significance. If an “ambidextrous” bifunctional PurE1/PurE2 is
never discovered, it will be difficult to reconstruct the series of events that gave rise to
the modern stark functional difference between PurE1 and PurE2.
PurE1 emerged either 1) in high-CO2 conditions as a way to exploit abundant NCAIR
forming spontaneously from AIR or 2) in low–CO2 conditions, to exploit NCAIR
produced by a serendipitous and likely promiscuous, activity of a PurK progenitor. In
either case, PurE1 did not need to acquire selectivity for CO2; its dependence on NCAIR
ensured CO2 would be available to shield the AIR carbanion. However, PurE2 may well
have acquired increased CO2 selectivity as the atmospheric O2 levels on early Earth
increased. The strict conservation of Lys in PurE2 (discussed in Chapter 5), suggests that
it might have once served as a CO2 concentrating mechanism, a useful feature under
increasing O2.
Is PurE Class “Choice” a Result of Positive Selection or is it an Accident? CO2 is a
membrane permeable gas produced by decarboxylations throughout cellular metabolism
in both anaerobes and aerobes. Most early anaerobic environments probably contained
abundant CO2. However, under modern aerobic conditions, CO2 produced from
metabolism must be captured as bicarbonate or it will escape to the environment. This
phenomenon explains why carbonic anhydrase is essential for aerobic bacteria and under
low CO2 conditions. Aerobic bacteria lacking carbonic anhydrase cannot efficiently
recycle CO2 so will starve for bicarbonate;16,17 which is important to support essential
subsequent anabolic processes such as fatty acid, amino acid, and nucleotide
biosynthesis.17 Carbonic anhydrase accelerates the spontaneous hydration of CO2 to
bicarbonate by ~105 fold. Carbonic anhydrase does not exist in most anaerobes including
archea and microbes containing a PurE2.3,18
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Like PurE2, systems containing PurE1-only simply require high CO2 (Chapter 1).
Selection of a PurE1+PurK system instead relies on bicarbonate as the source of CO2 for
purine biosynthesis. This system may place a burden on carbonic anhydrase to ensure
sufficient CO2 is recycled to support several high flux pathways. Selection of PurE2
under an anaerobic environment may confer a selective advantage. Because PurE2 can
directly use CO2, this would uncouple the demand for bicarbonate from the high flux
purine pathway and lessen competition for available bicarbonate with other high flux
pathways.

6.5

Future work

!
A TdPurE2-H40N crystal structure with authentic PRU nucleoside bound is a good first
step to test the hypothesis that crystalline TdPurE2-H40N produces PRU.
Synthetic PRU could also be used as a standard to unambiguously identify the AIR
oxygenase product in mutants with a higher oxygenase activity.

!

192
6.6

References

1.

Constantine, C. Z., Starks, C. M., Mill, C.P., Ransome, A. E., Karpowicz, S.J.,
Francois, J.A., Goodman, R.A. and Kappock, T. J. Biochemical and Structural
Studies of N5 -Carboxyaminoimidazole Ribonucleotide Mutase from the
Acidophilic Bacterium Acetobacter aceti. Biochemistry 45, 8193–8208 (2006).

2.

Hoskins, A. A., Morar, M., Kappock, T. J., Mathews, I. I., Zaugg, J. B., Barder, T.
E., Peng, P., Okamoto, A., Ealick, S. E. and Stubbe, J. N5-CAIR mutase: Role of a
CO2 Binding Site and Substrate Movement in Catalysis. Biochemistry 46, 2842–
2855 (2007).

3.

Tranchimand, S., Starks, C. M., Mathews, I. I., Hockings, S. C. and Kappock, T. J.
Treponema denticola PurE is a bacterial AIR Carboxylase. Biochemistry 50, 4623–
4637 (2011).

4.

Ellis, R. J. The Most Abundant Protein in the World. Trends Biochem. Sci. 4, 241–
244 (1979).

5.

Lorimer, G. H. and Andrews, T. J. Plant Photorespiration—An Inevitable
Consequence of the Existence of Atmospheric Oxygen. Nature 243, 359–360
(1973).

6.

Laing, W. A., Ogren, W. L. and Hageman, R. H. Regulation of Soybean Net
Photosynthetic CO2 Fixation by the Interaction of CO2, O2, and Ribulose 1,5Diphosphate Carboxylase. Plant Physiol. 54, 678–685 (1974).

7.

Kahn, K., Serfozo, P. and Tipton, P. A. Identification of the True Product of the
Urate Oxidase Reaction. J. Am. Chem. Soc. 119, 5435–5442 (1997).

8.

Fetzner, S. and Steiner, R. A. Cofactor-Independent Oxidases and Oxygenases.
Appl. Microbiol. Biotechnol. 86, 791–804 (2010).

9.

Hixon, M., Sinerius, G., Schneider, A., Walter, C., Fessner, W. and Schloss, J. V.
Quo Vadis Photorespiration: A Tale of Two Aldolases. FEBS Lett. 392, 281–284
(1996).

10.

Abell, L. M. and Schloss, J. V. Oxygenase Side Reactions of Acetolactate
Synthase and Other Carbanion-forming Enzymes. Biochemistry 30, 7883–7887
(1991).

11.

Sullivan, K. L., Huma, L. C., Mullins, E. a, Johnson, M. E. and Kappock, T. J.
Metal Stopping Reagents Facilitate Discontinuous Activity Assays of the de novo
Purine Biosynthesis Enzyme PurE. Anal. Biochem. 452, 43–45 (2014).

!

193
12.

Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram
Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal.
Biochem. 72, 248–254 (1976).

13.

Meyer, E. Two New Activities and a New Intermediate in the Purine Pathway.
Ph.D. Thesis, Massachusetts Institute of Technology (1996).

14.

Thoden, J. B., Holden, H. M., Paritala, H. and Firestine, S. M. Structural and
Functional Studies of Aspergillus clavatus N5-Carboxyaminoimidazole
Ribonucleotide Synthetase . Biochemistry 49, 752–760 (2010).

15.

Shively, J. M., van Keulen, G. and Meijer, W. G. Something from Almost
Nothing: Carbon Dioxide Fixation in Chemoautotrophs. Annu. Rev. Microbiol. 52,
191–230 (1998).

16.

Burghout, P., Cron, L. E., Gradstedt, H., Quintero, B., Simonetti, E., Bijlsma, J. J.
E., Bootsma, H. J. and Hermans, P. W. M. Carbonic Anhydrase is Essential for
Streptococcus pneumoniae Growth in Environmental Ambient Air. J. Bacteriol.
192, 4054–4062 (2010).

17.

Merlin, C., Masters, M., McAteer, S. and Coulson, A. Why is Carbonic Anhydrase
Essential to Escherichia coli? J. Bacteriol. 185, 6415–6424 (2003).

18.

Smith, K. S., Jakubzick, C., Whittam, T. S. and Ferry, J. G. Carbonic anhydrase is
an Ancient Enzyme Widespread in Prokaryotes. Proc. Natl. Acad. Sci. U. S. A. 96,
15184–15189 (1999).

!

194

!

6.7

Figures and Tables
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Figure 6.1 Rubisco and PurE2 reactions. (A) Rubisco carboxylase and oxygenase
activities begin with the deprotonation of RuBP C3 to generate the reactive endiol(ate).
This reactive intermediate can then react with either CO2 or O2. (B) PurE2 mediated AIR
carboxylation begins with formation of the AIR•CO2 ternary complex followed by
deprotonation to form CAIR.
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Figure 6.2 Destruction of AIR by the “inactive” mutant TdPurE2-H40N. (A) Crystal
structure (1.82 Å resolution) of TdPurE2 bound to AIR (PDB code 3RGG).3 An electron
density map (final 2Fo − Fc, blue mesh) is shown for nonprotein atoms with a 1.2σ
contour and 1.8 Å carve. The Fo−Fc map is contoured at +3σ (green mesh) and –3σ (red
mesh). (B) Crystal structure (1.45 Å resolution) of TdPurE2-H40N bound to a CAIRderived nucleotide modeled as PRU. Electron density maps are drawn as in panel A. (C)
AIR and candidate PRU structures for the ligand in panel B. (T. J. Kappock and I. I.
Mathews, unpublished observations).
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Table 6.1 Description of bacterial strains used in this chapter.
Strain
DH5 α

Description
F′ φ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1

Source
Lab stock

CC1215

F– ompT gal dcm lon hsdSB(rB- mB-) ΔpurE736::kan
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])

Chapter 3
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Table 6.2 Previously published plasmids used in this chapter.
Plasmid

Description

Source

Protein encoded

pJK175
pJK283
pJK376
pJK392

purE1Aa in pET23a
purE1Aa-H59N in pET23a
purE2Td in pET23a
purE2Td-H40N in pET23a

1

AaPurE1
AaPurE1-H59N
TdPurE2
TdPurE2-H40N

!
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3
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Figure 6.3! Decomposition of AIR (initially 50 µM) by 60 µM of the indicated enzyme
form. The red dotted line is a fit of the aerobic TdPurE2-H40N data to a first-order decay
function (half-life of 4 h), demonstrating that AIR is a substrate for a very slow
oxygenase reaction.
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Figure 6.4 Oxygenase reactions of Rubisco and PurE2. Electron-pushing mechanism for
the Rubisco ribulose-1,5-bisphosphate (RuBP) oxygenase reaction and electron-pushing
mechanism for the PurE2 AIR oxygenase reaction. PurE2 is reversible and may react
with O2 until a steric hindrance is imposed by the PurE2 active site (boxed in the dotted
line above).
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APPENDIX

Figure A.1 Fluorescence titrations with wild-type AaPurE. Excitation wavelength was
295 nm. Citrate titrations were performed with 0.64 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are
given in Table 3.7. AIR titrations were performed with 0.31 µM [subunit] in 50 mM TrisHCl, pH 8.0 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon
AIR addition.
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Figure A.2 Fluorescence titrations with AaPurE-H59N. Excitation wavelength was 295
nm. Citrate titrations were performed with 0.68 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR
titrations were both performed with 0.38 µM [subunit] in 50 mM Tris-HCl, pH 8.0 at 30
°C and data were fit to equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence
emission spectra with increasing amounts of citrate. (B) Recorded emission at 320 nm
upon citrate addition. (C) Fluorescence emission spectra with increasing amounts of AIR.
(D) Recorded emission at 320 nm upon AIR addition. (E) Fluorescence emission spectra
with increasing amounts of CAIR. (F) Recorded emission at 320 nm upon CAIR
addition.
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Figure A.3 Fluorescence titrations with AaPurE-H59N,Y154F. Excitation wavelength
was 295 nm. Citrate titrations were performed with 1.91 µM [subunit] in 50 mM
Potassium acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR
and CAIR titrations were performed with 0.80 µM [subunit] and 0.10 µM [subunit] in 50
mM Tris-HCl, pH 8.0 at 30 °C and data were fit to equation 3.3. Kd values are given in
Table 3.7. (A) Fluorescence emission spectra for titration with increasing amounts of
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon
AIR addition. (E) Fluorescence emission spectra with increasing amounts of CAIR. (F)
Recorded emission at 320 nm upon CAIR addition.
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Figure A.4 Fluorescence titrations with AaPurE-Y154F. Excitation wavelength was 295
nm. Citrate titrations were performed with 1.24 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations
were performed with 0.50 µM [subunit] in 50 mM Tris-HCl, pH 8.0 at 30 °C and data
were fit to equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission
spectra with increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate
addition. (C) Fluorescence emission spectra with increasing amounts of AIR. (D)
Recorded emission at 320 nm upon AIR addition.
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Figure A.5 Fluorescence titrations with AaPurEwwf. Excitation wavelength was 295 nm.
Citrate titrations were performed with 0.63 µM [subunit] in 50 mM Potassium acetate,
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are given in
Table 3.7. AIR titrations were performed with 0.63 µM [subunit] in 50 mM Tris-HCl, pH
8 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of citrate. (B)
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition.
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Figure A.6 Fluorescence titrations with AaPurEwwf-Y154F. Excitation wavelength was
295 nm. Citrate titrations were performed with 0.59 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are
given in Table 3.7. AIR titrations were performed with 0.59 µM [subunit] in 50 mM TrisHCl, pH 8 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon
AIR addition.
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Figure A.7 Fluorescence titrations with AaPurEwwf-H59N. Excitation wavelength was
295 nm. Citrate titrations were performed with 0.74 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR
titrations were performed with 0.59 µM [subunit] and 0.59 µM [subunit] in 50 mM TrisHCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in Table 3.7.
(A) Fluorescence emission spectra for titration with increasing amounts of citrate. (B)
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition.
(E) Fluorescence emission spectra with increasing amounts of CAIR. (F) Recorded
emission at 320 nm upon CAIR addition.
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Figure A.8 Fluorescence titrations with AaPurEwwf-H59N,Y154F. Excitation wavelength
was 295 nm. Citrate titrations were performed with 0.89 µM [subunit] in 50 mM
Potassium acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR
and CAIR titrations were performed with 0.59 µM [subunit] and 0.59 µM [subunit] in 50
mM Tris-HCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in
Table 3.7. (A) Fluorescence emission spectra for titration with increasing amounts of
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon
AIR addition. (E) Fluorescence emission spectra with increasing amounts of CAIR. (F)
Recorded emission at 320 nm upon CAIR addition.
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Figure A.9 Fluorescence titrations with AaPurEfww. Excitation wavelength was 295 nm.
Citrate titrations were performed with 1.49 µM [subunit] in 50 mM Potassium acetate,
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations were
performed with 0.56 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were fit to
equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission spectra with
increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate addition. (C)
Fluorescence emission spectra with increasing amounts of AIR. (D) Recorded emission at
320 nm upon AIR addition.
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Figure A.10 Fluorescence titrations with AaPurEfww-Y154F. Excitation wavelength was
295 nm. Citrate titrations were performed with 1.13 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations
were performed with 0.87 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were
fit to equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission spectra
with increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate
addition. (C) Fluorescence emission spectra with increasing amounts of AIR. (D)
Recorded emission at 320 nm upon AIR addition.
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Figure A.11 Fluorescence titrations with AaPurEfww-H59N. Excitation wavelength was
295 nm. Citrate titrations were performed with 0.65 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR
titrations were performed with 0.65 µM [subunit] and0.65 µM [subunit] in 50 mM TrisHCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in Table 3.7.
(A) Fluorescence emission spectra for titration with increasing amounts of citrate. (B)
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition.
(E) Fluorescence emission spectra with increasing amounts of CAIR. (F) Recorded
emission at 320 nm upon CAIR addition.
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Figure A.12 Fluorescence titrations with AaPurEfww-H59N,Y154F. Excitation
wavelength was 295 nm. Citrate titrations were performed with 2.11 µM [subunit] in 50
mM Potassium acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2.
AIR and CAIR titrations were performed with 0.71 µM [subunit] and 0.71 µM [subunit]
in 50 mM Tris-HCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given
in Table 3.7. (A) Fluorescence emission spectra for titration with increasing amounts of
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon
AIR addition. (E) Fluorescence emission spectra with increasing amounts of CAIR. (F)
Recorded emission at 320 nm upon CAIR addition.
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Figure A.13 Fluorescence titrations with AaPurEwyf. Excitation wavelength was 295 nm.
Citrate titrations were performed with 2.17 µM [subunit] in 50 mM Potassium acetate,
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are given in
Table 3.7. AIR titrations were performed with 0.89 µM [subunit] in 50 mM Tris-HCl, pH
8 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of citrate. (B)
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition.
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Figure A.14 Fluorescence titrations with AaPurEwyf-H59N. Excitation wavelength was
295 nm. Citrate titrations were performed with 2.98 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR
titrations were performed with 1.00 µM [subunit] and 1.00 µM [subunit] in 50 mM TrisHCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in Table 3.7.
(A) Fluorescence emission spectra for titration with increasing amounts of citrate. (B)
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition.
(E) Fluorescence emission spectra with increasing amounts of CAIR. (F) Recorded
emission at 320 nm upon CAIR addition.
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Figure A.15 Fluorescence titrations with AaPurEfwf. Excitation wavelength was 295 nm.
Citrate titrations were performed with 0.12 µM [subunit] in 50 mM Potassium acetate,
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations were
performed with 0.29 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were fit to
equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission spectra with
increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate addition. (C)
Fluorescence emission spectra with increasing amounts of AIR. (D) Recorded emission at
320 nm upon AIR addition.
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Figure A.16 Fluorescence titrations with AaPurEfwf-H59N. Excitation wavelength was
295 nm. Citrate titrations were performed with 0.79 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR
titrations were performed with 0.79 µM [subunit] and 0.79 µM [subunit] in 50 mM TrisHCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in Table 3.7.
(A) Fluorescence emission spectra for titration with increasing amounts of citrate. (B)
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition.
(E) Fluorescence emission spectra with increasing amounts of CAIR. (F) Recorded
emission at 320 nm upon CAIR addition.
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Figure A.17 Fluorescence titrations with AaPurEfwf-H59N,Y154F. Excitation
wavelength was 295 nm. Citrate titrations were performed with 1.65 µM [subunit] in 50
mM Potassium acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2.
AIR and CAIR titrations were performed with 1.01 µM [subunit] and 1.01 µM [subunit]
in 50 mM Tris-HCl, pH 8 at 30 °C and data for the AIR titration was fit to equation 3.3.
Kd values are given in Table 3.7. (A) Fluorescence emission spectra for titration with
increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate addition. (C)
Fluorescence emission spectra with increasing amounts of AIR. (D) Recorded emission at
320 nm upon AIR addition. (E) Fluorescence emission spectra with increasing amounts
of CAIR. (F) Recorded emission at 320 nm upon CAIR addition.
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Figure A.18 Fluorescence titrations with AaPurEfwf -Y154F. Excitation wavelength was
295 nm. Citrate titrations were performed with 2.01 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations
were performed with 0.61 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were
fit to equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission spectra
with increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate
addition. (C) Fluorescence emission spectra with increasing amounts of AIR. (D)
Recorded emission at 320 nm upon AIR addition.
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Figure A.19 Fluorescence titrations with AaPurEfwf -Y154L. Excitation wavelength was
295 nm. Citrate titrations were performed with 2.62 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations
were performed with 0.69 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were
fit to equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission spectra
with increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate
addition. (C) Fluorescence emission spectra with increasing amounts of AIR. (D)
Recorded emission at 320 nm upon AIR addition.
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Figure A.20 Fluorescence titrations with AaPurEfyw. Excitation wavelength was 295 nm.
Citrate titrations were performed with 9.85 µM [subunit] in 50 mM Potassium acetate,
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are given in
Table 3.7. AIR titrations were performed with 4.25 µM [subunit] in 50 mM Tris-HCl, pH
8 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of citrate. (B)
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition.
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Figure A.21 Fluorescence titrations with AaPurEfyw-H59N. Excitation wavelength was
295 nm. Citrate titrations were performed with 10.66 µM [subunit] in 50 mM Potassium
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR
titrations were performed with 5.21 µM [subunit] and 5.21 µM [subunit] in 50 mM TrisHCl, pH 8 at 30 °C and data were fit to equation 3.2. Kd values are given in Table 3.7.
(A) Fluorescence emission spectra with increasing amounts of citrate. (B) Recorded
emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra with
increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition.
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